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Abstract
Health care is a complex system and it is therefore expected to behave in a non-linear
manner. It is important for the delivery of health interventions to patients that the
best possible analysis of available data is undertaken. Many of the conventional
models used for health care data are linear. This research compares the performance
of linear models with non-linear models for two health care data sets of complex
interventions.
Logistic regression, latent class analysis and a classiﬁcation artiﬁcial neural network
were each used to model outcomes for patients using data from a randomised con-
trolled trial of a cognitive behavioural complex intervention for non-speciﬁc low back
pain. A Cox proportional hazards model and an artiﬁcial neural network were used
to model survival and the hazards for diﬀerent sub-groups of patients using an ob-
servational study of a cardiovascular rehabilitation complex intervention.
The artiﬁcial neural network and an ordinary logistic regression were more accurate
in classifying patient recovery from back pain than a logistic regression on latent
class membership. The most sensitive models were the artiﬁcial neural network and
the latent class logistic regression. The best overall performance was the artiﬁcial
neural network, providing both sensitivity and accuracy.
Survival was modelled equally well by the Cox model and the artiﬁcial neural net-
work, when compared to the empirical Kaplan-Meier survival curve. Long term
survival for the cardiovascular patients was strongly associated with secondary pre-
vention medications, and ﬁtness was also important. Moreover, improvement in
ﬁtness during the rehabilitation period to a fairly modest `high ﬁtness' category was
as advantageous for long-term survival as having achieved that same level of ﬁtness
by the beginning of the rehabilitation period. Having adjusted for ﬁtness, BMI was
not a predictor of long term survival after a cardiac event or procedure.
The Cox proportional hazards model was constrained by its assumptions to produce
hazard trajectories proportional to the baseline hazard. The artiﬁcial neural network
model produced hazard trajectories that vary, giving rise to hypotheses about how
the predictors of survival interact in their inﬂuence on the hazard.
The artiﬁcial neural network, an exemplar non-linear model, has been shown to
match or exceed the capability of conventional models in the analysis of complex
health care data sets.
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Chapter 1
Introduction
1.1 Complex interventions
A complex intervention is conventionally deﬁned as an intervention that has many
parts which may work independently or interdependently (Campbell et al. [2000]).
This thesis utilises data from two complex interventions which are described in detail
in Chapter 3. This chapter introduces complex interventions and describes how they
diﬀer from other intervention types and how their development, implementation and
evaluation are conducted using insights from complex adaptive systems concepts.
It is now accepted that many health care interventions are complex (Craig
et al. [2008], Emsley et al. [2010], Lancaster et al. [2010], Burton [2012]). The con-
trast with more simple interventions, such as a drug given to treat a single condition
is that in clinical trials to establish eﬃcacy, most sources of variability can be iden-
tiﬁed and controlled for, either directly or by randomisation (Burton [2012], Hawe
et al. [2004]). There is no sharp boundary between simple and complex interventions
(Craig et al. [2008]). The greater the diﬃculty in deﬁning precisely what exactly the
active ingredients of an intervention are and how they relate to each other, the
greater the likelihood that you are dealing with a complex intervention (Craig et al.
[2008]). Some highly complex interventions may comprise a set of individually com-
plex interventions, such as the Sure Start intervention to support families with young
children in deprived communities (Craig et al. [2008]).
The Medical Research Council identiﬁes 5 factors which make an intervention
complex:
• Number of interacting components within the experimental and control inter-
ventions
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• Number and diﬃculty of behaviours required by those delivering or receiving
the intervention
• Number of groups or organisational levels targeted by the intervention
• Number and variability of outcomes
• Degree of ﬂexibility or tailoring of the intervention permitted
(Craig et al. [2008]).
In addition to interventions, health problems themselves can have diﬀerent
levels of complexity. Campbell et al. (Campbell et al. [2007]) illustrate this with the
example of cardiovascular disease: High death rates in people with cardiovascular
disease are aﬀected by:
• Disease-Atherosclerosis, risk factors (cholesterol, blood pressure, smoking), co-
morbidity
• Patient-Beliefs about lifestyle, adherence to treatment, and symptoms
• Practitioner-Accessibility, prescribing practices, practices in health promotion
• Health service-Availability of eﬀective preventive and therapeutic care
• Policy-Policies on preventive services (tobacco control, diet, exercise, etc)
• Social context-Socioeconomic status, social support.
It is important to recognise that some health problems can occur at multiple levels,
if a decision to intervene at one level could be cancelled out or promoted by actions
at other levels. For example, improving practitioners' health promotion practices
may have no eﬀect on patients' health behaviour if social and environmental factors
obstruct response. One example of the importance of context was found in a trial of
a secondary prevention programme for cardiovascular disease. Interviews and focus
groups showed that because patients viewed heart attacks as self-limited episodes,
they were less willing to adopt long term lifestyle changes. It also showed that the
ability of practice nurses to provide skilled continuity of care was aﬀected by both
their lack of training and by their low status in the primary health care team. The
understanding of complex interventions include issues of service and organisation
and the frameworks of understanding that inform the behaviour of healthcare users;
these are features of the interactions between intervention and environment that
characterise complex interventions (Oakley et al. [2006]). This connection between
levels means that sometimes the psychological domain is targeted to bring relief
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to physical suﬀering, such as a cognitive behavioural approach to angina (Lewin
et al. [2002]) or back pain (Lamb et al. [2010b]), or a cardiovascular rehabilitation
intervention, which typically includes both psychological support and appropriate
medication, exercise, and education (Turner [2007]). Since there are, by deﬁnition,
many parts which may work independently or interdependently in a complex inter-
vention, it can be diﬃcult to design such an intervention such that it can be tested
for eﬃcacy and the successful parts or combinations identiﬁed. To this end, a panel
of experts produced a framework for the design and evaluation of complex inter-
vention in health in the year 2000 (Campbell et al. [2000]). They deﬁne a 5-stage
protocol, which need not be linear, where at each stage the ﬁndings may inform the
next or a reiteration of the previous stage. The 5 stages were:
• The preclinical stage for exploration of relevant theory
• Phase I modelling stage, for identifying the components of the intervention and
their modes of eﬀect.
• Phase II an exploratory trial where the insights from theory and modelling are
tested
• Phase III the deﬁnitive randomised controlled trial, testing the complex inter-
vention against an appropriate alternative
• Phase IV, the long-term implementation.
This framework was later criticised to be too close to the framework for a drug trial,
which is usually a simple intervention. The framework was reviewed and updated
in 2008 as experience of evaluating complex interventions accumulated and interest
in the methodology had grown (Craig et al. [2008]). Several papers had identiﬁed
limitations in the framework, recommending, for example, greater attention to early
phase piloting and development work, a less linear model of evaluation process, in-
tegration of process and outcome evaluation, recognition that complex interventions
may work best if they are tailored to local contexts rather than completely stan-
dardised, and greater use of the insights provided by the theory of complex adaptive
systems (Craig et al. [2008]). However, the 2000 framework provides a useful way
to organise an introduction to complex interventions and the issues that surround
them.
Preclinical or theory phase
In the preclinical stage, the relevant theory is explored in order to inform the design
and select the intervention, to develop a clear hypothesis and to identify major
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confounders and strategic design issues. Identifying evidence that an intervention
might have the desired eﬀect will include taking relevant evidence from outside health
sciences (e.g. theory of organisational change) and may lead to adjustment of the
hypothesis. Preliminary work can include simulation, qualitative testing through
focus groups, etc. and case studies. Qualitative research can be used to ascertain the
mechanism of eﬃcacy and barriers to be overcome. A range of research methods can
be used to collect evidence: systematic literature reviews, epidemiological research,
and expert opinion to quantify the extent of the problem and identify the groups most
at risk and the key modiﬁable risks. For example, reasons for delayed presentation
by patients with symptoms of lung cancer are poorly understood, so epidemiological
and qualitative research is being undertaken to identify and quantify determinants
and targets that may be amenable to intervention (Campbell et al. [2007]).
Conceptual modelling or mapping can clarify the mechanisms by which an in-
tervention might achieve its aims. The process involves mapping out the mechanisms
and pathways proposed to lead from the intervention to the desired outcomes, then
adding evidence and data to this map. Modelling of the intervention both depends
on, and informs, understanding of the underlying problem. The intervention must
engage the target group and aﬀect pathways amenable to change that are identiﬁed
as important to the problem (Campbell et al. [2007]).
The term 'mediator' is commonly used for a variable on a causal pathway,
and 'moderator' for a variable which modiﬁes the strength of part or all of a causal
pathway. Complex interventions have, by deﬁnition, multiple components and are
therefore characterised by complex treatment eﬀect mechanisms with multiple medi-
ators, with the possibility of moderators such as the background characteristics and
environment of the patient.(Emsley et al. [2010]).
Optimising combinations of components in the intervention is not a straight-
forward task and there is no consensus on how to achieve this. Once a conceptual
model has been formed, some complex interventions may be amenable to simulations
or carefully controlled experimental studies outside the normal clinical setting such
as simulated patients. In one study, simulated patients were used to test the inter-
vention with general practitioners, which identiﬁed the likely outcomes for a range
of patients and allowed general practitioners to comment on how the intervention
could be improved. Simulation can also be used to explore the eﬀect of changes in
dose on response, and changes in contextual inﬂuences. (Campbell et al. [2007]).
4
Phase I or Modelling phase
The second stage is Phase I when the intervention and the underlying mechanism
by which they will inﬂuence the outcome are identiﬁed. The purpose of this phase is
to provide evidence that prediction of the relation between the components and the
interaction between them can be made. Clearly, there is some overlap with the pre-
vious phase in methodologies used to achieve this; simulated patients, for example,
could be used in this phase, too. Preliminary surveys, focus groups and case studies
can be used to deﬁne components of the complex intervention and detailed descrip-
tions of the setting or intervention variants can inform the design. Potential barriers
can be identiﬁed through qualitative research, such as whether knowledge or lack of
time or resources is the main barrier, and the intervention can be designed appro-
priately. Some researchers identiﬁed barriers to patient participation that included
concerns about information and consent; patient preferences for treatment and ad-
ditional demands such as additional procedures. Barriers to clinician participation
included lack of staﬀ and training; concern about the impact on the doctor patient
relationship; time constraints and diﬃculties with the consent procedure (Lancaster
et al. [2010]).
Phase II or Exploratory Trial
Phase II of this scheme is the exploratory trial in which a fully deﬁned complex
intervention is compared with a suitable alternative. For this, the protocol must
be theoretically defensible, reproducible and adequately controlled. The study must
also have appropriate statistical power. Lancaster et al (Lancaster et al. [2010])
provide a detailed discussion of statistical issues related to complex interventions
in primary care, with particular emphasis on cluster randomised trials which are
commonly used with complex interventions. Complex intervention trials often have
designs with multiple parts and multiple routes through which an intervention can
act and operate. Consequently there are larger number of covariates that may predict
outcome, and which need to be considered to avoid confounding than would be found
in a simple intervention for the same health problem (Lancaster et al. [2010]).
The purpose of a trial, including the exploratory one, is to evaluate eﬃcacy
of the intervention, to identify the mechanisms of action, the components delivering
change and the potential for tailoring the complex intervention to individual pa-
tients. As such, the complex intervention trial needs to be a sophisticated clinical
experiment designed to test the theories motivating the intervention and will also
help understand the underlying nature of the clinical problem being treated (Emsley
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et al. [2010]).
Key objectives of a pilot study are:
• Test the integrity of the study protocol. This is especially important if multi-
ple sites are to be involved. This includes evaluating the inclusion/exclusion
criteria, determining if interim analyses are necessary.
• Sample size calculation. This is to obtain initial estimates, considering vari-
ability and an estimate of intra-class correlation coeﬃcient if the main trial is
to be cluster randomised.
• Recruitment and consent rates. This is important for planning the length of
the study, the strategy for recruitment of practices and participants, how to
explain the study in layman's terms, trial the readability of patient information
and consent forms.
• Develop and test the implementation of the complex intervention. To deter-
mine the optimal duration of delivery of the intervention, the ease of adherence,
testing of materials, equipment and techniques, including if self-administration
is possible, and whether support, such as an on-call help service is needed
• Determine the acceptability of the intervention to participants, assessors and
funders, ascertain if there are any side eﬀects and if costs are feasible and
undertake pre-trial modelling of cost-eﬀectiveness.
• Train staﬀ in delivery and assessment procedures, determine inter-rater and
intra-rater reliability if applicable, and carry out calibration of instruments. It
is also important to trial the data collection, recording and data entry.
• Selection of most appropriate primary outcome measure, and determine if it
would be useful to use more than one primary outcome measure or secondary
outcome measures or biomarkers. Whether patient-reported outcomes are ap-
propriate and reliable.
• Randomisation procedure implementation, including whether use of a 24 hour
randomisation service is needed and its acceptability to participants.
• Pilot data collection forms and/or questionnaires and assess their face/content
validity, whether the self-completion should take place at hospital or at home
and if the use of postal questionnaires is appropriate or whether home visits
and interviewers are required.
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• Prepare and plan data collection and monitoring procedures, covering databases,
data entry, validation methods, backup, forms for monitoring adverse events
and missing data minimisation strategies.
(Lancaster et al. [2010]).
The exploratory phase should ideally itself be randomised to allow assess-
ment of the size of the eﬀect. This initial assessment will provide a sound basis for
calculating sample sizes for the main trial. Other design variables can also be estab-
lished in an exploratory trial. Variability in individual level outcomes may reﬂect
higher level processes and sample sizes may need to be larger to take account of
the extra variability and cluster randomised designs considered (Craig et al. [2008]).
The ﬁndings from a trial of a complex intervention are more generalisable if the trial
takes place in the setting in which the eventual intervention is likely to be delivered
and with the population likely to be oﬀered the treatment.
In complex interventions, individual randomisation is often not possible, so
cluster randomisation frequently is used (in which clusters (or groups) of individuals,
rather than individuals themselves, are randomised.). This requires active partici-
pation from general practices, nursing homes or households, for example, depending
upon the unit of randomisation (Lancaster et al. [2010]). It is also often not pos-
sible to conceal the allocation of the treatment from the patient, practitioner and
researcher and the potential biases of unblinded trials need to be accounted for. A
preference trial design is one where any patient who expresses a preference for one
of the alternate treatment regimes is allocated to their preference and others at ran-
dom, but results from a preference trial design can be hard to interpret. There is
evidence that treatments patients prefer have greater eﬀects (Adamson et al. [2008]).
The CONSORT statements for individual and cluster randomised trials are helpful
and informative for planning randomisation. They cover issues such as procedure,
method and level of randomisation. The decision to randomise clusters requires
justiﬁcation because of the associated cost of the increased numbers of patients in-
volved. The avoidance of potential contamination between individuals in diﬀerent
study arms is a common justiﬁcation. It may also be the case that an individu-
ally randomised trial is impossible or that a cluster randomisation would reﬂect the
manner in which an intervention would ultimately be delivered. (Lancaster et al.
[2010]).
With this type of design, there is a higher probability that arms in a study
will become imbalanced in size, and that baseline covariates will show an imbalanced
distribution at the level below the unit of randomisation, usually individuals or possi-
bly, in studies with relatively few clusters, at the level of randomisation itself. There
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are two issues to consider for cluster randomised trials to optimise power: ensuring
equal numbers of clusters and ensuring equal numbers of patients per treatment arm.
In studies where few units of observation are randomised imbalances may lead to a
reduction in study power. A design-stage alternative is to eliminate the occurrence
of imbalance in chosen covariates by using a restricted randomisation method such as
stratiﬁcation by covariates when there are suﬃcient randomisation units for this to
be practicable (Lancaster et al. [2010]). Eldridge et al. (Eldridge et al. [2005]) give
examples of diﬀerent recruitment strategies and discuss what can be done to avoid
bias in identifying and recruiting participants to cluster randomised trials, where
recruitment may operate at a number of diﬀerent levels (Lancaster et al. [2010]).
Care must be taken, therefore with eligibility criteria and recruitment of
intervention sites and personnel: a trial of complex intervention needs to consider
expertise of health professionals as well as investigations, drugs, treatment guidelines,
arrangements for discharge and follow up and the organisation, management and skill
mix of the unit where the intervention is delivered
Appropriate methods of analysis for individually randomised trials are based
on standard methods of statistical analysis, which are well-documented. Whilst there
are more complex issues to consider when analysing cluster randomised trials, where
researchers have to account for groups of individuals within clusters (Lancaster et al.
[2010]), neither of the complex interventions considered in this thesis were assessed
through a cluster randomised trial, so details are not given here. Details of the
analysis methods used are given in Chapter 4.
During Phase II, it is important to test for eﬀects such as a learning curve, the
feasibility of delivering the intervention in diﬀerent places, consistency of delivery,
and the acceptability of the intervention to both providers and patients. If evidence
of a learning curve is found, adjustments should be made, such as a run-in period
before recruitment to a trial to overcome confounding due to a learning curve in
providers.
The feasibility and acceptability of an intervention can be measured by the
level of attrition found in the study in those that are willing to participate. A re-
search question that is considered to be important to primary care will usually make
recruitment easier, as it will engender greater interest at practice level. It is also
important to consider how the study will be perceived to impact on the patient-
doctor relationship more generally, and the priority given to the research question in
relation to other issues. Information about low participation rates can also provide
information about the feasibility and generalisability of likely uptake of the inter-
vention. A systematic review can be used to explore this across several randomised
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controlled trials. Relative attrition (attrition in the intervention group divided by
the attrition in the control group) has been used as a measure of acceptability that
allows the calculation of an overall eﬀect estimate and the study of diﬀerent levels
of attrition based on the population of each trial (Lancaster et al. [2010]).
Suitable outcome measures should be ascertained by the exploratory trial.
Outcomes can be measured at the individual level or at the level of a group or cluster,
which in primary care research is usually the GP practice. In choosing the primary
and secondary outcomes to be measured, it is vital that they are ﬁt for purpose,
both theoretically and practically. An example of an interventions in primary care
administered at the practice level might be the introduction of a universal parenting
programme to prevent early childhood behavioural problems, with main outcomes
concerning parenting, child behaviour and maternal mental health. In general, out-
come measures need to be valid (i.e. shown to have face/concurrent/predictive valid-
ity), to be repeatable (i.e. stable over time when the disease state is not changing),
to be reproducible (i.e. when applied by diﬀerent assessors), and to be objectively
measured in situations where self-reporting may be unreliable (for example, self-
reported smoking cessation with additional biochemical validation (Lancaster et al.
[2010]).
The MRC guidance on developing and evaluating complex interventions states
that researchers need to decide which outcomes are most important, which are sec-
ondary, and how they will deal with multiple outcomes in the analysis. A single
primary outcome and a small number of secondary outcomes are the most straight-
forward for statistical analysis but may not represent the best use of the data or
provide an adequate assessment of the success or otherwise of an intervention that
has eﬀects across a range of domains. It is important also to consider which sources
of variation in outcomes matter and to plan appropriate subgroup analyses (Craig
et al. [2008]).
All interventions need to be cost eﬀective if they are to be used. Model
building can be a cost-eﬀective way of evaluating the likely quality-adjusted life-
year (QALY) of an intervention from a complex intervention using data from a pilot
study, which can also provide estimates of likely eﬀectiveness and cost.
Eldridge et al. (Eldridge et al. [2005])developed a cost-eﬀectiveness model of
a complex falls prevention intervention from pilot study data in order to assess the
viability and design of a subsequent trial. Using two models, they ﬁrst estimated the
probability of falling over a 12-month period using a probability tree, and then used a
Markov simulation to assess the impact of the programme over time. The probability
tree model showed that the intervention would reduce the proportion falling by only
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2.8% over a 12-month period. The major reason for this small eﬀect was that less
than a quarter of older people at risk of falling were assessed using their screening
tool. Sensitivity analyses showed that the only scenarios that produced a substantial
increase in the eﬀect of the intervention were those in which all older people are
assessed, and this was not cost-eﬀective. They found that even if policy-makers
were willing to spend ¿30,000 per QALY gained, there was only a 40% chance that
the intervention would be cost-eﬀective (Lancaster et al. [2010]). The value of well
designed pilot or feasibility studies, prior to large multi-centre randomised controlled
trials, is illustrated by the feasibility study for the UK Back pain, Exercise, Active
management and Manipulation (UK BEAM) trial. The aim was to pilot all aspects
of the trial including the intervention, to identify problems in design or execution,
to investigate unresolved issues and to demonstrate that the main trial could fulﬁl
its aims, in terms of its design and implementation, and was therefore worthy of
funding. Overall, the feasibility study demonstrated that the majority of methods
and processes were successful. It identiﬁed where changes were required to the trial
design or execution and highlighted unexpected problems, allowing further design
changes before the start of the main trial. This study proved that pilot studies
are vital, especially when evaluating complex interventions, for providing planning
information and identifying unanticipated issues in advance of expensive, complex
trials (Lancaster et al. [2010]).
Using the information from the exploratory trial, the optimum intervention is
developed, possibly in a variety of versions, and consideration given to consistency of
delivery and whether there is evidence of improved performance of the intervention
over time. A suitable control intervention and outcome measures will have been
found.
Phase III the deﬁnitive trial
Having established the eﬀect size, sample sizes, inclusion and exclusion criteria, and
methods of randomisation, as well as the challenges of complex interventions in the
pilot, Phase III, the main trial, can be undertaken (Campbell et al. [2000]). Pro-
cess evaluation in a trial is an example of the trend to move beyond the rhetoric of
quantitative versus qualitative methods. Process evaluations within trials explore
the implementation, receipt, and setting of an intervention and help in the interpre-
tation of the outcome results. Process evaluation can help to distinguish between
interventions that are inherently faulty (failure of intervention concept or theory)
and those that are badly delivered (implementation failure). Process evaluations
are especially necessary in multi-site trials, where the "same" intervention may be
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implemented and received in diﬀerent ways (Oakley et al. [2006]). For example,
the RIPPLE (randomised intervention of pupil peer-led sex education) study was a
cluster RCT designed to investigate whether peer delivered sex education is more
eﬀective than teacher delivered sessions at decreasing risky sexual behaviour. By
integrating process and outcome data, the ability to interpret results according to
empirical evidence was maximised (Oakley et al. [2006]).
With most (simple) interventions, integrity is deﬁned as having the "dose"
delivered at an optimal level and in the same way in each site. Complex intervention
thinking deﬁnes integrity of interventions diﬀerently. The issue is to allow the form
to be adapted while standardising the process and function (Hawe et al. [2004]).
If standardisation is taken to mean that all the components of an intervention are
the same in diﬀerent sites, this treats a complex intervention as if it were a sim-
ple intervention. An alternative way of thinking about standardisation is that the
ﬁxed aspects of the intervention are the essential functions (the steps in the change
process that the elements are purporting to facilitate or the key functions that they
are meant to have) and the variable aspect is their form in diﬀerent contexts. In
this way an intervention evaluated in a pragmatic, eﬀectiveness, or real world trial
would not be deﬁned haphazardly. In evaluations seeking to identify active ingre-
dients within a complex intervention, strict standardisation may be required and
controls put in place to limit variation in implementation, but some interventions
are designed to be adapted to local circumstances. In complex interventions, the
function and process of the intervention should be standardised not the components
themselves. This allows the form to be tailored to local conditions and could im-
prove eﬀectiveness. Intervention integrity is then deﬁned as evidence of ﬁt with the
theory or principles of the hypothesised change process. For example, in a trial of a
school based intervention to promote health and wellbeing, schools were encouraged
to use a standardised process to develop strategies which suited them rather than
adopt a ﬁxed curriculum, resulting in widely varied practice between schools (Hawe
et al. [2004]). Reports of such studies should include a detailed description of the
intervention to enable replication, evidence synthesis, and wider implementation.
Phase IV, the long-term implementation
The ﬁnal phase is Phase IV which examines the implementation of the interven-
tion into practice. Its purpose is to determine whether others can reliably replicate
the intervention and results in uncontrolled settings over the long term. Long term
follow-up may be needed to determine whether outcomes predicted by interim or
surrogate measures do occur or whether short term changes persist. Although un-
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common, such studies can be highly informative.
Summary
In summary, the process of developing and evaluating a complex intervention has
several phases, which may not follow a linear sequence. Experimental designs are pre-
ferred to observational designs in most circumstances, but are not always practicable.
Complex interventions may work best if tailored to local circumstances rather than
being completely standardised. Understanding processes is important but does not
replace evaluation of outcomes (Craig et al. [2008]). Trials of complex interventions
are of increasing importance because of the drive to provide the most cost eﬀective
health care. Although such trials pose substantial challenges to investigators, the use
of an iterative phased approach that harnesses qualitative and quantitative meth-
ods should lead to improved study design, execution, and generalisability of results
(Campbell et al. [2000]).
Another deﬁnition
One of the more recent developments in the consideration of complex interventions
in heath care is the greater use of the insights provided by the theory of complex
adaptive systems (Shiell et al. [2008]). Shiell et al. state that although it is rarely
delineated, complexity in healthcare has two meanings. In the ﬁrst it is a property
of the intervention, and in the second it is a property of the system in which the
intervention is implemented. The ﬁrst view of complexity, that complex intervention
is "built up from a number of components, which may act both independently and
inter-dependently" makes it hard to deﬁne the "active ingredients" and to be sure
which component or combinations of components is more important. This is the
more often used deﬁnition and the one used above.
The second view is that complexity is considered to be a property of a system
not an intervention. A complex system is one that is adaptive to changes in its
local environment, is composed of other complex systems (for example, the human
body), and behaves in a non-linear fashion (change in outcome is not proportional to
change in input, Shiell et al. [2008]). The idea that healthcare is a complex system
is discussed in detail in Chapter 7. Whilst the active elements are subject to more
variation, making evaluation of complex interventions diﬃcult, economic evaluation
is still possible by measuring the resources required and the intended outcomes seen.
However, in a complex system it may be diﬃcult to measure and evaluate the spin-oﬀ
outcomes, such as a slow change in attitude which reaches a point where it creates
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the context for change e.g. the ban on smoking in public places (Shiell et al. [2008]).
The ﬁrst empirical evidence to support the argument that complex interven-
tions are interventions in complex systems was provided by Burton (Burton [2012]).
One testable property of complex systems is the presence of characteristic heavy-
tailed statistical distributions. Such distributions appear to be ubiquitous in nature
and have also been found in healthcare systems. These distributions are very diﬀer-
ent from the Gaussian (normal) distribution which characterises the distribution of
simple eﬀects. If complex interventions are truly interventions in complex systems
the eﬀect sizes of these interventions should be expected to show a heavy-tailed
distribution, typical of those seen in other complex systems (Burton [2012]).
The eﬀect sizes of a range of complex interventions collected and processed by
the methodologically rigorous Cochrane review group was used to reduce the chance
that the distribution of eﬀect sizes found was due to the inclusion of methodologically
weak studies with high risk of bias. When ﬁtting these data, Burton found the eﬀect
sizes had heavy tailed distributions typical of those seen in classical complex systems,
supporting the notion of complex interventions as interventions in complex systems
(Burton [2012]).
Under either deﬁnition, complex interventions oﬀer the possibility of tailoring
interventions to patients, and methodological techniques for the analysis of data from
complex interventions is needed. This thesis explores diﬀerent methods for analysing
data from two distinct complex interventions.
1.2 Aims of this research
Having established that health care interventions can be complex, the overarch-
ing aim of this research was to explore whether using non-linear models can better
model health care and so capture the information contained in health care data sets
of complex interventions. In this work, the term linear model was used in the usual
statistical sense of a model that is linear in the parameters, so that logistic regres-
sion and the non-parametric Cox model for survival analysis are linear models. The
non-linear model which was used as an exemplar was the artiﬁcial neural network
model consisting of two layers of adaptive weights with full connectivity between in-
puts and hidden units and using sigmoidal activation functions (called a multi-layer
perceptron). This choice was made because this particular architecture is capable of
universal approximation, meaning that it can approximate any continuous function
to arbitrary accuracy from a compact region of input space, provided the number
of hidden units is suﬃciently large, and provided the weights and biases are chosen
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appropriately (Nabney [2002]). This means these models have the full capability
required for modelling non-linear relationships between variables.
Two exemplar data sets were used, one from each of two common study
types in health research, namely the randomised controlled trial and the observa-
tional cohort study. Each data set contains information about patients' responses to
a complex intervention.
In order to achieve the aims of this research, one goal was to build on the
population-level information provided by the standard analysis in the Back Skills
Training Trial (BeST) of a cognitive behavioural approach to low back pain (Lamb
et al. [2010b]) and investigate whether non-linear models enable individual tailoring
to be possible for this treatment. i.e. to discover whether it is feasible to predict
which patients will beneﬁt from the treatment. If so, this has potential to inform
clinical decision making when recommending treatment for an individual presenting
with low back pain. The accuracy of predictions of both linear an non-linear mod-
els were compared to test the hypothesis that allowing for non-linear relationships
among the explanatory variables leads to improvements in performance in modelling
this complex system.
Another goal was to ascertain what predicts long-term survival after a car-
diac event or procedure using data from a cardiovascular rehabilitation population.
A linear and non-linear model was each ﬁtted using the same explanatory variables
and compared to ascertain which gave a better ﬁt to the population survival curve.
The two models were then be assessed for their performance to predict hazards for
groups of people with the same values of the explanatory variables. By comparing
plots that diﬀer in just one covariate, interrelations between the covariates were hy-
pothesised.
In order to achieve the research aim, a number of speciﬁc objectives were
formulated:
• Can latent class analysis identify sub-sets of patients within a cohort of patients
recruited to a clinical trial for non-speciﬁc low back pain?
• Is it possible to use linear models and the classes identiﬁed by the latent class
analysis to tailor interventions for non-speciﬁc low back pain to patients?
• How do the performances of the linear and non-linear models compare for
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the prediction of patient outcomes following a cognitive behavioural approach
intervention for non-speciﬁc low back pain?
• What is the potential for these linear and non-linear models to inform policy
on the treatment of non-speciﬁc low back pain?
• Using a linear model, what predicts long-term survival after a cardiac event or
procedure, at population level?
• Can a non-linear artiﬁcial neural network be used to model long-term survival
after a cardiac event or procedure?
• How do linear and non-linear models compare in modelling the survival and
hazard of a population who have experienced a cardiac event or procedure?
• What is the potential for this research to inform policy for those who have
experienced a cardiac event or procedure?
In Chapter 2, following, an overview of the literature relevant to the health
care applications and the analysis methods employed in this thesis is given. Then
the two data sets are introduced in Chapter 3, giving the context, collection and
demographics of the cohorts, and a description of previous work using these data
sets is given. Following this, the conventional methods, latent class analysis and
survival analysis, are described in Chapter 4 and then the artiﬁcial neural networks
methodology is introduced in Chapter 5. The results of using the linear models and
the non-linear models for both data setts is given in Chapter 6 and followed by a
discussion of results and the degree of success in achieving the objectives listed above
in Chapter 7. The conclusions are drawn in Chapter 8. The appendix contains copies
of the published and submitted research papers, diagnostic plots for the multiple
imputation of missing data, and a comparison of the survival analysis with the data
sets with missing data imputed.
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Chapter 2
Literature Review
This literature review is divided into four sections, each being mirrored by a section
in the results chapter. The ﬁrst section is an overview of classiﬁcation of patients
for the allocation of treatments for back pain, and discusses a variety of approaches
to classiﬁcation. The second section explores the use of Artiﬁcial Neural Networks
(ANNs) to classify patient outcomes. The next section gives and overview of what
is known about long and short term survival in cardiac patients, focusing on the
covariates that predict survival in those two time scales, and the ﬁnal section explores
the use of ANNs for survival analysis.
The purpose of this literature overview is to provide background for the research
question and an indication of where the question ﬁts with the existing literature.
It also provides background for the analysis decisions and the interpretation of the
results. A thorough search has been made for the latest reviews and studies, however
this overview is not claimed to be a systematic review in the formal sense.
2.1 Classiﬁcation for treatment allocation in back pain
There are a large number of treatments for back pain each of which provide dis-
cernible relief for a substantial proportion of patients. Almost everyone experiences
non-speciﬁc low back pain (LBP) sometime during their lifetime (Dionne [1999]).
Each year in the UK, about one third of the population experiences back pain of
which 20% consult their Geb=neral practitioner(GP, family doctor. NICE [2009]).
There are a number of interventions known to be eﬀective for non-speciﬁc low back
pain including exercise programmes, manual therapy, acupuncture (NICE [2009])
and a cognitive behavioural approach (Lamb et al. [2010b]). However, these inter-
ventions have small mean eﬀects. This has prompted researchers to try to identify
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ways of classifying those seeking treatment so that classes of patients can be matched
to interventions in order to maximize treatment eﬀect (Kent et al. [2010]). Many
diﬀerent classiﬁcations have been developed, including biopsychosocial classiﬁcations
(McCarthy et al. [2004]), but there is little consensus on their use (Kent and Keating
[2005]). For non-speciﬁc low back pain of greater than 6 weeks duration, the UK
National Institute of Health and Clinical Excellence (NICE) has suggested patient
preference should guide the choice of treatment from a range of eﬀective interventions
(NICE [2009]). The Latent Class Analysis (LCA) of the BeST data aimed to provide
additional guidance for patients and clinicians as whether or not to consider the use
of a cognitive behavioural approach (Lamb et al. [2010b], Barons et al. [2013a]).
In a recent systematic review of the role of clinical classiﬁcation systems in
chronic low back pain (Fairbank et al. [2011]), three types of classiﬁcation are identi-
ﬁed in the literature: those relying on clinical descriptor (Diagnostic), those describ-
ing prognosis (Prognostic), and those considering treatment response (Treatment-
based); the latter is where the LCA of the BeST data belongs. In the review (ibid)
they found 28 classiﬁcation systems in use including ﬁve in the treatment-based cat-
egory. In three of these, patients were classiﬁed by a clinician according to where
the pain manifest and under what postural conditions, using the McKenzie method.
This method was found to have high reliability, in that clinicians trained to use
the method matched each others' categorisation in a high proportion of cases (70-
100%). However, a 260-patient randomised contol trial (RCT) did not ﬁnd signiﬁcant
reduction in pain from tailoring treatments based on McKenzie classiﬁcation. The
strength of evidence was classiﬁed as high in the review. The Sikorski method of
classiﬁcation had no reliability studies, and the Van Dillen and O'Sullivan methods
had no clinical trial studies. The Canadian Back Institute Classiﬁcation was based
on location of pain and improvement or worsening with speciﬁc movements. It had
good agreement (78%) in a reliability study. In a study with 1,356 patients given
classiﬁcation-tailored treatments and compared with 754 who had usual care, those
having the individualised treatment regime speciﬁc to this classiﬁcation system had
decreased pain, improved function and less medication use. Evidence for the classiﬁ-
cation system was rated insuﬃcient, and for the eﬀectiveness, low because there was
only one study reporting moderate examiner agreement. The review concluded that
there is a need for a classiﬁcation of low back pain which directs both surgical and
non-surgical treatments. In all these studies, classiﬁcation was done by the clinician
and based wholly or in part on observations about pain location and change with
movement.
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The next section describes studies which did not appear in this review either
because they were published later, or were excluded from the review because they
are not clinical classiﬁcations but statistical partitioning of data.
Delitto's classiﬁcation-based treatment approach (Hebert et al. [2011]) was
compared with usual care in an RCT of 156 patients with sub-acute and chronic
back pain, split 74 to classiﬁcation and 82 to usual care (Apeldoorn et al. [2012]).
Classiﬁcation-based treatment was direction-speciﬁc exercise, spinal manipulation
or stabilization exercises. Delitto's classiﬁcation is also based on therapist observa-
tions, and the Apeldoorn study found no statistically signiﬁcant diﬀerences between
treatment groups. In an observational study, an association between cluster and
subjective pain intensity was found in patients who had participated in a chronic
pain-management programme (Chapman and Pemberton [1994]). 122 Patients were
followed up 6-66 months later and classiﬁed into 7 groups using the Minnesota Mul-
tiphasic Personality Inventory (MMPI) using repeated measures analysis of variance
(ANOVA). Clusters were also associated with occupation in univariate ANOVA.
In a cohort of 301 LBP patients, a hypervigilant sub-group was identiﬁed using a
standardised clinical examination with good between-therapist agreement and used
by physiotherapists (McCarthy et al. [2011]). This means of identiﬁcation of dis-
tinct patient sub-type is accompanied by a suggestion that the hypervigilant might
be targeted, but this was not tested. Distinguishing between neuropathic and non-
neuropathic pain using the PainDETECT questionnaire with 145 patients in sec-
ondary care with 3 to 12 months of LBP did not predict treatment response to a
usual care only intervention, but did predict prognosis - those patients with neu-
ropathic pain had more pain, more limited activity and poorer self-rated health at
baseline, 3 and 12 months (Morso et al. [2011]).
A variety of work has been published using statistical methods for partition-
ing data sets of patients with low back pain.
K-means clustering partitions cases into clusters in which each case belongs
to the cluster with the nearest mean, with `nearest' being deﬁned by some distance
metric (Hastie et al. [2009]). A k-means algorithm was used on samples of 127 male
(57%) and 94 female patients with LBP to form clusters based on their responses
to the Symptom Checklist 90 (SCL-90) which measures physical and psychiatric
symptoms (Shutty Jr. and DeGood [1987]). The responses were scored in both the
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standard 9-dimensions (S-Score) and in a modiﬁed 10-dimensions (F-Score) which
was formed by an alternative division of response scales. The SCL-90 was admin-
istered at baseline and at follow-up 2 weeks to one month later and compliance
to whatever treatment was recommended for the individual was recorded as a di-
chotomous variable. The optimal clustering using the S-Score was 3 clusters for
each gender, whilst using the F-score the optimal was 3 clusters for males and 4 for
females. The mean scores within each cluster on each of the score was reported.
The clusters were numbered by size and 37% of males and 48% of females changed
cluster number between scoring schemes. No links of cluster allocation to outcome
were tested, and there were no reliability studies. In addition, 65% of the cohort was
unemployed with 90% of those attributing their work status to the back pain.
A k-means algorithm was used to divide MMPI scores into 5 clusters for a cohort
of 401 patients (60% female) with chronic LBP (McCreary [1985]). The intital clus-
tering was performed on 271 cases, the remaining 130 reserved for cross-validation.
Outcome was improvement in pain intensity during the previous week evaluated at
baseline and follow-up 6 months to one year later (54% response rate). The same
cluster characteristics were found in the cross-validation set. Treatment was a tai-
lored combination of rest, exercises, advice and analgesic medication; the authors
do not say how the tailoring diﬀered. The ability to predict improvement in pain
intensity from cluster membership was superior in males, and one particular clus-
ter predicted both poor (below average) improvement in pain intensity for men and
good (above average) improvement in pain intensity for women, although the au-
thors concede that the small numbers in the separate-gender analyses may make
the results unstable. They concluded that a larger percentage of men showed severe
psychological disturbances and poor response to medical treatment.
The k-means clustering algorithm was used in an adapted form to learn a division
of 21 patients into those who did and did not experience signiﬁcant pain reduc-
tion of LBP using dynamic transcutaneous electrical nerve stimulation (DTENS)
(Akhmadeeva et al. [2010]). The algorithm was trained on 74 clinical and paraclin-
ical factors including health-related quality of life and the results of psychological
testing. For an independent cohort of 35 patients who all experienced signiﬁcant
pain reduction, the algorithm was able to able to predict signiﬁcant pain reduction
for 70% and possible pain reduction for the remaining 30%. Since the algorithm was
not tested on patients whose outcome was little no pain reduction, no assessment of
its use in the general population can be made.
Clustering was performed on data from three separate cohorts of LBP pa-
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tients (n=170, 82 & 124; Langworthy and Breen [1997]). A technique of sequential
testing of squared Euclidean distance was employed to construct dendograms to
identify clusters. (A dendogram is a tree diagram used to illustrate the arrangement
of the clusters produced by hierarchical clustering.) Two clusters was found to be
optimal in all three cohorts and these corresponded to patients with constant pain
and patients with cyclic pain (i.e. that is worse at certain times of the day) in each
cohort. None of the demographic features (age, sex, social class and job status) was
association with cluster membership. The clusters were not used to inform treatment
decision.
A longitudinal study of the time course of LBP collected monthly questionnaires
about pain intensity from patients for 6 months and used LCA to divide their pain
pathways into classes (Dunn et al. [2006]). Demographic information was collected
at baseline. At baseline and 12-month follow-up, disability was measured using the
Roland Morris Disability Questionnaire (RMQ), HADS was used to identify clinical
anxiety and depression and catastrophising was captured with the Coping Strategies
Questionnaire. 342 participants returned at least 4 of the questionnaires and were
included in the analysis. Four classes were identiﬁed: persistent mild (122 patients),
recovering (104 patients), severe chronic (71 patients) and ﬂuctuating (45 patients).
At 12 months, patients in the persistent mild class had the same pain but improved
psychological scores, the majority in the recovering group were pain free, more than
half of those in the severe chronic class were oﬀ work, and the patients classiﬁed as
ﬂuctuating were still consulting their practitioner and a persistent one third of those
were depressed. There was no investigation of a link between class membership and
treatment response, nor of whether patients could be allocated on baseline charac-
teristics alone, in order to inform treatments. Quality of life (QoL) as measured
by the SF36 was signiﬁcantly lower for patients in 2 of 4 latent classes when 1,391
17-year-olds were classiﬁed using LCA (Beales et al. [2012]). LBP was assessed using
the Nordic questionnaire for musculoskeletal symptoms, and general linear models
used to associate class with quality of life. Female patients having LBP, depres-
sion and anxiety and male patients having LBP and behavioural disorders had lower
QoL than others with or without LBP but without signiﬁcant comorbidity. The
Subgroups for Targeted Treatment (STarT) back screening tool was developed (Hill
et al. [2008]) based on referred leg pain, comorbid pain, disability (2 items), both-
ersomeness, catastrophizing, fear, anxiety, and depression. The tool demonstrated
good reliability and validity and was acceptable to patients and clinicians. Patients
were classiﬁed as low risk, medium risk and (those scoring high on a psychosocial
subscale) high risk of persistent disability. STarT was trialled with 851 patients as-
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signed randomly 2:1 to intervention and control (Hill et al. [2011]). In the control
group, treatment decisions were made on the basis of the physiotherapists' clinical
judgment, without knowledge of a participant's STarT Back Tool classiﬁcation. In
the intervention group, the high risk patients received support for psychosocial barri-
ers to recovery in addition to the physiotherapy for symptoms and function received
by the medium risk group. All groups in the intervention received advice, a copy of
The Back Book, information about exercise facilities and saw a a 15-min educational
video entitled `Get Back Active'. There was a larger improvement in RMQ scores
in the intervention group at 4 and 12 months, and the cost was lower (Whitehurst
et al. [2012]). The tool is published on the web and is free to download. Some prac-
titioners in the UK and elsewhere have declared themselves to be users and describe
the treatment they use. (STarT [accessed 18/05/13])
Many studies have used classiﬁcation techniques to distinguish between cat-
egories of patients with low back pain, and a few have used such classiﬁcations to
inform treatment regimens. In the few cases where an attempt was made to asso-
ciate classiﬁcation with outcome, only pain intensity was considered, and not back
pain disability as measured by tools like the RMQ. In the one case where RMQ
was used as an outcome, a new back screening tool was being tested and the treat-
ment was related to items that could potentially be modiﬁed by treatment options
in primary care. Very few studies have used classiﬁcations deﬁned solely by patient
questionnaires and just one has used the factors interventions may tackle as the basis
for classiﬁcation. The conclusion of the 2011 systematic review largely still stands;
there continues to be a need for classiﬁcation which directs treatments. In particu-
lar, research that increases understanding of the complex interaction within people,
within complex interventions and between people and the interventions, would be
very beneﬁcial, particularly in decision support, design of interventions and tailoring
interventions to patients.
2.2 Non-linear relationships and machine learning for
back pain
One of the motivations for selecting ANNs to classify LBP data is that LBP has
been found to have non-linear relationships with covariates. ANNs have the facility
to capture non-linear relationships between variables. In this section, the evidence
for non-linear relationships between LBP and covariates is illustrated, and this is
followed by the background for the use of ANNs to model LBP.
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2.2.1 Non-linear relationships
Previous studies on non-speciﬁc low back pain have found non-linear relationships
between physical activity and back pain.
In a cross-sectional survey of employees in two Swiss national companies undertaken
between 1996 and 1998, frequency of physical activity per week during leisure time
had a signiﬁcant but non-linear relationship to back pain (Lee et al. [2005]). Par-
ticipation was 41% of all employees giving 10,321 participants (6,251 = 60.6% male,
mean age 39.9 ± 10.8 years and 4,070 = 39.4% female, mean age 37.9 ± 11.3 years).
Using both a self-administered questionnaire and physical ﬁtness tests, this study
assessed participants' general constitution, physical problems, back pain, work en-
vironment, stress, smoking habits and physical activity. Participants were asked
whether they performed physical activity (running, cycling, aerobics, etc.) in their
leisure time at least once a week and on how many days a week. The number of days
(one to seven times per week) was taken as an indicator for physical activity. A ﬁt-
ness test was carried out under the supervision of doctors and nurses who visited the
various branches of both companies and assessed endurance, ﬂexibility, upper body
strength and abdominal musculature, which was then compared with the normal
range of the healthy population for those age groups. 4,945 (48%) reported having
had mild back pain in the previous 4 weeks, and 696 (7%) reported having suﬀered
from severe back pain. The severe back pain group comprised 340 (48.9%) women
and 356 (51.1%) men; the percentage of men was statistically signiﬁcantly higher.
No association between body mass index (BMI: weight in kilogrammes divided by
(height in metres)2) and back pain was found. In univariate analyses, ﬂexibility,
upper body strength, abdominal strength, age (especially over 55 years), smoking
category, and the sum of the stress factors were statistically signiﬁcant. Stress factor
scores for smokers, non-smokers and ex-smokers were signiﬁcantly diﬀerent. Fre-
quency of physical activity per week had a signiﬁcant but non-linear relationship to
back pain: no or little activity (none to two times a week), but also intensive phys-
ical activity (six to seven times a week), was associated with back pain. However,
moderate activity (three to four times a week) was associated with less back pain
(χ2=30.86, P<0.001). A similar relationship was found for intense back pain and
physical activity (χ2=31.78, P<0.001). In multivariate analyses, back pain preva-
lence of any intensity decreased with increasing age and a weak upper body and
personal stress increased the likelihood of back pain, as did smoking and ex-smoker
status. The variables gender, obesity, strength of the abdominal musculature and
frequency of physical activity were insigniﬁcant in multivariate analysis.
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A previous, similar workplace cross-sectional study had uncovered an inter-
action between ergonomic work variables and poor psychosocial work environment
(a composite of workload, work content and social support, Linton [1990]). In this
study, a relationship between regular exercise and back pain was not found, but
back pain was not categorised or clearly deﬁned by minimum pain intensity or du-
ration, and the authors admit that this may have masked the eﬀect. Heavy lifting,
monotonous work, uncomfortable posture, vibration, age, workload, work content
and social support was each associated with low back pain. In addition, an inter-
action between psychosocial environment and each of monotonous work, lifting and
posture was found to be of greater signiﬁcance than the constituent variables alone.
Furthermore, the relationship between age and psychosocial factors was found to
be nonlinear, with the under-30 and over-50 age groups more strongly aﬀected by
psychosocial environment than the intermediate age groups.
EuroQol (EQ-5D) measures health-related quality of life and is composed of 5 dimen-
sions, each with 3 levels and a visual analogue scale. To account for the diﬀerences
between national characteristics, the scoring of the 5 dimensions is calibrated by cal-
culating speciﬁc national coeﬃcients in the linear model that relates the dimension
levels with the visual analogue scale to produce a single-number summary. Using a
cohort of 633 patients with low back pain, the Spanish version of EQ-5D was shown
to give statistically diﬀerent model coeﬃcients for those with LBP than the gen-
eral population (Zamora et al. [2007]). It was also shown that a non-linear model
(in which the regression coeﬃcients noticeably indicated the presence of non-linear
eﬀects in the diﬀerent dimensions of the EQ-5D instrument) gave a more accurate
prediction of the visual analogue scale from the scores of the 5-dimensions.
In addition to the non-linear relationships between physical activity and back
pain, previous studies on non-speciﬁc LBP have found non-linear relationships be-
tween anxiety and pain (Beesdo et al. [2009]) and between anxiety and depression
(Katerndahl [2009]). A systematic review (Ramond et al. [2011]) found that LBP
is a complex condition and that depression, psychological distress, passive coping
strategies and fear-avoidance beliefs were psychosocial factors sometimes found to
be independently linked with transition from acute to chronic non-speciﬁc LBP in
the adult general population, whereas most social and socio-occupational factors
were not. The authors concluded that psychosocial factors should be considered
as momentary and partial indicators of more complex and dynamic distress, which
required tailored management. Therefore, appropriate treatments for back pain are
of great importance.
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2.2.2 Machine learning for back pain
Artiﬁcial Neural Networks (ANNs) belong to a class of learning methods that de-
veloped separately in the distinct ﬁelds of statistics and artiﬁcial intelligence, based
on essentially identical models and are described in detail on page 89. They can be
represented by a network diagram like Figure 5.1, and their architecture is described
by the number of layers, and the number of units in each layer e.g., 6-3-2 is a 3
layer network with 6 input units (explanatory variables), 3 hidden units (units in
the single hidden layer) and 2 output units (response variables). The transfer or
activation function is the function applied to the weighted sum of the inputs to a
unit to provide the output of the layer.
Whilst clinical applications of ANNs are widespread (Dybowski and Gant
[2001]), the literature on using ANNs to model LBP data is sparse. A 3-layer feed-
forward ANN with sigmoidal transfer functions (242-20-3 architecture) was used to
classify patients into healthy, LBP suﬀerers and malingerers (Gioftsos and Grieve
[1996]). The training data was derived from 36 people, a similar number from each
category, with malingerers represented by actors pretending to have LBP. Each study
participant's movements were video recorded from the side whilst they stood up from
and sat down on a chair. The changes in ﬂexion-extension angles of the hip, knee
and lumbar spine were captured electronically and the horizontal and vertical foot
pressure measured with a force plate in front of the chair. Five episodes of sitting
and standing were captured and the normalised pressures and angles used as inputs
to the ANN. The root means squared error was the loss function and leave one out
cross validation was used to evaluate the performance of the trained network, giv-
ing 31 (86%) correct. The video recordings were used to allow 9 physiotherapists
to classify the same participants into the 3 categories. They found it easy to dis-
criminate between the normal and abnormal patterns, despite the fact that they
had not been trained to assess patients by watching them on monitors, but hard to
distinguish LBP cases from malingerers. Each physiotherapist's accuracy was sta-
tistically signiﬁcantly lower than the ANN. Another study used a 3-layer ANN with
sigmoidal activation (or transfer) functions (3-3-1 architecture) to classify patients
into pain / no pain 6 months after hospitalisation (Hallner and Hasenbring [2004]).
The training data was derived from 71 people who were treated conservatively or by
surgery and had their pain intensity measured at the beginning of hospitalisation and
6 months later. The number of neurons in the hidden layer were reduced until the
accuracy began to decline. Inputs to the ANN were psychosocial variables, with the
three with highest predictive power used in the ﬁnal version (depression, suppressive
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behaviour, thoughts of suppression). Accuracy was 83% with sensitivity 78% and
speciﬁcty 97%, with no reported validation. The authors conclude that this could aid
the early detection of risks for chronicity which could lead to improved cognitive, be-
havioural and emotional management of patients to aid the avoidance of chronicity.
Another 3-layer ANN (378-n-5, n not given) was used to classify patients referred to
surgical spine clinic into one of 5 diagnoses using pain drawings used routinely as a
diagnostic tool (Sanders and Mann [2000]). Types of pain were marked on a human
outline and a clinician examined the patterns to see if they follow a dermatomal
pattern, a segmented ﬁeld of skin innervated by a spinal nerve. The drawings were
digitised using a video camera and segmented into 85 regions derived from low back
pain dermatomes and gross anatomical regions. The number of pixels with a pain
mark was normalised by the number of pixels in the region. Training was carried out
on 200 samples and testing on 50, and overﬁtting avoided by early stopping. The
ANN sensitivity was 49% which was statistically equivalent to the physicians (51%)
and was a statistically signiﬁcantly improvement over discriminant analysis (46%).
The authors conjecture that low number of cases and an inadequate image capture
might explain the disappointing sensitivity.
ANNs have been employed to aid diagnosis of genuine back pain, to assess
risk of chronicity and to diagnose the origin or type of back pain. No literature has
been found that uses ANNs to predict the outcome of a speciﬁc treatment for back
pain based on baseline measurements of the patient characteristics that the inter-
vention was designed to tackle. Similarly, no literature has been found addressing
the usefulness of ANN prediction of outcome to tailor treatments to patients.
2.3 Cardiovascular Survival
Coronary heart disease is estimated to cost the UK economy ¿33bn (Euro40bn;
$53bn) annually, of which just under half is due to direct health costs (Allender
et al. [2008]). It remains the leading cause of mortality in the United Kingdom, with
coronary heart disease accounting for 18% of all deaths in men and 13% in women
(Scarborough et al. [2010]). The UK has been experiencing dramatic falls in death
rates from coronary heart disease in recent years due to the fall in smoking preva-
lence (Hardoon et al. [2008]) and due to improvements in treatment, particularly
secondary prevention (Unal et al. [2004], Hughes et al. [2011]).
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There are a number of factors known to be associated with the development of
cardiovascular disease (CVD). A recent study, based on the Framingham Oﬀspring
cohort, assessed the eﬀect of risk factors measured at baseline on the long term
(30-year) risk of developing hard cardiovascular disease (hard CVD is used to mean
coronary death, myocardial infarction and fatal and non-fatal stroke) in those free of
CVD and cancer at baseline examined using Cox regression (Pencina et al. [2009]). In
a secondary model full CVD was used as outcome. Considering the extensive length
of follow-up and the potential bias due to the competing risk of non-cardiovascular
mortality in the prediction of long-term risk, the estimates were adjusted for the
competing risk of non-CVD mortality as those who die of non-cardiovascular causes
are ineligible for development of CVD events. Standard CVD risk factors (male sex,
age, systolic blood pressure, anti-hypertensive treatment, total and HDL cholesterol,
smoking and diabetes) were highly signiﬁcant in the multivariate model. BMI was
weakly signiﬁcant in the ﬁnal model, but in a simpliﬁed oﬃce-based risk model in
which BMI replaced the lipids it was highly signiﬁcant along with all other risk fac-
tors. In time-dependent analysis updating all variables approximately every 4 years,
all standard risk factors remained signiﬁcantly related to the hard CVD outcome
with hazard ratios similar to those obtained in 30-year risk models. BMI lost its
entire impact in time-dependent model. The authors conclude that this ﬁnding il-
lustrates how the eﬀect of BMI is mediated through other risk factors: it was present
in 30-year risk model when the follow-up is extended for a long period from the base-
line but then it impacted the individual risk factors, and after controlling for this
impact in time-updated models, BMI lost its signiﬁcance.
2.3.1 Primary prevention
Primary prevention is preventing illness in someone who does not currently have the
illness. There is no single cause for coronary heart disease, although a cluster of risk
factors has been identiﬁed which make individuals more prone to developing it. Some
are unalterable, such as being male or inheriting a family history, but other known
risk factors such as smoking, depression, raised cholesterol and sedentary lifestyle
can be modiﬁed.
Smoking cessation reduced risk for coronary heart disease substantially more than
cholesterol lowering (Critchley and Capewell [2003]). The evidence was suﬃcient
to infer a causal relationship between smoking and coronary heart disease (Sur-
geon General [2004]) and 11,500 deaths from ischaemic heart disease among those
over 65 in England were estimated to be smoking attributable (Twigg et al. [2004]).
IMPACT, a widely used and replicated epidemiological model was used to synthe-
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sise estimates stratiﬁed by age, gender, and area deprivation quintiles for the English
population aged 25 and older between 2000 and 2007. IMPACT is an epidemiological
model used to explain the contributions of population-level risk factor changes (inci-
dence reduction) and uptake of evidence-based treatments (case fatality reduction)
to the change in CHD deaths between two points in time. This model suggested that
approximately half the recent CHD mortality fall in England was attributable to im-
proved treatment uptake. This beneﬁt occurred evenly across all social groups. The
single largest contribution to the overall CHD mortality decrease came from a popu-
lation fall in systolic blood pressure amongst those not on hypertensive medications
with relatively small gains from hypertension therapies. Furthermore, moderate de-
clines in smoking levels were actually greater in deprived areas (Bajekal et al. [2012]).
A recent Cochrane review into the reduction and alteration of fat in the diet (Hooper
et al. [2012]) concluded that total mortality and cardiovascular mortality were unaf-
fected by reduction of fat in the diet; there was a small reduction in cardiovascular
risk on modiﬁcation of dietary fats but not reduction in total fats.
The most successful CVD primary prevention strategies have been reduction in smok-
ing and blood pressure and uptake of medications.
2.3.2 Secondary prevention
Secondary prevention is used to mean methods to diagnose and treat existent disease
in early stages before it causes signiﬁcant morbidity.
While many studies have reported on the eﬀects of treatment on short term case
fatality (Gale et al. [2008], Vale et al. [2011b], Greenhalgh et al. [2010], Nordmann
et al. [2005], Elfstrom et al. [2012], Mikhail [2005], Kodama et al. [2009], Singh [2003])
there is much less evidence published on factors associated with the long term sur-
vival (greater than 5 years) of individuals who have experienced a coronary event
(e.g. myocardial infarction, MI, heart attack) or procedure (e.g. coronary artery
bypass graft, CABG, percutaneous coronary intervention, PCI) (Grundtvig [2012],
Grundtvig et al. [2011], Hannan [2012], Kavanagh et al. [2002]) and predictors of
long- and short-term survival diﬀer (Filardo et al. [2012], Fox et al. [2008], Shahian
et al. [2012]). This review investigates what is know about risk factors for short and
long term survival for such individuals.
Long term (5-year) prognosis after hospital admission for MI is improving
(Dudas et al. [2012]). Preoperative risk factors, which are good predictors of short-
term outcomes, have been found to contribute little information to the prediction of
long-term survival in CABG patients (Filardo et al. [2012]). Traditional predictors
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of early survival in CABG patients over the age of 65 do not aﬀect long-term sur-
vival, but late mortality is increasingly associated with chronic diseases and health
behaviours (Shahian et al. [2012]). Patients who were deﬁned as having limited
functional status before undergoing CABG did not have a diﬀerent long-term all-
cause mortality from those who did not (Cervera et al. [2012]). Patients undergoing
CABG or valve surgery and who have prolonged stay in intensive care also have
poorer long-term survival (Elfstrom et al. [2012]). The change in deﬁnition of MI
which was introduced in 2000 (Antman et al. [2000], Thygesen et al. [2012]), diag-
nosed many more patients with MI than under the previous deﬁnition. However,
the long-term survival of patients diagnosed with MI under either scheme is not
signiﬁcantly diﬀerent (Grundtvig [2012]). Fitness as measured peak oxygen intake,
V O2 max, (most accurate measure of exercise capacity) was found to be a predic-
tor of long-term mortality of both men and women; even moderate ﬁtness conferred
a 50% reduction in cardiac mortality (Kavanagh et al. [2002], Kavanagh et al. [2003]).
Statins are a class of drugs used to lower cholesterol levels by inhibiting the
enzyme HMG-CoA reductase, which plays a central role in the production of choles-
terol in the liver. Statins have gained a pivotal role in the primary and secondary
prevention of coronary artery disease, and are thought to improve perioperative
outcomes in patients undergoing cardiac surgery. A recent Cochrane review (Li-
akopoulos et al. [2012]) identiﬁed eleven randomised controlled trials with a total
of 984 patients undergoing cardiac surgical procedures, and found that preoperative
statins reduced postoperative atrial ﬁbrillation and was associated with a shorter
stay in the intensive care unit. Statins failed to inﬂuence short-term perioperative
mortality and there was no reduction in MI. Early statin treatment (initiation within
14 days) for patients with acute coronary syndrome (ACS) reduced the occurrence of
unstable angina at 4 months following ACS, but did not reduce death, MI or stroke
up to 4 months following ACS (Vale et al. [2011a]).
Beta blockers (BB) and angiotensin-converting-enzyme inhibitor (ACE inhibitor) are
used in patients experiencing acute cardiovascular events. The eﬀect of early treat-
ment (within 24 hours of event) with these and other drugs on short-term mortality
was investigated in a Cochrane review (Perez et al. [2009]). Whilst Nitrates reduced
all-cause mortality during the ﬁrst two days following acute MI, ACE inhibitors had
a signiﬁcant eﬀect only at 10 days and Beta blockers and calcium channel block-
ers had no eﬀect on mortality at 2, 10 or 30 days. There was no information on
their eﬀect on mortality risk at 5 years or beyond. In a systematic review of sec-
ondary prevention of ischaemic cardiac events, survival beneﬁts of BB were similar
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in men and women. The highest absolute beneﬁt from beta-blockers was found in
people who were over 50 years of age, with a higher heart rate at study entry, with
a history of MI, angina pectoris, hypertension, or treatment with digitalis, and with
transient signs or symptoms of mechanical or electrical failure in the early phases
of MI (Skinner and Cooper [2011]). The same review advised that ACE inhibitors
should be considered for secondary prevention in all patients after acute MI with
left ventricular systolic dysfunction and in high-risk patients without left ventricular
systolic dysfunction. It further suggested that after CABG, ACE inhibitors should
be initiated with caution in low-risk patients without left ventricular dysfunction.
The beneﬁts of ACE inhibitors in very low-risk patients with a previous MI and
without left ventricular dysfunction may warrant further investigation. If this ad-
vice is followed, those taking ACE inhibitors are those at increased risk.
2.3.3 Cardiac rehabilitation
Following a cardiac event or procedure, patients are routinely referred to Cardiac
rehabilitation (CR, Bethell et al. [2009]). Cardiac rehabilitation is the process by
which patients with cardiac disease are encouraged and supported to achieve and
maintain optimal physical and psychosocial health and is a complex intervention
consisting of three core elements: education, exercise training and psychological
support (Heran et al. [2011], Jolliﬀe et al. [2009], Bethell and Mullee [1990], Bethell
et al. [1983], Bethell et al. [2009], Plüss et al. [2008], Taylor et al. [2004], Turner
et al. [2003], Turner et al. [2002], Unal et al. [2004], West et al. [2011]). In this
section, literature describing what is known about the various elements of cardiac
rehabilitation, especially long-term eﬀects, is discussed.
The education element of cardiac rehabilitation
A recent review of the education element of CR concluded that there is some evi-
dence to suggest that education may improve health-related quality of life, and that
it may reduce costs by reducing subsequent use of health care, but there was no
strong evidence of an eﬀect of education on all-cause mortality, cardiac morbidity or
hospitalisation (Brown et al. [2011]).
Depression and anxiety in psychological rehabilitation
Psychological interventions showed small to moderate eﬀects on depression and anx-
iety following a cardiac event in a Cochrane review which also found that in smaller
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studies (with some evidence of small-study bias) there was a modest positive eﬀect
of psychological interventions on cardiac mortality (Whalley et al. [2011]). Overall,
there was no strong evidence that psychological intervention reduced total deaths, or
risks of revascularisation and non-fatal infarction. Relative to placebo, antidepres-
sants produced no change in cardiovascular function in heart disease, in respiratory
function in lung disease, or in vital signs or laboratory tests in cancer, although were
signiﬁcantly likely to improve depression (Gill and Hatcher [2000]). Depression 7
days after MI has been associated with 18-month cardiac mortality (Frasure-Smith
et al. [1995]) but only medical history related to heart disease and was controlled
for in this study. One meta-analysis of observational studies concluded that depres-
sion is more strongly associated with short-term than long-term mortality (5 years
and longer) and that more studies of long term mortality are needed (Barth et al.
[2004]). A later observational study of 588 followed up for up to 8 years after MI
found no association between depression and cardiac mortality, whether measured
just before MI or at 12 months follow-up (Dickens et al. [2007]). Fitness is known
to aﬀect depression (Turner [2007]) but was not measured in this study. Another
meta-analysis of prospective studies found that the presence of depressive symptoms
after MI was not uncommon and was associated with a 2- to 2.5-fold increased risk
of impaired cardiovascular outcome within 2 years (van Melle et al. [2004]). The
authors state that confounding factors are possible and a causal inference cannot be
drawn. A subsequent prospective study employed a case-control design and assessed
depression using a structured interview (i.e. met diagnostic criteria for either major
depression, minor depression, or dysthymia on the Depression Interview and Struc-
tured Hamilton) in contrast to patient questionnaires (e.g. HADS). This study found
that depression was an independent risk factor for death 5 years after an acute MI
and minor depression was associated with an increased risk of death, although the
authors stated it was not known whether treating depression can improve survival
or not (Carney et al. [2008]). Again only medical items directly associated with MI
were controlled for, and ﬁtness was not measured. A systematic review of depression
screening tools in CVD patients found that sensitivity ranged from 39% to 100%
(median, 84%) and speciﬁcity ranged from 58% to 94% (median, 79%). The screen-
ing tools have a known high false positive rate and a clinical interview is necessary to
conﬁrm a diagnosis of depression. Additionally, this systematic review found depres-
sion treatment with medication or cognitive behavioral therapy resulted in modest
reductions in depressive symptoms in those with CVD, and there was no evidence
that depression treatment improved cardiac outcomes (Thombs et al. [2008]). The
failure of psychological interventions to reduce mortality suggested the association
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is not causal (Dickens et al. [2007]).
A LCA of the course of depression symptoms found that there is a class of pa-
tients whose risk of a new cardiovascular risk is raised (Kaptein et al. [2006]). Scores
on the Beck Depression Inventory for 475 patients (385 men [80%], 90 women, mean
age 60.6 years) who had MI were assessed during hospitalisation and at 3, 6, and 12
months. The prevalence of depressive symptoms was 22.7% during hospitalization.
The analysis identiﬁed 5 classes: no depressive symptoms (56.4%), mild depressive
symptoms (25.7%), moderate and increasing depressive symptoms (9.3%), signiﬁcant
but decreasing depressive symptoms (4.6%), and signiﬁcant and increasing depres-
sive symptoms (4.0%). Participants in this last class had a statistically signiﬁcantly
higher risk of a new cardiovascular event compared with those without depressive
symptoms. Controlling for baseline cardiac status and sociodemographic data did
not alter the association; ﬁtness was not measured and there was no long-term folow-
up.
Depression predicted failure to complete cardiac rehabilitation (Casey et al. [2008],
Turner [2007]).
Exercise in cardiac rehabilitation
Exercise-based cardiac rehabilitation has been found to reduce overall mortality, car-
diovascular mortality and hospital admissions in the short and medium term. The
vast majority of studies have less than two years follow-up, and only three had longer
than ﬁve years follow up. These three studies are described in this section.
The National Exercise and Heart Disease Project examined whether a supervised ex-
ercise programme improved 19-year survival in 30- to 64-year-old male MI patients
(Dorn et al. [1999]). This 3-year multi-centre randomised clinical trial was conducted
in the United States from 1976 to 1979 and involved 651 men with neither hyper-
tension nor signiﬁcant comorbidity and with a ability to exercise at an intensity
level ≥ 3 metabolic equivalents (METs) and a supine resting diastolic blood pres-
sure <100 mm Hg. After completion of a 6-week, low level exercise program run-in
period (those failing to complete were excluded), the men were randomly assigned
to the exercise-treatment group (n=323) or non-exercising control group (n=328).
The exercise prescription consisted of brisk physical activity in the laboratory for 8
weeks, exercising 1 hour per day, 3 days per week. Thereafter activities consisting of
15 minutes of continuous jogging, cycling, or swimming, were followed by 25 minutes
of recreational games until the end of the study period. The duration of individual
programs ranged from 6 weeks to 48 months, and follow-up periods ranged from 24
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to 60 months. The research found that the exercise group had non-signiﬁcantly re-
duced mortality risks early in the follow-up period. Beneﬁts diminished as time since
participation increased, which suggested that the protective mechanisms associated
with the program may be short term. Analyses were performed with intention-to-
treat and by the end of 2 years, 23% of the treatment group had stopped attending
sessions and did not report exercising elsewhere, whereas 31% of the control group
reported they were exercising regularly. Contamination between groups over time
could also explain the diminished eﬀects, because increased maximal physical work
capacity (as determined by exercise testing) provided survival beneﬁts up to 19 years.
In a study of 95 consecutive men aged 49 to 60 years suﬀering a ﬁrst, recent
MI study, La Rovere et al. report the impact on survival, during a 10-year follow-
up period, of producing an exercise-induced increase in baroreﬂex sensitivity (BRS,
causing changes in heart rate to maintain blood pressure) of ≥ 3 ms/mm Hg. The
men were were randomly assigned to a 4-week endurance training period (n=49) or
to no training (n=46). The exercise sessions were 30 minutes, 5 times a week for a 4-
week training period and consisted of calisthenics and stationary bicycle ergometry.
Exclusion criteria were atrial ﬁbrillation or abnormal sinus node function, insulin-
dependent diabetes, exercise-induced myocardial ischemia, and hypertension. There
was a marginally statistically signiﬁcant reduction in cardiac deaths in the trained
group. However, those within both groups who had signiﬁcantly improved BRS also
had statistically signiﬁcantly lower mortality; an improvement in exercise capacity
not paralleled by signiﬁcant changes in BRS was not accompanied by a better prog-
nosis (La Rovere et al. [2002]).
The Alton cardiac rehabilitation trial, an exercise-only trial, randomized 200
men who had suﬀered acute MI to either a 3 month supervised exercise course or
an advice only group and followed them up for 11 years (Bethell et al. [1999]). The
included patients were age 65 or under and were recruited between December 1979
and March 1984 and were excluded if they lived more than 25 miles from Alton, if
they had medical or orthopaedic problems that precluded their taking part in the
exercise course, if they had insulin dependent diabetes mellitus or were in atrial
ﬁbrillation, if they had previously been through the course, or if they were on the
investigator's personal general practice list (Bethell and Mullee [1990]). The follow-
up questionnaire response rate fell from approximately 90% of survivors at year 1
to 72% at year 11. There had been 54 exclusions and 28 pre-randomization deaths
among the original 311 patients and a further 12 died and 17 were excluded between
32
randomization and the ﬁrst exercise test, leaving 200 for the study. Eighteen were
excluded on medical grounds and these would have included some sicker patients
with poor prognoses. There was no signiﬁcant diﬀerence between the two groups for
non-fatal reinfarction nor for long-term mortality. It did not reduce the risk of total
MI, CABG or PCI. One or more previous myocardial infarcts, increasing age and
low initial ﬁtness were among the signiﬁcant predictors of cardiac death.
All these studies included only men without signiﬁcant comorbidity and under
the age of 65 who do not fully reﬂect the typical characteristics of patient population
who have experienced a cardiac event or procedure.
Eﬃcacy of cardiac rehabilitation
A recent Cochrane review (Heran et al. [2011]) analysed 47 studies randomizing
10,794 patients to exercise-based cardiac rehabilitation or usual care. It found that
cardiac rehabilitation did not reduce the risk of total MI, CABG or PTCA. Despite
the inclusion of more recent trials, the population studied in this review was still
predominantly male, middle aged and low risk. It concludes that well-designed, and
adequately reported RCTs in groups of coronary heart disease (CHD) patients more
representative of usual clinical practice are still needed.
There have been recent claims that the inclusion of historic trials has biased
the Cochrane reviews in favour of cardiac rehabilitation (West et al. [2011]). Based
on the RAMIT multi-centre RCT, West et al. suggested that there was no diﬀerence
between patients referred to CR and those given usual care. The RAMIT study
included 1,813 patients in England and Wales recruited between 1997 and 2000 with
903 allocated to comprehensive cardiac rehabilitation and 910 to usual care without
cardiac rehabilitation. They found there was no signiﬁcant diﬀerence between the
two groups either at 2 years or at 7-9 years in all-cause mortality, morbidity, health
service use, health-related quality of life (as measured by SF36), psychological gen-
eral well-being and cardiovascular risk factors at 1 year. The evidence in favour of
CR in the Cochrane review of 2000 is said to be heavily weighted by early trials
when mortality was high. The improvement in mortality following CR is not seen
when pooling just those trials in the Cochrane review that followed the WHO trial
in 1983. This may be because the establishment of coronary care units, care regi-
mens and secondary prevention medication have so altered the context of CR. This
paper calls into question the value of cardiac rehabilitation as practiced in the UK at
present. However, West acknowledges that extended cardiac rehabilitation training
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(Plüss et al. [2011]), HF-ACTION Randomized Controlled Trial (O'Connor et al.
[2009]), and GOSPEL Italian RCT (Giannuzzi et al. [2008]) may have beneﬁts that
current UK cardiac rehabilitation does not.
Plüss et al followed up for ﬁve years participants in a single-centre prospec-
tive randomised controlled trial of standard cardiac rehabilitation versus expanded
cardiac rehabilitation (Plüss et al. [2011]). The expanded rehabilitation group expe-
rienced reduced cardiovascular events. Of the original 828 candidates, there were just
224 patients in the trial, split 113 to standard and 111 to expanded rehabilitation.
The most common reason for exclusion was age over 75 years (308) followed by living
outside the hospital catchment (101), loss to screening (25), severe co-morbidity (17)
and language diﬃculties (15). The patients were recruited between May 1999 and
May 2002 and all had recent acute MI or CABG. The expanded CR included all the
elements of standard care (physical training, cardiologist counselling session, `heart
school' education, individual counselling as needed and smoking cessation) and in
addition a ﬁve-day stay at the `patient hotel' with physical training and informa-
tion, 22 group stress management session over a year, and three cooking sessions
with diet counselling. Most patients were taking secondary prevention medications
(Beta-blockers, aspirin, statins, and ACE inhibitors). Follow-up was by national
registry and so was nearly 100%. Cox proportional hazards models were compared,
using the primary end points of cardiovascular mortality, acute MI, or readmission
to hospital for CVD. The result of the study was that the expanded cardiac rehabili-
tation cohort had a hazard ratio (HR) of 0.47 for non-fatal MI and 0.76 for ischaemic
stroke. The total number of hospitalization and the number of days of hospitalization
were each signiﬁcantly lower for the expanded CR group. This contrasted with the
one-year follow-up which found no diﬀerence in biochemical risk markers or exercise
performance between the two groups (Plüss et al. [2008]). Fitness was not measured.
The GOSPEL RCT investigated the value of a multi-factorial intervention
consisting of one-to-one support held monthly from month 1 to month 6, then every
6 months for 3 years (Giannuzzi et al. [2008]). Each session consisted of 30 min-
utes of supervised aerobic exercise, plus lifestyle and risk factor counseling lasting
at least 1 hour and reinforcement of preventive interventions lasting approximately
30 minutes. To improve adherence, a booklet was distributed and the support of
family members was encouraged in ad hoc meetings. There were 3,778 patients re-
cruited after MI between January 2001 and December 2002 randomised 1,620 to
intervention and 1621 to usual care, after losses due to exclusion and loss to follow
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up. Exclusion criteria were age over 75, poor short-term prognosis, disease limiting
exercise and logistic diﬃculties. The targets of the intervention strategy were to give
up smoking, adopt a healthy Mediterranean diet, increase physical activity up to at
least 3 h/wk at 60% to 75% of the mean maximum heart rate, BMI of 25 or less,
blood pressure of 140/85mm Hg or lower, total cholesterol level of 200 mg/dL or
lower, low-density lipoprotein (LDL) cholesterol level lower than 100 mg/dL, blood
glucose level of 110 mg/dL or lower, and haemoglobin A1c (HbA1c) level lower than
7.0% in subjects with diabetes. The intensive intervention decreased CV mortality
plus nonfatal MI and stroke by 33% (95% CI, 0.47-0.95; P=0.02), cardiac death plus
nonfatal MI by 36% (95% CI, 0.43-0.94; P=0.02), and nonfatal MI by 48% (95% CI,
0.31-0.86; P=0.01) with respect to usual care. Total mortality, sudden death, and
total stroke decreased, although not signiﬁcantly. The authors conclude that the
GOSPEL intervention was eﬀective in decreasing the risk of several important CV
outcomes, particularly nonfatal MI, although the overall eﬀect was small (Giannuzzi
et al. [2008]). Fitness was not measured.
The HF-ACTION RCT was designed to investigate the safety and eﬃcacy of
exercise training for those with heart failure (O'Connor et al. [2009]). 2,331 patients
were randomised to usual care or usual care plus aerobic exercise training, consisting
of 36 supervised sessions followed by home-based training. The trial was delivered at
82 centres in 3 countries and follow-up was at clinic visits every 3 months for the ﬁrst
2 years and yearly thereafter for up to 4 years. Cardiopulmonary exercise testing and
a 6-minute walk test were performed at the 3-, 12-, and 24-month follow-up visits.
Exclusion criteria included major comorbidities or limitations that could interfere
with exercise training, recent or planned major cardiovascular events or procedures,
performance of regular exercise training, or use of devices that limited the ability to
achieve target heart rates. The 6-minute walk test (distance walked in 6 minutes)
was also performed at the 3-year and ﬁnal visits. Patients made their ﬁnal visit at
the end of the study follow-up period or at 4 years. To provide comparable levels
of attention from study personnel in the 2 randomized arms, all patients were to be
called and asked about their exercise every 2 weeks for the ﬁrst 9 months, monthly
until 24 months of follow-up, and quarterly thereafter. At all time points, approx-
imately 30% or more of the patients in the exercise training group exercised at or
above the target exercise minutes per week. In the exercise group, 37 patients had at
least 1 hospitalization due to an event that occurred during or within 3 hours after
exercise. In the usual care group, 22 patients had such a hospitalization, despite
not undergoing a formal exercise programme. There was no signiﬁcant diﬀerence
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in the number of deaths (189 [16%] in the exercise group vs 198 [17%] in the usual
care group). The authors concluded that exercise training resulted in nonsigniﬁcant
reductions in the primary end point of all-cause mortality or hospitalization. Fitness
was not measured.
Home-based cardiac rehabilitation is an attractive alternative to no cardiac
rehabilitation for elderly patients (over 65) with coronary heart disease who decline
participation in centre-based CR (Oerkild et al. [2012]). In an RCT, a physiother-
apist made 2 home visits in a 6-week period in order to develop an individualised
exercise programme that could be performed at home and surrounding outdoor area.
Risk factor intervention, medical adjustment, physical and psychological assessments
were oﬀered at baseline and after 3, 6 and 12 months to both intervention and control
groups. The primary outcome was 6 min walk test. Secondary outcomes were blood
pressure, body composition, cholesterol proﬁle, cessation of smoking, health-related
quality of life, anxiety and depression. The study population was characterised by
high age (median age 77 years, range 65 to 92 years) and high level of comorbidity.
Patients receiving home-based CR had a signiﬁcant increase in the 6 min walk test
at 3 months, whilst the usual care group did not signiﬁcantly improve, but with no
signiﬁcant diﬀerences between the groups. At 12 months follow-up, there was a sim-
ilar decline in 6 min walk test in both groups (55.2m and 52.1m for intervention and
control respectively). Participation in home-based CR improved exercise capacity
among elderly patients with coronary heart disease, but there was no statistically
signiﬁcant diﬀerence between the home intervention and the control group. In addi-
tion, no statistically signiﬁcant diﬀerence was found in the secondary outcomes and
during the follow-up (mean 4.5 years), there was no diﬀerence in all-cause mortality.
When intervention ceased, the initial increase in exercise capacity was rapidly lost.
This cohort had little depression so that statistically signiﬁcant improvement was
not possible.
A systematic review of home-based CR interventions compared to usual care
and centre-based supervised rehabilitation found that home-based cardiac rehabili-
tation for low-risk patients does not have signiﬁcantly poorer outcomes compared to
centre-based programmes. However, duration of follow-up is short and there are only
limited data on mortality rates and from well conducted RCTs (Jolly et al. [2006]).
A recent narrative review of CR concludes that observational studies in the
new millennium consistently conclude that CR does signiﬁcantly reduce mortality
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even in the context of improved medical and revascularization strategies (Dobson
et al. [2012]). The authors suggest that advances in the quality of cardiac rehabili-
tation programmes and European-wide guidelines have led to improved survival.
Long-term survival after a cardiac event
In this section, studies investigating long-term survival (≥ 5 years) after a cardiac
event are discussed and the factors known to aﬀect long-term survival identiﬁed.
In a recent study, long-term survival ﬁgures were evaluated based on Eu-
roSCORE, a widely utilized as a pre-operative risk prediction tool (O'Boyle et al.
[2012]). A number of the risk factors in EuroSCORE have previously been identiﬁed
by Cox regression analysis as signiﬁcant factors with regard to long-term survival,
leading to some authors utilizing EuroSCORE as a possible predicator of long-term
survival despite its derivation being based on in-hospital operative mortality. Only
patients who had undergone an isolated CABG were included and long-term follow
up was from 6 months to 12 years, mean 6.6 years. Cox regression analysis demon-
strated that age, diabetes, ejection fraction, BMI, dialysis, logistic EuroSCORE, cre-
atinine kinase myocardial isoenzyme (CKMB), left internal mammary artery (LIMA)
usage and peripheral arterial disease were signiﬁcant factors aﬀecting long-term sur-
vival. Except for diabetes, BMI, CKMB and LIMA usage, all these variables were
incorporated in the EuroSCORE, however their weighting will vary. The authors
concluded that this explains why EuroSCORE was a reasonable approximation as
a predictor for long-term survival, but the incidence of diabetes, CKMB and LIMA
usage will aﬀect its accuracy.
Non-high-density lipoprotein cholesterol (non-HDLC) can predict the risk of
cardiovascular events among general population without coronary heart disease and
may be a practical predictor of long-term cardiac death in patients with CHD after
CABG (Fukushima et al. [2012]). A more active lifestyle is signiﬁcantly associated
with improved survival in elderly (over 70 years) CABG patients. The nonlinearity
of the relation suggests that more sedentary patients could have the most beneﬁt
on survival by increasing their exercise lifestyle habits. The improved outcome is
explained by both cardiac and overall mortality reduction (Rengo et al. [2010]). In
a study of 1,158 (84%)men and 215 women aged 35 to 64 years, followed-up for 12
years for non-fatal and fatal CHD events and all-cause mortality, the overall sur-
vival of men who underwent CABG was similar to the survival of the corresponding
background population for about ten years but started to worsen after that (Keto-
nen et al. [2008]). The CHD mortality of men who had undergone the operation
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was clearly higher than in the background population. Among women, the all-cause
mortality after CABG was about twice the expected mortality in the corresponding
background population. In Cox proportional hazards models age, smoking, history
of MI, BMI and diabetes were signiﬁcant predictors of mortality. Fitness was not
measured.
In a study of 10,268 patients, multivariate logistic regression analyses showed
that underweight was associated with higher early mortality after CABG surgery
(van Straten et al. [2010]). Multivariate Cox regression analyses revealed morbid
obesity as an independent predictor of late mortality. A study to analyze the im-
pact of varying BMI on early clinical outcome and long-term survival in a group
of patients who underwent CABG and/or cardiac valve procedures found there was
no association between BMI and hospital mortality in the entire patient population
(Rahmanian et al. [2007]). Multivariate analysis revealed obesity as an independent
predictor of hospital mortality in patients who underwent valve surgery. Obesity
was associated with an increased risk for sternal infection , whereas underweight
correlated with postoperative bleeding. Underweight was an independent predictor
for decreased long-term survival. Fitness was not measured.
The Basingstoke and Alton study
There is a need for studies of survival after a cardiac event or procedure that that
measure ﬁtness and can identify the relative importance of ﬁtness and BMI. Survival
in these patients has been improved by secondary prevention and especially medi-
cation. There is some evidence that CR improves survival, especially programmes
that include a signiﬁcant exercise component. Few studies have followed up patients
in the long term and very few have measured ﬁtness.
2.4 Artiﬁcial Neural Networks for Survival
Artiﬁcial neural Networks (ANNs) have been widely used in clinical applications
(Dybowski and Gant [2001]), predominantly in classiﬁcation problems i.e. to as-
sign the patient to one of a small set of classes based on their measured features.
ANNs have recently been used for survival analysis, but most of the literature has
been devoted to treating the problem as a classiﬁcation one or making piecewise or
discrete approximations of the hazard function (Bottaci et al. [1997], Tangri et al.
[2008], Regnier-Coudert et al. [2012], Biglarian et al. [2013]). This literature review
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will focus largely on use of ANNs for regression, where time is used as a continuous
variable and a survival probability distribution is produced. The key contributions
in this ﬁeld have been made by Ruth Ripley, Rashmi Joshi and the collaboration
group including Antoni Eleuteri, Azzam Taktak, Paulo Lisboa and Bertil Damato.
2.4.1 The continuous-time approach
The use of artiﬁcial neural networks in non-linear survival analysis began in 1992
when Ravdin and Clark used them to predict the survival probability of breast can-
cer patients, given the prognostic variables, using time as an input variable (Ravdin
and Clark [1992]). Ravdin and Clark ﬁrst introduced the idea that time to event or
censoring should be coded as one of the prognostic variables. Their data set con-
sisted of 1,373 breast cancer patients followed up for a minimum of 36 months. The
prognostic variables included patient age and a number of medical measurements of
the tumour. Some of the variables were transformed by taking the logarithm of the
variable plus a constant in order to approximately equate the median and mean of
the distributions. All prognostic variables were normalised to lie in [−1, 1] for use
with the tanh transfer (or activation) function. The data were split into training,
validation and testing sets of size 500, 453 and 420 cases respectively. Time was
divided into periods where 10% decrement in survival was seen, i.e. 12 months, 18
months, 27 months, 40 months and 60 months, by which time 50% of cases had
died. These time intervals were coded 1 to 5 and predictions were made for survival
at these time intervals. In order to correct the bias introduced by 231 of the cases
within time 5 (maximum) having died in the interval and 45 having survived, the
authors selected at random 45 of the 231 of the deceased cases for inclusion and
deleted the remainder to match the 50% survival shown on the Kaplan-Meier es-
timate. The multi-layer perceptron (MLP) used had a 9-7-1 architecture and was
optimised using the back-propagation algorithm (described on page 93). The weight
vectors were stored at intervals during the training and the resulting network varaints
were evaluated using the validation set. The optimal number of training iterations
was determined by calculating the goodness of ﬁt for the prognostic indices using
the global χ2 statistic of a Cox regression on the same transformed variables using
the validation data set. The inﬂuence of the individual inputs was investigated by
omitting each in turn and measuring the global χ2 statistic. The patients predicted
to have excellent and poor early and late prognosis by the network were identiﬁed
and their Kaplan-Meier survival estimates used to conﬁrm their qualitative cate-
gorisation. There was no attempt to produce conﬁdence intervals, use alternative
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learning rules or to optimise over network architectures. Although this paper used
time in a piecewise approximation of the hazard, it was the ﬁrst to demonstrate that
using time as a prognostic variable, an ANN can make a set of predictions for given
patients over time.
Brian and Ruth Ripley summarised the use of neural networks as non-linear
statistical methods in survival analysis (Ripley and Ripley [2001]). They point out
the pitfalls of using neural networks (overﬁtting, sensitivity and speciﬁcity) and that
standard statistical models can be more robust in that they can be built up from
simple models, with each stage of added complexity being tested for a signiﬁcant
improvement in ﬁt. There is no analogue for this in ﬁtting ANNs.
The performance of 7 diﬀerent neural network models were compared using a data
set of times to ﬁrst relapse in days since surgery for 1,335 patients with primary
ductal breast cancer (Ripley et al. [2004]). That study used a MLP and back prop-
agation with a quasi-Newton method for optimisation. In three models time to ﬁrst
recurrence was categorical and in the remaining 4 it was continuous.
The ﬁrst discrete time model predicted probability of relapse within 5 years using a
standard classiﬁcation neural network. The following 2 models estimated the prob-
ability of relapse in the time periods less that one year, one to two years, two to
three years, three to ﬁve years, and greater than ﬁve years. The ﬁrst of these two
discrete time models ignored the ordering of the time periods and ﬁtted the model
using a softmax neural network (see page 94). The second discrete time model in-
corporated the ordinality of the outcomes, and was the ﬁrst time such a method
was used for survival analysis with ANNs. The continuous time models were three
extensions of linear models (log-logistic, log-normal, and proportional hazards) and
a time-varying extension of the proportional hazards model. The authors observed
that use of back-propagation of errors was not possible in these cases as the log
partial likelihood was not a sum over data examples. By ordering the patients in
reverse order of time of relapse, the risk set always consisted exactly of the patient
under consideration plus all those previously processed. This allowed the partial
sums to be accumulated as the patients were processed in order and allowed for ef-
ﬁcient programming of the exact derivatives and their use in standard optimization
algorithm. The performance of the seven models was compared on a breast cancer
data set of 1,335 women obtained from the Imperial Cancer Research Fund Medical
Oncology Unit in Oxford. There were 680 cases with no missing data and missing
values for the remainder were estimated using multiple regression on available vari-
ables. For patients censored before the end of the observation period, the authors
40
estimated the conditional probability that the censored patient would have survived
to the end of the observation period conditional on the fact that they survived until
their censoring time. 276 patients suﬀered relapse in the observation period (Ripley
[1998]). Comparison of results with the same analysis using only the complete cases
produced similar results. The basis for comparison of the models was the prediction
of relapse within 5 years using the sum of the log probabilities, accuracy, sensitivity
and speciﬁcity on the cross-validation data and based on a probability cut oﬀ of
0.5; ﬁve-fold cross validation was used since the data set was too small to split into
a training and testing set. The size of the artiﬁcial neural networks' hidden layers
and the value for the weight decay parameter were also assessed by cross validation.
These tests showed that the binary model and the continuous time models did best,
the ordinal model second best and the multiple time model least well. Accuracy of
the best models was around 78%. The sensitivity (correct prediction of relapses)
ranged between 31 and 41% and the speciﬁcity (correct prediction of non-relapses)
90-94%. The authors conclude that the improvement due to non-linearity is not very
great in this case, and that the binary model is a useful system to predict risk of
relapse in newly diagnosed patients.
Joshi and Reeves have reported work on artiﬁcial neural networks for malig-
nant melanoma prognosis (Joshi et al. [2003], Joshi et al. [2005], Reeves and Johnston
[2008] and Joshi [2004]). The data comprised 1,946 patients diagnosed with malig-
nant melanoma between 1987 and 1996, of which 1,160 (60%)were female, 786 were
male and 1,628 (84%) were living at follow up to 31st December 1999 (Joshi et al.
[2005]). Cox survival model analysis showed violations of the proportional hazards
assumption, so the data was stratiﬁed in the non-proportional variables, and a strat-
iﬁed Cox model was ﬁtted. This identiﬁed 4 signiﬁcant prognostic variables with
between 2 and 5 categories, making 120 possible combinations. Since the ANN ap-
proach was to enter all prognostic variables into the network as binary variables, the
5-level variable was dropped leaving 24 combinations. These were the inputs to the
ANN along with bias and scaled time as event time divided by maximum event time.
The ANN had 3 hidden nodes; 5 nodes was known to produce superior results but
was computationally intensive. The data was split into the 24 subsets each with a
uniform distribution of responses to the 4 prognostic variables and the ANN weights
were optimised by minimising the log-likelihood, with weight decay regularisation
to avoid over-ﬁtting. A monotonic survival function is ensured by constraining the
weights relating to the time input from the hidden layer to the output are of dif-
ferent sign to the weights from the inputs to the hidden layer. The optimal brain
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surgeon technique was used to assess the signiﬁcance of each of the 34 weights and
to prune the network to 24 weights. The Hessian of the log likelihood was required
for this procedure, and could also be used to produce the large sample approximate
variance-covariance matrix. The ANN model was assessed by plotting the survival
probability for each of the 24 subsets against the equivalent Kaplan-Meier estimate,
the stratiﬁed Cox model and a log-normal model and this showed that the ANN
most closely matched the data. The 10-year survival probabilities for the Kaplan-
Meier, Cox, ANN and another ANN optimised by minimising least squares were
compared for each subset, and the sum of the absolute diﬀerences compared to the
Kaplan-Meier. By this measure, the least squares ANN was most accurate, followed
by the Cox model. The standard errors on the ANN weights were constructed using
the weight ± 1.96×√jj component of F isher Information Matrix. Conﬁdence
intervals on the output of the ANN were produced using a bootstrap approach on
the multivariate normal distribution simulated by Cholesky decomposition of the
variance-covariance matrix of the optimised ANN.
2.4.2 A Bayesian approach
The collaboration group including Antoni Eleuteri, Azzam Taktak, Paulo Lisboa
and Bertil Damato have produced a number of papers since 2003. In Eleuteri et al.
[2003], a standard sigmoidal activation function was used in a multi-layer perceptron
(MLP) for the covariates, except for time, which had instead a logarithmic activation
function. The only input to this unit through the weight was the time unit; neither
biases nor other inputs fed through this unit. The purpose of this was to ensure that
the survival function at time zero was 1 and at +∞ was zero. In order to ensure
that the survivor function was non-increasing as time increased, they constrained the
weights associated with the time input to be non-negative. Instead of a conventional
approach to training which minimizes an error function with a single weight vector,
the authors use a Bayesian scheme which considers a probability distribution over
weights. For the unconstrained weights, a zero mean Gaussian prior was selected,
whilst the positivity constraint weights had an Levy prior, which has positive sup-
port and leads to a stable, non-degenerate joint distribution of the weights out of the
activation functions. This strategy was tested on data on 12 covariates from 1,776
patients with colon cancer. The data was split 700 for testing and 1,076 for training
and the outputs for the ANN and a Cox model compared to the Kaplan-Meier esti-
mate. The authors concluded that their novel ANN architecture performed as well
as the Cox PH model.
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The Bayesian approach to modelling survival with an ANN has been further
developed by this group to include automatic relevance determination (PLANNARD,
Taktak et al. [2006]), adjustment for skew and labeling of missing data (Lisboa et al.
[2003]), modelling of the log of the hazard rate function (CHENN, Eleuteri et al.
[2007a], Eleuteri et al. [2007b]), applications in Choroidal Melanoma (Damato et al.
[2008]), colon cancer (Dolgobrodov et al. [2007]), Ocular melanoma (Taktak et al.
[2008]), competing risks (Lisboa et al. [2009]), and model selection using Genetic
Algorithms (Ambrogi et al. [2007]).
Artiﬁcial neural networks have been used in medical applications, often for
decision support (Dybowski and Gant [2001]) including myocardial infarction detec-
tion (Haraldsson et al. [2004]), medical diagnosis (Kononenko [2001]), pathological
staging of prostate cancer (Regnier-Coudert et al. [2012]). The use of ANNs to model
survival is not widespread. The literature that exists has been overwhelmingly in
the classiﬁcation context, where survival for a speciﬁed time is a binary prediction.
The use of survival time as one of the inputs during training, and the consequent
ability to produce a survival probability distribution curve is much less frequently
used, and has been used only on Cancer data sets. Whilst there have been exemplar
hazards produced by these ANNs (Ripley et al. [2004], Lisboa et al. [2009]), produc-
ing hazard rates for speciﬁc subgroups of patients and comparing them with hazard
rates produced by other survival models to generate hypotheses has not been done.
Artiﬁcial neural network (ANN) modelling has been used to model time to relapse
in cancer patients (Joshi et al. [2003], Joshi [2004], Ripley et al. [2004], Joshi et al.
[2005]), but modelling the long-term survival of patients who have has a cardiac
event or procedure with ANNs is new. There is a need to extend continuous time
ANNs to survival on non-cancer data sets (Joshi [2004]). The ability of ANNs to pro-
duce hazard rates has not been exploited either by comparison to rates provided by
other models, or to produce research hypotheses. This research has addressed these
omissions, selecting the Joshi methodology in order to make a direct comparison.
The following chapter gives details of the two data sets used in this research
and the work that has already been done using those data sets.
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Chapter 3
Data
The purpose of this chapter is to give details of the two data sets that have been used
in this thesis, and the analysis and results of the original study teams who collected
them. The methods used in my re-analysis of the data for this research are detailed
in chapters 4 and 5 (starting on pages 64 and 87 respectively) and the results of my
analyses in the Results chapter starting on page 103.
The two data sets are: the Back Skills Training Trial, designed and undertaken
by Professor Sallie Lamb and colleagues at Warwick Clinical Trials Unit, which is
a multi-centred randomised controlled trial of a primary-care based cognitive be-
havioural program (a complex intervention) for low back pain; The Basingstoke
and Alton Cardiovascular Rehabilitation data set is an observational study designed
and undertaken by Dr. Sally Turner who collected and analysed it with a view to
determining the role of depression and ﬁtness on survival in a cohort attending a
community cardiovascular rehabilitation programme (a complex intervention).
3.1 Introduction to the Back Skills Training Trial Data
3.1.1 Introduction
The Back Skills Training Trial (BeST) was a large, randomised controlled trial of
a cognitive-behavioural approach to the relief of back pain, conducted by Warwick
Trials Unit and published in The Lancet (Lamb et al. [2010b]). The motivation for
the trial was the signiﬁcant prevalence and cost to the economy of lower back pain
coupled with evidence that psychological risk factors play an important role in the
progression of lower back pain. Starting in 2000 there has been a major change in the
management of lower back pain in primary care to active management which is ad-
vice to engage in physical activity and avoid bed rest, to take appropriate medication
44
and to take a positive attitude. This advice was summarised in a booklet called `The
Back Book', routinely handed to patients being treated for lower back pain. Cog-
nitive behavioural approaches for back pain were ﬁrst introduced in secondary care
for chronic and severe lower back pain. Trials of the cognitive behavioural approach
for subacute and chronic low back pain produced a mixed picture, and variable ad-
herence to the principles of cognitive behavioural approach was hypothesised as an
explanation. The aim of the BeST trial was to develop and test a group-based cog-
nitive behavioural approach intervention for lower back pain that could be accessed
from UK NHS primary care (Lamb et al. [2010a]).
3.1.2 Methods
A complex intervention is deﬁned as an intervention that has many parts which
may work independently or interdependently (Campbell et al. [2000]). The BeST
trial compared active management (AM) with a complex intervention comprising
active management plus group treatment using a cognitive behavioural approach
(AM+CBA), and found that AM+CBA was eﬀective in treating subacute and chronic
low back pain (LBP) in both short and long term, and that it was cost-eﬀective.
Training was provided to health care professionals in order to deliver both treatments
eﬀectively. To deliver the active management consistently, primary care nurses were
given a 1-hour training session on the best practice for the management of LBP,
and asked to cascade this within their practices. To deliver the active management
plus cognitive behavioural management consistently, other nurses, physiotherapists,
psychologists, and occupational therapists attended a 2-day course, supported with
remote mentoring.
701 patients with at least moderately troublesome back pain of at least 6
weeks' duration were recruited from 56 general practices in 7 regions in the UK be-
tween April 2005 and April 2007. The patients were randomised 2:1 in favour of the
cognitive behavioural approach arm of the trial. Originally, randomisation was to
have been balanced 1:1 between the two treatment arms, but such a randomisation
would have produced too few participants to run the cognitive behavioural approach
groups, so it was switched to 2:1 randomisation in favour of the AM+CBA arm.
Those in the control group received active management which is best practice care,
including advice to keep active, to use painkillers, and take a positive outlook. They
were also given a copy of `The Back Book', which was designed by LBP experts to
reinforce these messages. Those in the intervention group received this same treat-
ment, but in addition were invited to attend a series of six cognitive behavioural
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group sessions with about eight participants in each. In the group sessions, the
topics of goal setting, pacing, challenging beliefs, managing pain, and improving
communication with health professionals were covered. Compliance with treatment
was deﬁned as attendance at least three of the six sessions. Patients recruited to
the trial had subacute and chronic lower back pain that was at least moderately
troublesome and of at least 6 weeks duration and had attended general practice,
were at least 18 years of age, and had not been managed previously in a cognitive
behavioural programme.
Demographic and clinical data were collected at the pre-randomisation stage, includ-
ing date of birth, sex, lower back pain symptoms in the last six weeks, frequency of
pain in the last six weeks, ethnic origin, age when left full-time education, and em-
ployment details. The two primary outcomes were the Roland Morris Questionnaire
(RMQ, Roland and Morris [1983], Roland and Fairbank [2000]) and the Modiﬁed
Von Korﬀ (MVK, Korﬀ and Anthony [1982]) scale.
The Roland Morris Questionnaire (Roland and Fairbank [2000]) is the most
widely used measure of lower back pain disability in primary care trials. It contains
24 yes / no responses relating to a range of functions commonly aﬀected by lower
back pain, and the score is the sum of the responses. There were concerns expressed
by the trial report authors that the RMQ does not conform to the assumptions of
scaling and normality of distribution that underpin its use in statistical analysis. It
has been shown to be diﬀerentially sensitive at low, mid and high ranges, with better
sensitivity in the mid-range (Lamb et al. [2010a]). Previous trials have adopted a
clinically signiﬁcant diﬀerence between groups of 2.5 RMQ points.
The Modiﬁed Von Korﬀ Scale assesses two dimensions, pain and disability,
associated with back pain in the last four weeks. It is made up of six items, each
of which is rated on a scale from 0 (no pain or disability) to 10 (worst pain or dis-
ability). The ﬁrst three items relate to disability and the interference of pain with
daily activity, recreation and ability to work. The last three items relate to worst
pain, average pain and rating of back pain today. RMQ is scored by summing the
responses and so has a maximum score of 60 (Korﬀ and Anthony [1982]).
Secondary outcomes were occupational disability and limited activity days,
participant satisfaction, psychological and behavioural measures, quality of life (QoL),
health economics (including quality-adjusted life year (QALY)) and resource use.
The psychological and behavioural measures were included because they measure
46
constructs hypothesised to lie on the causal pathway of eﬀect, and might provide
some explanation as to why the treatment was or was not eﬀective.
The Fear Avoidance Beliefs Questionnaire (FABQ) is a measure of the degree
of fear of pain and disability, and the avoidance of physical activities that can result
(Vlaeyen and Linton [2000]). Each item is scored on a Likert scale 0 to 6 and mea-
sures fear avoidance beliefs about work and fear avoidance beliefs about physical
activity. The latter was selected for use as it has generic applicability. The sum
score has a maximum of 24, with a higher score indicating a greater degree of fear
and avoidance beliefs.
Pain self-eﬃcacy (PSE) is a measure of a patient's conﬁdence to carry out a
range of activities despite their back pain. There are ten items on a Likert scale each
with responses 0 to 6, sum score up to 60, with higher score indicating the higher
attribute of good pain self-eﬃcacy (Nicholas [2007]).
Quality of life is measured using the Short Form 12 (SF12) a measure of health
related quality of life widely used in back pain trials. There is a manual for scoring
the physical and mental components on a scale of 1 to 100 for each and designed
to have a mean of 50 and a standard deviation of 10 in a representative sample of
the U.S. population, so that a score greater than 50 represents above-average health
status (Ware et al. [1996]).
The Hospital Anxiety and Depression Scale (HADS) is a self-report rating
scale designed to measure both anxiety and depression. It consists of two sub scales,
each containing seven items on a 4-point scale (ranging from 0-3). The HADS is
scored by summing the ratings for the 14 items to yield a total score, and by sum-
ming the ratings for the 7 items of each sub scale to yield separate scores for anxiety
and depression (Lisspers et al, 2007).
Troublesomeness was reported as a response to the question `How troublesome
has your back been during the past 6 weeks?' on a single likert scale, with options
`Not at all troublesome', `Slightly troublesome', `Moderately troublesome', `very
troublesome', and `Extremely troublesome'. Those whose responses were `Not at
all troublesome' or `Slightly troublesome' were not recruited to the trial.
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3.1.3 Missing values
The data losses occurred because not all participants responded to every question,
therefore some of the responses needed to calculate the scores were missing. The
complete cases all match the trial HTA report (Lamb et al. [2010a]), where it re-
ports them:
Fear Avoidance 662 complete cases, as on page 239 of HTA report
PSE 676 complete cases, as on page 240 of HTA report
RMQ baseline 700 complete cases, as on page 238 of HTA report
RMQ 12months 498 complete cases, as on page 238 of HTA report
SF12 687 complete cases, consistent with page 241 of HTA report (Complete cases
for individual questions is not given)
Appendix 12 of HTA report does not include details on the following:
HADS anxiety 686 complete cases
HADS depression 693 complete cases
Troublesomeness 638 complete cases
Taking the complete cases only in a sequential manner we now arrive at 407
complete cases altogether; accumulated missingness is detailed in table 6.1 on page
107 in Chapter 6.
Where items making up the RMQ were missing, the mean was taken of the responses
that were given and multiplied by 24, consistent with published research (Kent and
Laurisden [2011]). For all other variables, a missing item response meant the variable
was considered missing.
3.1.4 Previous results
Follow up was measured at 3, 6 and 12 months and outcomes were summarised as
the change from baseline score. At 12 months, the mean change from baseline in
the RMQ score was 1.1 (95% CI 0.39 to 1.72) in the control (AM) group and 2.4
(95% CI 1.89 to 2.84) in the AM+CBA group. The diﬀerence of 1.3 (95% CI 0.56
to 2.06) is statistically signiﬁcant (p = 0.01), and can be delivered at low cost to the
provider. 1,465 people of the 9,771 initially identiﬁed appeared to be eligible, and
after excluding those who no longer had back pain, or who had only infrequent pain,
or pain that was not troublesome, or were pregnant, 705 were randomised of whom
four did not provide baseline data, leaving 701 for the trial analysis. Of these, 70%
experienced pain every day, 55% had moderately troublesome pain and the remain-
der had very or extremely troublesome pain.
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The average age of the trial participants was 54 years, 60% were women, most
had left full-time education before age 15, and half were currently working, mostly
full-time; most of those not working had retired. Stratiﬁed block randomisation was
carried out by an independently administered telephone randomisation service at
the MRC clinical trials unit in London.
There was no statistically signiﬁcant diﬀerence in the follow-up questionnaire
return rates between the two arms of the trial at any of the observation points nor
any evidence of a systematic diﬀerence in the baseline characteristics of participants
who provided follow-up data and those who did not. Attendance at all six of the
cognitive behavioural sessions was achieved by 25% of the participants allocated to
the AM+CBA arm, 63% attended at least three sessions and were considered to
have received the basic elements (adhered), and just over 10% did not attend any.
There were no diﬀerences between the patients who were adherent and those who
were not in any of RMQ score, troublesomeness of pain, fear avoidance beliefs, sex
or Modiﬁed Von Korﬀ disability at baseline. Adherent patients had slightly lower
MVK pain scores at baseline (mean diﬀerence 4.5, 95% CI 0.95 to 8.19) and were
older (average 4.5 years older, 95% CI 1.8 to 7.5). There were 62 groups run with
mean size of 8 (SD 1.62, range 4-12) and a range of times were oﬀered to meet the
needs of participants. There was no evidence of either group or therapist eﬀects.
Improvements in the AM only arm were, on average, 1.1 RMQ points, with
change occurring between baseline and three months and no further improvement
thereafter. The change in the CBA arm was almost double by three months, and the
treatment diﬀerence continued to widen at six and twelve month follow-up points.
The mean treatment diﬀerence was 1.1 Roland Morris Questionnaire points at three
months, 1.4 at six months and 1.3 at twelve months, and all were statistically sig-
niﬁcant.
The MVK disability scale showed improvement over both arms of the trial,
with the improvement in the active management arm occurring between baseline
and three months and declining thereafter, and the cognitive behavioural approach
arm showing a greater improvement. The mean diﬀerence between the two arms
was 4.3% at three months, 8.1% at six months, and 8.4% at twelve months. The
MVK pain scale also showed improvement over both arms, with the active manage-
ment arm improving gradually over the twelve months, and greater improvements
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in the cognitive behavioural approach, particularly at three months. The diﬀerence
between the two arms was 6.8% at three months, 8% at six months and 7% at twelve
months, and all were statistically signiﬁcant.
The SF12 physical subscale showed improvements in both arms of the trial in
the ﬁrst six months, but greater improvement in the cognitive behavioural approach
arm, and in the active management arm there was no diﬀerence from baseline by
twelve months. The mean diﬀerence between the two arms was 2.2 at three months,
1.8 at six months, and 4.1 at twelve months, all statistically signiﬁcant. The SF12
mental subscale showed no signiﬁcant improvement or diﬀerences between the two
arms at twelve months. There were statistically signiﬁcant improvements in the
cognitive behavioural arm at six months, but by twelve months the improvement
disappeared. Fear avoidance beliefs did not change in the active management arm
but substantial improvements occurred in the CBA arm between 0 and three months
and were maintained to twelve months. The mean diﬀerence at three months was
2.6, 3.1 at six months and 3.0 at twelve months, and the diﬀerences between treat-
ments were signiﬁcant at all time points.
Pain self-eﬃcacy improved in the cognitive behavioural arm, with peak im-
provement at six months maintained at twelve months. In the active management
arm, there were no discernible changes in pain self-eﬃcacy, the mean diﬀerence at
three months was 3.2, 4.1 at six months and 3.8 at twelve months.
Distributions of patient scores is given in Table 3.1. Subgroup analysis re-
vealed that fear avoidance beliefs at baseline was not associated with treatment
eﬀects measured by the RMQ, but there was a statistically signiﬁcant interaction
between baseline fear avoidance and outcomes measured by MVK for disability, with
those not fear avoidant at baseline having a larger treatment eﬀect. However these
observations were not consistent across all primary outcomes. The treatment eﬀect
was larger for people with moderately troublesome back pain as opposed to severe
pain. Active management had little or no eﬀect for these patients which accounts
for the diﬀerence, and the interaction was not signiﬁcant. There was no diﬀerence
in the results between the observed case analysis and an analysis based on multiple
imputation, and the ﬁndings appeared insensitive to the method of dealing with
missing data.
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Variable Male Female Total
Number 161 (39.6%) 246 (60.4%) 407 (100%)
Mean age in years (sd) 54.2 (14.7) 53.9 (14.3) 54.0 (14.0)
N % N % N %
Age group under 40 years 31 11.9 44 17.9 75 18.4
Age group 40-49 years 34 30.7 54 21.9 88 21.6
Age group 50-59 years 35 30.7 60 24.4 95 23.4
Age group 60-69 years 45 37.9 58 23.6 103 25.3
Age group 70 years and over 16 19.5 30 12.2 46 11.3
Treatment allocation
Active management only 51 31.7 75 30.5 126 31.0
Active management and CBA 110 68.3 171 69.5 281 69.0
RMQ improvement of 3+ points
Achieved 64 39.8 117 47.6 181 44.5
Not achieved 97 60.2 129 52.4 226 55.5
Anxiety
Not anxious 91 56.5 86 35.0 177 43.5
Borderline 43 26.7 80 32.5 123 30.2
Anxious 27 16.8 80 32.5 107 26.3
Depression
Not depressed 113 70.2 144 58.5 257 63.1
Borderline 40 24.8 75 30.5 115 28.3
Depressed 8 5.0 27 11.0 35 8.6
Pain self eﬃcacy
Very low 6 3.7 20 8.1 26 6.4
Low 25 15.5 36 14.6 62 15.0
Moderate or better 30 80.8 190 77.3 320 78.6
Troublesomness
Somewhat 2 1.3 1 0.4 3 0.7
Moderately 82 50.9 113 45.9 195 47.9
Very 57 35.4 102 41.5 159 39.1
Extremely 20 12.4 30 12.2 50 12.3
interference with
social activities
All of the time 3 1.9 6 2.5 9 2.2
Most of the time 15 9.3 30 12.2 45 11.0
Some of the time 50 31.1 81 32.9 131 32.2
A little of the time 30 18.6 46 18.7 76 18.7
None of the time 63 39.1 83 33.7 146 35.9
Table 3.1: The numbers and proportions of patients in each category of each score
in the BeST trial.
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3.1.5 Discussion
This was a large scale randomised controlled trial which demonstrated the long-term
eﬀectiveness and cost-eﬀectiveness of a cognitive behavioural approach in treating
subacute and chronic lower back pain, with beneﬁts lasting at least to twelve months
and the cost per QALY less than half that of most other interventions for lower back
pain. The intervention was delivered by NHS staﬀ, demonstrating that it could be
delivered within the NHS, which was the aim. Since the trial sample was recruited
from a range of general practices, the external validity is good. The sample is repre-
sentative of those who will accept an invitation to a cognitive behavioural approach,
and of the ethnic mix within the UK, and there was no upper age limit imposed.
The study was powered to be deﬁnitive and the statistical signiﬁcance of the
comparisons across a range of measures supported the rejection of the null hypothesis
that there was no diﬀerence between the groups. Just over half the people randomised
to the cognitive behavioural approach reported improvements, which is more than
would be expected from natural recovery or from provision of active management
alone. The trial team hypothesise that this approach could be adapted to treat a
range of musculoskeletal pain.
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3.2 Introduction to Basingstoke and Alton
Cardiac Rehabilitation data
3.2.1 Introduction
The Basingstoke and Alton cardiovascular rehabilitation data set is an observational
study of an unselected cohort of 2,714 patients passing through routine NHS reha-
bilitation service in the 10-year period between 1st January 1993 and 31st December
2002 (Turner et al. [2002]). This cohort has now been followed up for an average
of 11.5 years (range between one day and 18 years and three months), providing
11,871 person-years of follow-up. The study original hypothesis was formed and the
data were collected by Dr Sally Turner (ST) during her employment as a programme
coordinator at Basingstoke and Alton cardiac rehabilitation centre, and the prelim-
inary analysis was performed in the course of her PhD research (Turner [2007]). ST
describes the motivation of her research in terms of a particular patient who was
being treated medically for clinical depression and who enrolled in cardiac rehabili-
tation following his discharge from hospital with a diagnosis of myocardial infarction
(heart attack). This patient attended the rehabilitation programme regularly for
three months, and on completion not only had his ﬁtness improved, but he enjoyed
improvements in his depression such that his antidepressant medication had been
reduced. This case prompted ST to look more closely at the outcomes collected
at this cardiac rehabilitation centre and to investigate whether baseline ﬁtness or
changes in ﬁtness as a result of ﬁtness training, or baseline psychological scores and
changes in these would predict the prognosis of cardiovascular rehabilitation patients.
The study hypotheses formulated by ST were that risk of mortality in this
coronary population:
• is predicted by baseline ﬁtness, ﬁtness on completion of cardiovascular reha-
bilitation programme, and the change in ﬁtness during the programme, where
ﬁtness is measured by peak exercise performance on an exercise treadmill or
bicycle ergometer;
• is predicted by the severity of depressive symptoms at baseline, at time of
discharge from the programme, or the degree of change in the depression score
as measured by the Hospital Anxiety and Depression Scale (HADS);
• is associated with a statistically signiﬁcant interaction between baseline ﬁtness
and baseline depression scores, between ﬁtness and depression scores at grad-
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uation from the programme, and between change in ﬁtness level and change in
depressive symptoms by graduation from the programme.
Cardiac rehabilitation is the process by which patients with cardiac disease
are encouraged and supported to achieve and maintain optimal physical and psy-
chosocial health. Patients were referred to the Basingstoke and Alton cardiovascular
rehabilitation programme by cardiologists and general practitioners at Basingstoke
and North Hampshire Hospital and neighbouring general hospitals and primary care
trusts. The programme was provided at three locations, the hospital physiotherapy
gymnasium at Basingstoke, in a community centre at Tadley, 9 miles north of the
hospital, and at purpose-built premises at Alton, 16 miles south of the hospital.
There are four phases of cardiovascular rehabilitation: Phase I is when the patient is
in hospital and being supported, along with their family, by specialist medical staﬀ
including the provision of going home advice and/or a self-help manual to assist
convalescence; Phase II is the period immediately after hospital discharge, whilst
surgery wounds heal, and the advice from Phase I is put into practice; Phase III is
the active physical recovery provided through an individualised, incremental exercise
prescription together with continuation of lifestyle advice and risk factor monitoring
as provided in the Phase I and II; Phase IV involves patients complying with healthy
lifestyle and risk factor control in the long term, and lasts for life.
This programme oﬀers Phase I, III, and IV. The Phase III active physical
recovery component lasted between six weeks and six months according to need, and
is oﬀered to all myocardial infarction (heart attack) patients discharged from the
hospital, and to patients recovering from cardiac surgery or revascularisation and
who lived within the catchment area which extended to a 25-mile radius of the Al-
ton premises. The Phase III programme on oﬀer at Basingstoke and Alton cardiac
rehabilitation centre assessed patients for physical and psychological health at the
beginning and end of the programme. They began a supervised aerobic exercise
class once or twice a week, with home aerobic exercises in between. The supervised
sessions comprised circuit training for 40 minutes, with those patients needing to
rest between diﬀerent aerobic exercises switching to strength and endurance exer-
cises for `active recovery'. Besides the exercise programme, a health education and
stress management component was oﬀered, to which patients' spouses or partners
were also invited. This component covered relaxation techniques and a health educa-
tion programme (understanding coronary heart disease, cholesterol, healthy eating,
blood pressure, the beneﬁts of regular physical activity, smoking advice, cardiac
medications) and stress management.
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3.2.2 Method
The Basingstoke and Alton cardiac rehabilitation data consists of baseline measures,
taken at the ﬁrst visit, of:
• ﬁtness
• anxiety and depression
• a list of medications
• blood pressure
• age
• gender
• reason for referral
• former exercise habit
• employment status
• occupation
• quality of life score
• diabetes
• other co-morbidities
• blood cholesterol
• triglycerides
• thyroid function
• postcode (to be related to index of deprivation)
• weight
• Height (routinely recorded starting in 1998)
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At the end of the rehabilitation, when the patient had reached the required
ability to complete the exercises in the supervised session without recourse to active
recovery, measurements were made of:
• ﬁtness
• anxiety and depression
• blood pressure
• a list of medications
• the number of sessions attended
• any adverse events during rehabilitation
The date and cause of death were also recorded, being obtained automatically from
the medical research department of the Oﬃce for National Statistics (National Statis-
tics). These are coded using a binary indicator variable as Cardiac deaths or oth-
erwise. Descriptive statistics and preliminary survival analysis using a Cox propor-
tional hazards model was performed by ST and presented in her PhD Thesis (Turner
[2007]).
Risk stratiﬁcation
All patients who are recruited to exercise-based CR undergo risk stratiﬁcation dur-
ing initial assessment. In the Basingstoke and Alton CR, patients' risk level was
assessed as standard. Exercise testing was a part of this process. Risk stratiﬁcation
enables an appropriate and individualised exercise prescription to be planned for pa-
tients that reﬂects the severity of cardiac illness, co-morbidity and current medical
state. The American Association of Cardiovascular and Pulmonary Rehabilitation
[(ACVPR) was the ﬁrst to lay down criteria for risk stratiﬁcation. Comorbidity as
measured by the D'Hoore co-morbidity index were calculated for each Basingstoke
and Alton CR patient (D'Hoore et al. [1996]).
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Risk stratiﬁcation criteria for cardiac patients (AACVPR 1999)
LOW RISK
• Uncomplicated MI, CABG, angioplasty or atherectomy
• Functional capacity equal to or greater than 6 METS 3 or more weeks after
clinical event
• No resting or exercise induced myocardial ischaemia manifested as angina
and/or ST segment displacement
• No resting or exercise-induced complex arrhythmias
• No signiﬁcant left ventricular dysfunction (Ejection fraction equal to or greater
than 50%)
MODERATE RISK
• Functional capacity less than 5- 6 METS 3 or more weeks after clinical event
• Mild to moderately depressed left ventricular function (Ejection fraction 31-
49%)
• Failure to comply with exercise prescription
• Exercise induced ST-segment depression of 1-2mm or reversible ischaemia de-
fects (echocardiography or nuclear radiography)
HIGH RISK
• Severely depressed left ventricular function (Ejection fraction equal to or less
than 30%)
• Complex ventricular arrhythmias at rest or appearing or increasing with exer-
cise
• Decrease in systolic blood pressure of >15mmHg during exercise or failure to
rise consistent with exercise workloads
• MI complicated by Congestive Heart Failure, cardiogenic shock and/or complex
arrhythmias
• Patients with severe CHD and marked (>2mm) exercise induced ST-segment
depression
• Survivor of a cardiac arrest
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D'Hoore co-morbidity index
Table 3.2 gives details of the D'Hoore co-morbidity index.
D'Hoore co-morbidity index
Weight Condition
1 Myocardial infarct*
Congestive heart failure*
Peripheral vascular disease
Dementia
Cerebrovascular disease †
Chronic pulmonary disease
Connective tissue disease
Ulcer disease
Mild liver disease‡
2 Hemiplegia ‡
Moderate/severe renal disease (end stage) 
Diabetes
Any tumour ♣
Leukaemia ♣
Lymphoma ♣
3 Moderate or severe liver disease
6 Metastatic solid tumour
Table 3.2: *Myocardial infarct and congestive heart failure were omitted from the
index because they are included in the AACVPR risk stratiﬁcation for events.
†includes patients with history of stroke or history of cerebrovascular disease.
‡Mild liver disease and hemiplegia were omitted from index because it could not be
quantiﬁed in Zoghbi database
Includes patients with end stage renal disease
♣ Labelled as one category (malignancy)
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3.2.3 Missing values
Details of the number and percentage of missing values are given in tables 6.18, 6.19
and 6.20 on pages 146, 147 and 148 in Chapter 6.
3.2.4 Previous results
Of the 2,714 patients who entered the study with a baseline ﬁtness score, 1,398 com-
pleted cardiac rehabilitation (CR) and had an exit ﬁtness score taken using the same
protocol (bicycle or treadmill, Turner [2007]). There were statistically signiﬁcant dif-
ferences between patients who completed the CR programme and those who did not.
There were twice as many current smokers in the group who did not complete CR.
A greater proportion of patients with elementary occupations did not complete, and
a higher proportion of managers and senior oﬃcials did complete. The patients who
completed CR included 1.47% who reported no social support at all, whilst 4.48% of
the non-completers reported no social support at all. Those who did not complete
CR had a lower median ﬁtness and greater median depression and anxiety than those
who completed CR.
The mean age of the cohort was 62 years, with females (mean age 64.7 years)
statistically signiﬁcantly older than males (mean 61.0). The majority of patients
were male (79.8%). Females were less ﬁt than males (median V O2 of 14.0ml/kg/min
compared with 20.2ml/kg/min) and had higher median HADS anxiety scores (7 cf 6)
and depression (4 cf 3). 4.6% of the cohort showed signs of being clinically depressed
at baseline with 10.6% borderline on the depression scale. Myocardial infarction
(MI) was the most common reason for referral (53.5%) with coronary artery bypass
graft (25.4%) next and then angioplasty (PCI) (9.3%, a further 3.7% with MI plus
PCI). Current smoking was reported in 8.9% of the patients, with a further 30.6%
who had given up smoking within the previous year.
Comparison of those measures taken both before and after CR showed a
16.8% improvement in mean ﬁtness, but systolic and diastolic blood pressure rose
signiﬁcantly (the expectation is that systolic blood pressure falls with increasing
ﬁtness). Almost half the patients categorised as low ﬁtness at baseline moved into
the medium ﬁtness category by the end of CR, and just over half from the medium
into the high ﬁtness category, whilst very few moved to a lower ﬁtness category.
Anxiety and depression median scores and mean weight decreased signiﬁcantly, and
perception of social support rose.
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Variable Male Female Total
Number 1320 (86.3%) 209 (13.7%) 1529 (100%)
Mean years of follow-up (sd) 11.3 (3.8) 11.1 (3.6) 11.3 (3.7)
Mean age in years (sd) 61.0 (9.4) 62.9 (9.0) 61.3 (9.4)
N % N % N %
Age group under 50 years 158 11.9 19 9.1 177 11.5
Age group 50-59 years 405 30.7 50 23.9 455 29.8
Age group 60-69 years 500 37.9 85 40.7 585 38.3
Age group 70 years and over 257 19.5 55 26.3 312 20.4
Diagnostic Category
Myocardial Infarction (MI) 673 51.0 108 51.7 781 51.1
Coronary Artery Bypass
Graft (CABG) 382 28.9 51 24.4 433 28.4
Percutaneous Coronary
Intervention (PCI) 124 9.4 22 10.5 146 9.5
MI + PCI 56 4.3 7 3.3 63 4.1
Angina 61 4.6 19 9.1 80 5.2
Other cardiac 24 1.8 2 1.0 26 3.8
Smoking history
Never smoked 347 26.3 93 44.4 440 28.8
Not for 10 years+ 430 32.6 30 14.4 460 30.1
Not for 1-10 years 56 4.2 9 4.3 65 4.3
Recent quitter 407 30.8 64 30.6 471 30.8
Current smoker 80 6.1 13 6.3 93 6.0
D'Hoore Co-morbidity score
None 968 73.3 141 67.5 1109 72.5
1 (least) 150 11.4 22 10.5 172 11.2
2 168 12.7 42 20.1 210 13.7
3 21 1.6 3 1.4 24 1.6
4 (most) 13 1.0 1 0.5 14 1.0
Diagnosis of diabetes 158 12.0 29 13.9 187 12.2
Family history of CHD 613 46.4 115 55.0 728 47.6
Weight at baseline
A under 75kg 407 30.8 144 68.9 551 36.0
B 75-90kg 608 46.1 39 18.7 647 42.3
C over 90kg 305 23.1 26 12.4 331 21.7
Medications
ACE inhibitor No 665 50.4 88 42.1 753 49.2
ACE inhibitor Yes 655 49.6 121 57.9 776 50.7
Aspirin No 45 3.4 12 5.7 57 3.7
Aspirin Yes 1275 96.6 197 94.3 1472 96.3
Table 3.3: Baseline values for patients at recruitment to the programme.
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Variable Male Female Total
N % N % N %
Statin No 455 34.5 57 27.3 512 33.5
Statin Yes 865 65.5 152 72.7 1017 66.5
Beta blockers No 727 55.1 108 51.7 835 54.6
Beta blockers Yes 593 44.9 101 48.3 694 45.4
Occupation
Managers & senior oﬃcials 236 17.9 16 7.6 252 16.5
Professional Occupations 143 10.8 11 5.3 154 10.1
Associate Professional 145 11.0 25 12.0 170 11.1
Administrative & secretarial 125 9.5 67 32.1 192 12.6
Skilled trade 362 27.4 13 6.2 375 24.5
Personal service 23 1.7 34 11.5 47 3.1
Sales and customer 26 2.0 16 7.6 42 2.7
Process, plant & machines 155 11.7 12 5.7 167 10.9
Elementary occupations 105 8.0 25 12.0 130 8.5
Fitness
High baseline 590 44.7 29 13.9 619 40.5
Mid baseline 509 38.6 81 38.7 590 38.6
Low baseline 221 16.7 99 47.4 320 20.9
Depression at baseline
Not depressed 1162 88.0 160 76.6 1322 86.5
Borderline 113 8.6 36 17.2 149 9.7
Depressed 45 3.4 13 6.2 58 3.8
Anxiety at baseline
Not anxious 930 70.5 122 58.4 1052 68.8
Borderline 251 19.0 42 20.1 293 19.2
Anxious 139 10.5 45 21.5 184 12.0
Median baseline estimated
V O2 ml/kg / min 21.0 15.5 20.1
(10th, 90th percentiles) (13.09, 29.70) (8.38, 24.50) (11.0, 29.2)
Table 3.4: baseline values of patients at recruitment to the programme, continued.
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3.2.5 Discussion
Before the work of ST, the evidence base for cardiovascular rehabilitation consisted
of studies on mainly male patients in the middle age bracket with a low risk for a
further cardiac event, and could not be generalised to females, to the elderly or to
those with signiﬁcant co-morbidity. Improved treatments and advancing diagnostic
techniques have changed the proﬁle of the cardiac rehabilitation population. The def-
inition of myocardial infarction was changed again in 2005 (Thygesen et al. [2012]),
with increased diagnosis including more patients than under the old, narrower deﬁ-
nition. Many patients now have a diagnosis before suﬀering a myocardial infarction
and have revascularisation (bypass) surgery or angioplasty and stenting (where the
artery is opened up and a stent inserted to prevent it narrowing again). These pa-
tients have a swifter initial recovery period and can progress more quickly to Phase
III exercise, and undertake a greater intensity of exercise. In addition, post-event
medication has improved, with the use of cholesterol reduction with statins, ACE
inhibitors, beta-blockers and anti-platelet therapy becoming standard and helping
secondary prevention of coronary heart disease.
This cohort of patients was more representative than that of previous studies be-
cause it was an observational study of all those coming through the Basingstoke and
Alton Cardiac Rehabilitation programme over a period of ten years. These include
both elderly and female patients and those with signiﬁcant co-morbidity, unlike the
previous studies, which were small randomised controlled trials and meta-analyses.
This cohort was also larger than other studies with 2,714 patients included in the
study, giving it greater credibility.
This work was limited by the need to measure ﬁtness using a treadmill or bicycle
ergometer, rather than with sophisticated lab equipment. However, the equipment
used is typical of the facilities used in NHS clinics, giving the work practical ap-
plicability. A further limitation was the small numbers of patients exhibiting signs
of clinical depression using HADS, which limits the power of the data set to detect
the inﬂuence of depression in the mortality of this cohort. Statins were not widely
available until the mid 1990s and ACE inhibitors were less commonly prescribed
until mid-way through the study period. There is variability in the drug protocol for
patients which is time-dependent, further limiting the applicability. Nevertheless,
this data provides an important opportunity for understanding a typical cardiac
rehabilitation cohort, especially since most of the previous studies have restricted
eligibility for participation in ways which make the population under consideration
atypical.
62
The Cox proportional hazards survival model was built using the 385 deaths
from all causes (25.2% of 1,529) including 192 (12.6%) from cardiovascular causes
as at March 2011. Age, gender, diagnosis, co-morbidity score, ﬁtness category after
CR and ﬁtness category before CR were all signiﬁcant in explaining both all-cause
and cardiovascular deaths. There was evidence that depression increased mortality,
but this became not signiﬁcant when ﬁtness category was added to the model.
The next chapter introduces the methods used in the re-analysis of these two
data sets.
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Chapter 4
Methods 1: Conventional Methods
`The study of complex systems is about understanding indirect eﬀects. Problems that
are diﬃcult to solve are hard to understand because the causes and eﬀects are not
obviously related' New England Complex Systems Institute (NECSI Team [2000]).
Health care data are often complex because, although the eﬀects are seen,
the mechanism which connects causes to eﬀects is not well understood, for example
the connection between patient attitude of mind and physical illness and symptoms.
There is usually structure in medical data due to correlations between data collected
at similar times or locations, and especially from the same patient. Data may also
vary over time and space, and in a medical context this can mean slow changes in
treatments over time due to new discoveries, equipment and policies, variation in
treatment protocols between countries or hospitals, and even new diseases or redeﬁ-
nitions of existing ones. The two medical data sets we consider here are both complex
in most of these ways. They are also both observations from complex interventions,
treatments having many parts which may act independently or interdependently, as
detailed on page 1 (Campbell et al. [2000]). In order properly to evaluate the contri-
bution made by the artiﬁcial neural network (ANN) approach to complex health care
data, it is ﬁrst necessary to analyse the data using conventional methods to establish
a baseline against which to compare the performance, advantages and disadvantages
of the ANNs. In this chapter, the conventional methods used on each data set are
explained. The results of conventional analysis were used as a basis for comparison
of the outputs of the non-linear ANN models, to make a valid judgment as to the
additional information provided by adding the non-linearity in the model by this
method.
The ﬁrst commonly used method is latent class analysis, a model-based approach to
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dividing units of observation (often people) into subgroups. The subgroups cannot
be observed directly, but are observed indirectly by means of two or more observed
variables. This technique is applied to the Back Skills Training trial (BeST) data
to ascertain if there are `types' of patients whose response to this treatment diﬀers.
This is then a basis for comparison of the ability of the ANN to distinguish between
patients with a positive response to the treatment and those without.
The second conventional method is standard survival analysis using the Cox propor-
tional hazard model and this is applied to the Cardiovascular Rehabilitation (CR)
data. This is then a basis for comparison of the ability of the ANN to produce a
survival curve and to predict, both in the short and long term, the survival prob-
ability for a given patient. The further conventional method described here and
used to explore the data is multiple imputation for missing data. This is required in
the analysis of the cardiovascular rehabilitation data to assess the impact of missing
data in real data sets. These will not be modelled directly by the artiﬁcial neural
network, but their impact on predictions was assessed.
4.1 Latent Class Analysis
Latent Class Analysis (LCA) is a method for identifying sub classes of people used
in many ﬁelds, for example ADHD and comorbid symptoms in a population sample
of adolescent female twins (Neuman et al. [2001]), longitudinal cohort study on back
pain (Dunn et al. [2006]), symptom proﬁles of persons who experience traumatic
events (Breslau et al. [2005]), satisfaction-with-life-domain proﬁles (Eid et al. [2003]),
identifying clinically distinct subgroups of self-injurers among young adults (Klonsky
and Olino [2008]), eating disorder phenotypes (Keel et al. [2004]), developmental
trajectories of crime (Eggleston et al. [2004]), ADHD symptoms in a school sample of
Brazilian adolescents (Rohde et al. [2001]), human herpes virus 8 assay performance
and infection prevalence in sub-Saharan Africa and Malta (Engels et al. [2000]),
course of depressive symptoms after myocardial infarction and cardiac prognosis
(Kaptein et al. [2006]), child behaviour checklist anxiety and depression in children
and adolescents (Wadsworth et al. [2001]), country and consumer segmentation of
ﬁnancial product ownership (Bijmolt et al. [2004]), symptoms associated with chronic
fatigue syndrome and ﬁbromyalgia (Sullivan et al. [2002]), distinguishing phenotypes
of childhood wheeze and cough (Spycher et al. [2008]), underage problem drinking
of 16 to 20 year olds (Reboussin et al. [2006]).
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4.1.1 Introduction to latent class analysis
The objective of LCA is to categorise people into classes using the observed variables
and to identify those items which best distinguish between classes (Nylund et al.
[2007]).
LCA was introduced as a way of formulating latent variables from dichotomous
survey items in data about attitudes (Lazarsfeld and Henry [1968]). LCA models
identify an error-free latent class variable, which is unobserved and categorical, by
measuring a number of observed response variables, which are assumed to be subject
to error. Statistical analysis based on latent variable models attempts to separate the
latent variable and the measurement error (Collins and Lanza [2010]). LCA models
assume that the latent variable is categorical, in contrast to factor analysis which
posits continuous latent variables. Factor analysis is a variable-oriented approach
where the focus is to identify the relationship between variables which, it is supposed,
applies across all people. LCA is a person-oriented approach which seeks to identify
subtypes of individuals who exhibit similar patterns of individual characteristics. In
this application the aim is to identify patient types and their likely responses to the
complex intervention tested in the BeST trial. For this reason, the patient-oriented
LCA approach was used.
LCA assumes that each observation (patient) is a member of one, and only one, of C
latent classes. The classes are not observed directly, but observed via the responses
of the individuals given to the variables measured. The categorical latent variable
which we seek to discover, L, has c = 1 . . . C latent classes. The prevalence of each
latent class is the probability of membership in latent class c of latent variable L,
and is denoted γc. Since the latent classes are mutually exclusive and exhaustive,
the prevalences sum to one
C∑
c=1
γc = 1 (4.1)
In general, the latent class model has j = 1 . . . J observed variables and observed
variable j has rj = 1 . . . Rj response categories. Cross tabulating the J variables
forms a contingency table with W =
∏J
j=1Rj cells. The entire range of possible
combinations of responses forms an array of response patterns Y with W rows and
J columns. Each response pattern y is associated with a probability P (Y = y) and∑
P (Y = y) = 1. The item-response probability ρj,rj |c is the probability of response
rj being given to observed variable j, conditional on membership in latent class c.
For example, the probability of a patient being classiﬁed `clinically anxious', given
they have been assigned to a certain class. Since each patient provides only one of
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the response alternatives to variable j, the vector of item-responses for a particular
variable conditional on a particular latent variable sums to 1
Rj∑
rj=1
ρj,rj |c = 1 ∀ j (4.2)
If yj represents element j of response pattern y, and indicator function I(yj = rj) = 1
when the response to variable j = rj , and 0 otherwise, then the probability of
observing a particular vector of responses is given by
p(Y = y) =
C∑
c=1
γc
J∏
j=1
Rj∏
rj=1
ρ
I(yj=rj)
j,rj |c . (4.3)
The log likelihood function that is maximised with respect to ρj,rj |c and γc in a data
set with N observations is
ln L =
N∑
i=1
ln
C∑
c=1
γc
J∏
j=1
Rj∏
rj=1
ρ
I(yj=rj)
j,rj |c . (4.4)
The expectation-maximisation (EM) algorithm (Dempster et al. [1977]) is
often used to estimate the parameters in LCAmodels. Finding a maximum likelihood
solution requires taking the derivatives of the likelihood function with respect to all
the unknown values, resulting in a set of interdependent equations in which solving
for the parameters requires the latent variables and vice-versa. This is overcome by
an iterative algorithm which estimates the parameters and the latent variables by
ﬁrst picking values for one and then using those values in solving for the other. Then
those solutions are used in ﬁnding better estimated for the ﬁrst, and so on. This is
repeated until the log likelihood ceases to increment beyond some arbitrarily small
value (Linzer and Lewis [2011a])
There are few modelling assumptions associated with LCA; the one funda-
mental assumption is that, conditioned on the latent variable, the observed variables
are independent. This is called the assumption of local independence, and underpins
equation (4.3) so that the responses are conditioned on the classes and not also on
each other. This is not to say that the the observed variables in the data set to be
analysed are independent, but that the relations among the observed variables are
explained by the latent classes. The latent classes are assumed nominal and their
categorical indicators (the variables used to identify the classes) have a joint multi-
nomial distribution. It is therefore unnecessary to assume a distributional form, for
example, a multivariate normal distribution on the model.
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4.1.2 Model selection
Since item-response probabilities are not regression coeﬃcients but conditional prob-
abilities, it is necessary to examine the pattern of item-response probabilities across
all response alternatives for the variable and across all latent classes and not just
a single probability when determining the strength of the relation of the observed
variable and the latent variable (Collins and Lanza [2010]). There are two criteria
which together reveal a strong relation between an observed variable j, and a latent
variable L, namely an array of item-response probabilities that are close to 0 or 1
corresponding to the variable j and a distribution for the conditional probabilities
ρj,rj |c that varies across the latent classes. When the observed variable and the latent
variable are independent, the conditional probabilities are the same as the variable's
marginal proportions for each response, i.e. ρj,rj |c = Pj,rj . When they are not in-
dependent, we have ρj,rj |c 6= ρj,rj |c′ for some c and c′. If ρj,rj |c = 1 for rj = k, then
ρj,rj |c = 0 ∀ rj 6= k i.e. conditional on membership of class, a particular response (k)
can be determined with certainty. An item response probability of 1 clearly reﬂects
a high degree of certainty. An item response probability, rj , of 0 also reﬂects a high
degree of certainty, and if there are just two response alternatives, then the other
response must have probability 1. In such a case, 0 reﬂects as much certainty as
1, but if there are more alternatives, a 0 probability for one response does not give
any information on the probability of other responses. Where the marginal response
proportions are close to 0 and 1, then independence between the observed variable
and the latent variable cannot be discounted, hence the requirement for both criteria
in determining the strength of the relation.
Homogeneity and latent class separation are helpful aids to interpretation of the
latent classes. Latent class c is highly homogeneous when members of c are highly
likely to provide the same observed response pattern, implying this response pat-
tern is characteristic of latent class c. If the response patterns seen in class c are
highly variable, then there is low homogeneity. Recalling equation (4.3) and that
γc = P (L = c),
p(Y = y|L = c) =
J∏
j=1
Rj∏
rj=1
ρ
I(yj=rj)
j,rj |c . (4.5)
Homogeneity of latent class c is perfect when ρj,rj |c is 0 or 1 for all variables j and
all response categories rj . In this case, there is a unique response pattern y′ for
which P (Y = y′|L = c) = 1 when ρj,rj |c = 1 ∀ ρ 6= 0 and P (Y = y′|L = c) = 0 for
all the remaining response patterns. Good latent class separation occurs when the
pattern of item-response probabilities across indicator variables clearly diﬀerentiates
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among the latent classes. Perfect latent class separation is seen when for each latent
class c′ there is a unique response pattern y′ for which P (Y = y′|L = c′) = 1 and
P (Y = y′|L = c) = 0 ∀ c 6= c′. Homogeneity and latent class separation are based on
the same quantities and a high degree of latent class separation implies a high degree
of homogeneity since if for latent class c′, P (Y = y′|L = c′) = 1 then it follows that
P (Y = y′|L = c) = 0 ∀ c 6= c′. Perfect homogeneity for latent class c′ requires P (Y =
y′|L = c′) = 1 but this does not give any information about the homogeneity of the
other classes; 1 ≥ P (Y = y′|L = c) ≥ 0 holds for c 6= c′. Homogeneity and latent
class separation are closely related to uncertainty in probability of membership in
class c conditional on response pattern y, P (L = c|Y = y). To obtain an expression
for this, equations (4.3) and (4.5) are substituted into Bayes' theorem
P (A|B) = P (B|A)P (A)
P (B)
(4.6)
which in the LCA context becomes
P (L = c|Y = y) = P (Y = y|L = c)P (L = c)
P (Y = y)
(4.7)
substituting equations (4.3) and (4.5),
P (L = c|Y = y) =
(
∏J
j=1
∏Rj
rj=1
ρ
I(yj=rj)
j,rj |c )γc∑C
c=1 γc
∏J
j=1
∏Rj
rj=1
ρ
I(yj=rj)
j,rj |c
. (4.8)
Equation (4.8) can be used to obtain a vector of classiﬁcation probabilities for each
individual based on that individual's observed response pattern and the latent class
prevalence and item-response probabilities from any latent class model ﬁt to the
data. The vector will include the probability of membership in each of the C latent
classes for that individual (Collins and Lanza [2010]) and will sum to 1. These pos-
terior probabilities tend to be large for one single latent class and small for all others
where there is both strong latent class separation and strong homogeneity, i.e there
is little classiﬁcation uncertainty. When either homogeneity or class separation is
weak, there is greater classiﬁcation uncertainty seen as posterior probabilities which
are more similar across latent classes.
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4.1.3 Latent class analysis in R
The R package poLCA (R Development Core Team [2011]) was used to build the
Latent class models. The poLCA package uses the expectation-maximisation and
Newton-Raphson methods to ﬁnd maximum likelihood estimates of the model pa-
rameters, the proportions of observations in each class, γc, and the probabilities of
observing each response to each manifest variable conditional on latent class, ρj,rj |c,
(Linzer and Lewis [2011b]). In order to ensure a global maximum likelihood has been
obtained, rather than a local one, use was made of the facility within the poLCA
package to re-estimate the model automatically a speciﬁed number of times and
then retain the models with the greatest likelihood. Ten replications were speciﬁed
and a maximum of up to 10,000 iterations, to ensure convergence to the parameter
estimates that produce the global maximum likelihood. Several repeats of model-
ﬁtting with these settings produced models with consistent maximum log likelihood,
parsimony measures AIC (equation (4.23)) and BIC (equation(4.24)), likelihood ra-
tio (G2) (Equation (4.22)), and Pearson's χ2 goodness of ﬁt for observed versus
predicted cell counts. The optimal number of latent classes is not automatically
determined by the package but speciﬁed by the user, so in the case of the BeST
data, models with two to six models were ﬁtted and compared using the goodness
of ﬁt statistics listed above. Evaluation of diﬀerent information criteria for assess-
ing the number of latent classes has been investigated through a simulation study
(Yang [2006]). The performance of the various criteria was aﬀected by sample size
and number of latent classes in the underlying simulated data. AIC out-performed
BIC at the sample sizes and for the range of latent class numbers investigated here.
But in a subsequent simulations study, BIC was found to perform more accurately
(Nylund et al. [2007]). Therefore, both are considered in the analysis of the BeST
data given on page 108
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4.2 Survival Analysis
Survival analysis is the phrase used to describe the analysis of data in the form of
times from a well-deﬁned time origin until the occurrence of some particular event or
end-point. In medical applications, these often correspond to recruitment of a patient
into the study and an event such as recurrence of illness or patient death respectively.
This approach is widely described as time-to-event analysis, since the methodology
used in modelling survival of patients can also be used in other applications, such as
failure times of plant and machinery in reliability analysis, time to drop-out from a
course of study in education research, etc. Survival (or reliability) data are said to
be censored when the event of interest is not observed. Often censoring occurs when
the data from a medical study, where the end-point of interest is patient death, are to
be analysed at a point in time when some of the individuals are still alive. Censoring
can also occur when the survival status of one or more individuals is not known at
the date of analysis because they have been lost to follow-up, perhaps because they
have relocated and their current address is unknown to the study team, or because
they died of another cause, such as a road traﬃc accident rather than the event of
interest. Through a modelling approach to the analysis of survival data, the survival
experience of a group of patients, and how it depends on the values of one or more
explanatory variables, whose values have been recorded for each patient at the time
origin, can be explored (Collett [2003]).
4.2.1 Introduction to survival analysis
Informative censoring
An important assumption in the analysis of censored survival data is that the ac-
tual survival time of an individual, t, is independent of any mechanism that causes
an individual's survival time to be censored at time c, where c < t. This means
that if we consider a group of individuals, all of whom have the same values of
relevant prognostic variables, an individual whose survival time is censored will be
representative of those at risk at the censoring time if the censoring process oper-
ates randomly. When survival data are to be analysed at a predetermined point in
calendar time, or at a ﬁxed interval of time after the origin for each patient, the
prognosis for individuals who are still alive can be taken to be independent of the
censoring, so long as the time of analysis is speciﬁed before the data are examined.
Informative censoring is the case where the censoring is related to the survival time,
such as if patients in a trial comparing treatments were withdrawn from one arm of
the study because that treatment caused life-threatening side eﬀects. The survival
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rates for that treatment would appear larger than they were, leading to an incorrect
estimate of the treatment diﬀerence. In such a case, sensitivity analysis is performed
to compare the original data analysis to analysis which ﬁrst assumes the censored
patients were high risk and experienced the event right after censoring, and then
assumes they were low risk and survived the longest. If informative censoring begins
only after a signiﬁcant period of time, survival up to onset of censoring cause can be
analysed. The assumption of uninformative censoring can be examined by plotting
observed survival times against the values of explanatory variables, distinguishing
censored from uncensored survival times. If there is a greater proportion of censored
survival times in patients with a particular range of values of explanatory variables,
there is evidence of informative censoring.
Kaplan-Meier estimate of the survivor function
The ﬁrst step in the analysis of censored survival data is often to calculate the
Kaplan-Meier estimate of the survivor function, Sˆ(t), from the data. It can be
shown that the Kaplan-Meier estimator maximizes the generalized likelihood over
the space of all distributions so its evaluation on large data sets gives a good qual-
itative description of the true survival function (Eleuteri et al. [2003]). To obtain a
Kaplan-Meier estimate, a series of time-intervals is created, each containing a single
death time. Each death event is assumed to have occurred at the beginning of the
time interval. The Kaplan-Meier estimate of the survivor function is based on the
assumption that the r death times of the n individuals in the sample occur inde-
pendently of one another. If nj individuals are alive just before dj deaths occur at
time tj then the estimated probability of survival through the time interval from
tj − δ to tj , where δ is small and contains only one death, is (nj−dj)nj . Then, the
estimated survivor function at any time, t, in the kth constructed time interval from
t(k) to t(k+1) , k = 1, 2, . . . , r, where t(r+1) is deﬁned to be ∞, will be the estimated
probability of surviving beyond t(k). This is actually the probability of surviving
through the interval from t(k) to t(k+1) and all the preceding intervals, and leads to
the Kaplan-Meier estimate of the survivor function, which is given by:
Sˆ(t) =
k∏
j=1
(nj − dj)
nj
(4.9)
for t(k) ≤ t < t(k+1).
72
Basic equations of survival modelling
Survivor function is the probability that the survival time T is greater than some
value t:
S(t) = P (T ≥ t). (4.10)
F (t) is the cumulative density function of T , and f(t) is the probability density
function of T :
F (t) = P (T < t) =
∫ t
0
f(u)du = 1− S(t), (4.11)
so
f(t) =
dF (t)
dt
= −S′(t). (4.12)
The hazard function is the risk or hazard of death at time t, and is derived from the
probability that an individual dies at time t conditional on their having survived up
to that time. This conditional probability is expressed as probability per unit time
by dividing by the time interval δt to give a rate (sometimes called the hazard rate,
the force of mortality, or the instantaneous death rate), and the hazard function,
h(t), is the limiting value as δt tends to zero. This leads to:
h(t) =
f(t)
S(t)
= − d
dt
(logS(t)) . (4.13)
The cumulative hazard, H(t) is
H(t) =
∫ t
0
h(u)du = −logS(t), (4.14)
so that
S(t) = exp (−H(t)) . (4.15)
When ﬁtting survival models to data, estimates of the unknown parameters are found
by maximising the logarithm of the likelihood.
The likelihood function for randomly censored data
When the censoring times are not informative, the likelihood function is derived
(Collett [2003]) as follows:
The likelihood function for randomly censored data of n individuals, with observed
time ti for ith individual, i = 1, 2, . . . , n, and event indicator ∆ which takes the value
∆ = 1 if ti is an event time and ∆ = 0 if the event of interest is censored.
Let Ti be the random variable associated with event time of the ith individual and
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Ci be the random variable associated with time to censoring. Then the value ti is
an observation on the random variable τi = min(Ti, Ci). The density function of
Ti is fT i(t) and the survivor function ST i(t). Similarly, the the random variable
associated with censoring time Ci has density function fCi(t) and survivor function
SCi(t).
The probability density distribution for the pair (τi,∆i) for censored observations,
so that ∆ = 0 is described by
p(τi = t,∆i = 0) = P (Ci = t, Ti > t).
This joint probability is a mixture of continuous and discrete components but to
simplify the presentation, P (Ti = t), for example, will be understood to be the
probability density of function of Ti. Assuming independence of the event time
distribution Ti from censoring time Ci,
P (Ci = t, Ti > t) = P (Ci = t)P (Ti > t)
= fCi(t)STi(t)
,
and so
P (τi = t,∆i = 0) = fCi(t)STi(t).
Similarly, if the observations are not censored, so that ∆ = 1
P (τi = t,∆i = 1) = P (Ti = t, Ci > t)
= P (Ti = t)P (Ci > t)
= fTi(t)SCi(t)
,
again assuming that the distributions of Ci and Ti are independent.
Combining these results, the joint probability, or likelihood of the n observations,
t1, t2, . . . , tn, is
n∏
i=1
(fTi(ti)SCi(ti))
∆i(fCi(ti)STi(ti))
(1−∆i)
which can be written as
n∏
i=1
(fCi(ti)
(1−∆i)SCi(ti))
∆i ×
n∏
i=1
(fTi(ti)
∆iSTi(ti))
(1−∆i).
Under the conditions of non-informative censoring, the ﬁrst product will not contain
any parameters that are relevant to the distribution of survival times, and so can be
regarded a constant. The likelihood of the observed data is therefore proportional
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to the second product:
L =
n∏
i=1
(fTi(ti)
∆iSTi(ti))
(1−∆i). (4.16)
Log-likelihood is
log L =
n∑
i=1
[∆i log(f(ti)) + (1−∆i) log(S(ti))] (4.17)
which can be maximised to ﬁt a survival model to data.
4.2.2 Cox proportional hazards model
The Kaplan Meier estimate of the survival function is a non-parametric approach. In
most medical studies, survival data is supplemented by physiological variables and
lifestyle factors which can be used as explanatory variables. Statistical modelling
is used to explore how the survival experience of a group of patients depends on
the explanatory variables, whose values have been recorded for each patient. In the
analysis of survival data, the risk or hazard of death at any time after the origin of
the study is the centre of interest. As a consequence, the hazard function is modelled
directly in survival analysis.
The most widely used survival speciﬁcation which takes into account the sys-
tem features is the proportional hazards model. The two most common approaches
are either to choose a parameterized functional form for the baseline hazard and
then make use of Maximum Likelihood to ﬁnd values for those parameters, or to
make a Maximum Likelihood estimation of only the feature dependent part of the
model without ﬁxing the baseline hazard, and derive a non-parametric estimate for
the baseline hazard (Eleuteri et al. [2003]).
There are two broad reasons for modelling survival data. One objective of the
modelling process is to determine which combination of potential explanatory vari-
ables aﬀects the form of the hazard function, H(t). In particular, the eﬀect that the
treatment has on the hazard of death can be studied, as can the extent to which the
other explanatory variables aﬀect the hazard function. Another reason for modelling
the hazard function is to obtain an estimate of the the hazard function itself for an
individual, in contrast to regression analysis where the mean response is modelled.
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This hazard function may be of interest in its own right, but in addition, from the
relationship between the survivor function and hazard function described in equation
(4.15), an estimate of the survivor function can be found for the individual. This
will in turn lead to an estimate of quantities such as the median survival time, which
will be a function of the explanatory variables in the model. The median survival
time could then be estimated for current or future patients with particular values of
these explanatory variables. The resulting estimate could be particularly useful in
devising a treatment regimen, or in counselling a patient about their prognosis.
When the hazard of death at any time for any individual in one group is proportional
to the hazard at that time for a similar individual in another group, the assumption
of proportional hazards may be employed. The proportional hazard model proposed
by Cox in 1972 is based on the assumption of proportional hazards, and since no par-
ticular form of probability distribution is assumed for the survival times, the model
is a semi-parametric model.
Let the set of values of the explanatory variables in the proportional hazards model
be the vector x = (x1, x2, . . . , xp)′. When the values of all the explanatory variables
that make up the vector x are zero, the hazard function is called the baseline hazard
function, h0(t). The hazard function for the ith individual can then be written
hi(t) = ν(xi)ho(t), (4.18)
where ν(xi) is a function of the values of the vector of explanatory variables for the
ith individual, and can be interpreted as the hazard at time t for an individual whose
explanatory variable is xi 6= 0 relative to an individual whose explanatory variable is
xi = 0. Since the relative hazard ν(xi) cannot be negative, it is convenient to write
it as exp(ηi) where (ηi) is a linear combination of the explanatory variables. The
general proportional hazards model then becomes
hi(t) = exp(β1x1i + β2x2i + . . .+ βpxpi)h0(t) (4.19)
so that the log of the hazard ratio is a linear regression:
ln
(
hi(t)
h0(t)
)
= β1x1i + β2x2i + . . .+ βpxpi. (4.20)
The estimation of the β parameters in the linear component of a propor-
tional hazards models is all that is required to draw inferences about the eﬀect of
explanatory variables in the model on the hazard function. These can then be used
to estimate the hazard function itself, and the corresponding survivor function. The
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estimates of the baseline hazard, survivor and cumulative hazard functions can be
used to obtain corresponding estimates for an individual patient with vector of ex-
planatory variables xi.
Factors can be included in the Cox model in the same way as variates, except
that one level of the factor has to correspond to the baseline hazard, and so the
other levels of the factor are expressed in proportion to this reference level. Similarly,
interactions between factors can be included along with their relevant main eﬀects,
as can mixed terms formed of an interaction between a factor and a variate. Fitting
the Cox model entails estimating the unknown coeﬃcients (βi) of the explanatory
variables using the method of maximum likelihood to give the maximum likelihood
estimates. Cox showed that the relevant likelihood function for the proportional
hazards model is given by
L(β) =
r∏
j=1
exp(β′x(j))∑
l∈R(t(j))
exp(β′xl)
. (4.21)
where R(t(j)) is the set of individuals at risk at time tj , i.e those alive and uncensored
at a time just prior to tj . The proportional hazard model for survival data assumes
the hazard function is continuous and under such an assumption, tied survival times
are not possible. In practice, the recording of deaths to the nearest day, month or
year can give rise to tied survival times. Kalbﬂeisch and Prentice gave the appro-
priate likelihood function for this case (Kalbﬂeisch and Prentice [2002]), but often a
simpler approximation to the likelihood function is used. This work uses the Breslow
method for tied times (Breslow [1975]). Having estimated the coeﬃcients (βs), the
approximate 95% conﬁdence interval can be calculated using the standard normal
distribution. Evidence that the value of β is not zero is given if this interval does
not contain zero, and testing the null hypothesis β = 0 using the statistic βˆ
seβˆ
using
the standard normal distribution gives a small p-value, also provides such evidence.
Equivalently, the Wald test uses the square of this statistic compared to the per-
centage points of a χ2 distribution. In the usual case where there are a number of
explanatory variables, the eﬀect of each term depends on the other terms currently
in the model. If another model is built using a subset of the terms in the origi-
nal model, it is said to be parametrically nested within the original model. Nested
models can be compared using the ratio of their likelihoods, and
−2 log
(
Lˆ(1)
Lˆ(2)
)
(4.22)
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follows a χ2 distribution with degrees of freedom equal to the diﬀerence between the
number of independent β parameters between the nested models, q. Comparison of
models, which need not be nested, can be made using Akaike's information criterion
AIC or Bayesian information criterion (BIC) which both take account of the number
of parameters and are deﬁned as:
AIC = −2 ln Lˆ+ 2q, (4.23)
BIC = −2 ln Lˆ+ q ln (n) (4.24)
The smaller the value of the AIC or BIC, the better the model ﬁt; the value of the
information criteria will rise when unnecessary parameters are added to a model,
although the AIC penalises the number of parameters less strongly than does the
BIC.
The usual recommended strategy for model selection is ﬁrst to use each vari-
able as a lone predictor and ascertain which models are a signiﬁcant improvement
on the null model, h0(t). These variables are then ﬁtted together in a single model,
and nested models formed by removing each variable in turn are tested, with those
leading to a signiﬁcant decrease in the −2 log Lˆ retained in the model, and the
remainder removed. Variables which were not signiﬁcant as sole predictors are then
added one at a time and the same statistic is used to determine if they have become
signiﬁcant in the presence of other variables. Only after this are interactions and
other higher order terms (such as powers of variates) tested for inclusion. Higher
order terms are used to capture non-linearity suspected of existing in the system.
When a model has been selected by this optimisation procedure, the coeﬃcients of
each variate are interpreted as the logarithms of the ratio of the hazard of death
to the baseline hazard. The linearity assumption means that the hazard ratio, for
example between a patient aged 80 relative to to one age 75, is the same as the
hazard ratio between a patient aged 20 relative to one aged 15. If this assumption
does not hold, the variate can be divided into levels of a factor and these can be
tested for inclusion in the model instead.
Although the proportional hazards model ﬁnds widespread applicability in
the analysis of survival data, there are relatively few probability distributions for
the survival times that can be used with this model. Moreover, the distributions
that are available, principally the Weibull and Gompertz distributions, lead to haz-
ard functions which increase or decrease monotonically.
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A model that encompasses a wider range of survival time distributions is the
accelerated failure time model. In circumstances where the proportional hazards as-
sumption is not tenable, models based on this general family may prove to be fruitful.
Again, the Weibull distribution may be adopted for the distribution of survival times
in the accelerated failure time model, but some other probability distributions are
also available.
One other general family of survival models, known as the proportional odds
model, may be useful in some circumstances. Although any continuous distribution
for non-negative variables might be used, the properties of the log-logistic distribu-
tion make it a particularly attractive alternative to the Weibull distribution. The
lognormal, gamma and inverse Gaussian distributions are sometimes used in accel-
erated failure time modelling.
One limitation of the Weibull hazard function is that it is a monotonic func-
tion of time. However, for example, following a heart transplant, a patient faces an
increasing hazard of death over the ﬁrst 10 days or so while the body adapts to the
new organ. The hazard then decreases with time as the patient recovers. The log-
logistic distribution is so called because the variable log T has a logistic distribution,
a symmetric distribution whose probability density function is very similar to that
of the normal distribution.
The gamma distribution, like the Weibull distribution, includes the exponen-
tial distribution as a special case. Indeed the gamma distribution is quite similar to
the Weibull distribution and and inferences based on either model will often be very
similar. The generalised gamma distribution is actually more useful and includes
the Weibull and lognormal distributions as special cases.
The inverse Gaussian is a ﬂexible model that has some important theoretical prop-
erties, but the complicated form of the survivor function makes this distribution
diﬃcult to work with.
When the number of observations in a single sample is reasonably large, an em-
pirical estimate of the hazard function could be obtained using the life table or
Kaplan-Meier methods. A plot of the estimated hazard function may then suggest
a suitable parametric form for the hazard function.
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Model Checking
If the model ﬁtted to the observed data is satisfactory, then a model-based estimate
of the survivor function Sˆi(ti) for the ith individual at ti, the survival time of that
individual, will be close to the corresponding true value Si(ti). This suggests that
if the correct model has been ﬁtted, the values Sˆi(ti) will have properties similar to
those of Si(ti). Then the negative logarithms of the estimated survivor functions,
−log Sˆi(ti), i = 1, 2, . . . , n will behave as n observations from a unit exponential
distribution. These estimates are the Cox-Snell residuals. If the observed survival
time for an individual is right-censored, then the corresponding value of the residual
is also right-censored. The residuals will therefore be a censored sample from the
unit exponential distribution, and a test of this assumption provides a test of model
adequacy. Modiﬁed Cox-Snell (Cox and Snell [1968]) residuals take account of the
fact that censored observations lead to residuals that cannot be regarded on the
same footing as residuals derived from uncensored observations.
Modiﬁed Cox-Snell residuals can be reﬁned further into Martingale residu-
als (Therneau and Grambsch [2000]) with zero mean when uncensored. Unlike the
above, Martingale residuals are similar to residuals encountered in other areas of
data analysis in that it is the diﬀerence between the observed number of deaths
and the corresponding estimated expected number on the basis of the ﬁtted model.
They are not, however, symmetrically distributed about zero, so Therneau et al.
introduced Deviance residuals (Therneau et al. [1990]), which are symmetrically dis-
tributed about zero.
Two disadvantages of the residuals described above are that they depend
heavily on the observed survival time and require an estimate of the cumulative
hazard function. Both these disadvantages are overcome in the Schoenfeld residuals
(Schoenfeld [1982]). This residual diﬀers from the others in one other important
respect: that there is not a single value of the residual for each individual, but a
set of values, one for each explanatory variable included in the ﬁtted Cox regression
model. Schoenfeld residuals are standard for time-to-event analysis.
We need to assess the validity of the β values and the proportionality assumption
in evaluating Cox model ﬁt. The functional form of the covariates can be checked
using the Martingale residuals obtained from ﬁtting the null model (no covariates).
Plotting these against the values of each covariate in the model then this should
display the functional form required for the covariate, as shown by Therneau. In
particular, a straight line plot indicates that a linear term is needed.
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Inﬂuential observations can be identiﬁed by examining the extent to which
the estimated parameters in the ﬁtted model are aﬀected by omitting the observa-
tion. Testing the assumption of proportional hazards can be performed as follows:
if the log-cumulative hazard functions for individuals with diﬀerent values of their
explanatory variables are plotted against time, the curves so formed will be parallel
if the proportional hazards model is valid. In terms of assessing the overall ﬁt of a
model, a plot of the deviance residuals against the risk score gives information on
observations that are not well ﬁtted by the model, and their relation to the set of
values of the explanatory variables. Plots of residuals against survival times, the
rank order of the survival times or explanatory variables may also be useful.
4.3 Missing Data
4.3.1 Introduction to analyses with missing data
Standard statistical analysis methods have largely been developed for use with rect-
angular data sets comprising rows of cases or observations and columns of variables
(Little and Rubin [2002]). A common approach to cases that have some observations
missing is to omit such cases from the analysis, and work with the remainder as if
it were the entire data set. This is called `complete-case analysis'. In situations
where missing values are conﬁned to a tiny percentage of cases, this is likely to leave
the conclusions drawn from the analysis unchanged. However, in many real-world
applications, cases with missing observations comprise a substantial proportion of
the collected data. The reasons why the data is missing dictates how it may be
treated. If a survey respondent declined or omitted to answer some of the ques-
tions, or the measurement equipment in an experiment suﬀered a failure, then it is
reasonable to suppose that there are actual underlying values that would have been
observed had the data gathering mechanism performed better. In contrast, if an
opinion survey asks a respondent to choose between two or more options, it is not
clear whether non-response is due to omission or to indecision, in the latter case pos-
sibly representing a `don't know' stratum of the population (Little and Rubin [2002]).
It is possible to code the non-responses as missing and even to have several
codes to distinguish between `don't know', `refuse to answer', or `out of legitimate
range'. Some statistical packages default to complete-case analysis and simply ex-
clude cases that have data missing in any of the variables involved in the analysis.
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Complete-case analysis is generally inappropriate since the investigator is usually
interested in making inferences about the entire target population, rather than just
the portion of the target population that would provide responses on all relevant
variables in the analysis.
Missing data patterns describe which values are observed and which are miss-
ing in the data matrix. Missing data mechanisms concern the relationship between
missingness and the values of variables in the data matrix.
Some example of missing data patterns are :
• Univariate missing data where the missing values all occur in a single variable,
e.g. values are missing for an entire plot in an agricultural experiment.
• Unit and item non-response survey data:
Item non-response occurs where values are missing on particular items, e.g. in
a questionnaire and typically have a haphazard pattern.
Unit non-response occurs where variables are all observed or missing on the
same set of cases, e.g. where some of the respondents cannot be contacted for
part of the survey.
• Attrition in longitudinal studies having a monotone missing data pattern:
Participants drop out over time so all data is available for some variables, but
later collections show increasing missingness.
• File matching problem with two sets of variables never jointly observed. When
variables are never observed together, parameters relating to the association
between them cannot be estimated.
• Latent variable indicator variables with manifest variable patterns that are
never observed.
It is assumed that the missingness indicators in all these cases hide true values that
are meaningful for analysis, so that it makes sense to ﬁll in (impute) the missing
values of the unobserved variables.
Mechanisms that lead to missing data are a diﬀerent issue to patterns of missing
data. Whether the fact that variables are missing is related to the underlying values
in the data set informs the analyst which missing data methods are appropriate.
In 1976, Rubin formalised the crucial role of mechanism (Little and Rubin [2002])
by treating the missing-data indicators as random variables and assigning them a
distribution as follows:
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Deﬁne the complete data Y = (yij) and the missing data matrix M = (Mij). The
missing data mechanism is characterised by the conditional distribution of M given
Y and unknown parameters φ i.e. f(M |Y, φ)
• Missing completely at random (MCAR) : Missingness does not depend on the
values of the data Y , missing or observed.
f(M |Y, φ) = f(M |φ) ∀ Y, φ (4.25)
• Missing at Random (MAR): Missingness depends only on the components Yobs
of Y that are observed and not on the components that are missing, Ymiss.
This is equivalent to saying that the behaviour of two units who share observed
values have the same statistical behaviour on the other observations, whether
observed or not.
f(M |Y, φ) = f(M |Yobs, φ) ∀ Ymiss, φ (4.26)
• Missing not at random (MNAR) The distribution ofM depends on the missing
values in the matrix Y . Even accounting for all the available observed infor-
mation, the reason for observations being missing still depends on the unseen
observations themselves.
4.3.2 Imputation and multiple imputation
Imputing values by any method and then assuming analyses for complete data sets
can be used with impunity is a mistake (Little and Rubin [2002]). Imputations are
means or draws from a predictive distribution of the missing values and require a
method of creating a predictive distribution for the imputation based on the observed
data. The two generic approaches are explicit modelling (formal statistical model e.g.
multivariate normal with explicit assumptions) and implicit modelling (algorithm
supplies an underlying model with implicit assumptions which need to be recognised
and assessed for reasonablity).
Explicit methods:
• Mean Imputation: means from responding units are used, can be weighted.
• Regression Imputation: regression of the missing item on items observed for the
unit, usually calculated from units with both observed and missing variables
present.
• Stochastic regression imputation: replaces missing values by a value predicted
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by regression plus a residual, drawn to reﬂect uncertainty about the missing
value.
Implicit modelling:
• Hot deck imputation: substituting individual values drawn from `similar' re-
sponding units. Literature on the theoretical properties of this approach are
sparse (Little and Rubin [2002]).
• Substitution: used for unit non-response at the ﬁeld work stage; an alternative
unit is selected into the sample to replace the nonresponsive one. The substi-
tuted units are responders and may diﬀer systematically from non-responders.
• Cold deck imputation: substitutes a constant value from an external source,
e.g. a previous survey.
• Composite methods: e.g. combination of predicted mean for a regression with
a residual randomly chosen from empirical residuals.
The weaknesses of these is that the inferences about parameters based on the ﬁlled-
in data do not account for imputation uncertainty. Multiple imputation addresses
both this drawback and the loss of eﬃciency.
To estimate imputation uncertainty:
• Apply explicit variance formulae that allow for non-response.
• Modify the imputations so that valid standard errors can be computed from a
single ﬁlled-in data set.
• Apply the imputation and analysis procedure repeatedly to re sampled versions
of the incomplete data. Uncertainty is estimated from the variability of point
estimates of parameters from a suitable samples drawn from the original sample
(bootstrap or jackknife, Efron and Tibshirani [1993]).
• Create multiply imputed data sets that allow additional uncertainty from im-
putation to be assessed. This provides consistent standard errors under broad
classes of imputation procedures. Complete-data estimates and standard errors
from each imputed data set are combined with between-imputation uncertainty
derived from variability in estimates across the data sets.
Multiple imputation refers to the procedure of replacing each missing value by a
vector of D ≥ 2 imputed values. The D values are ordered in the sense that D
completed data sets can be created from the vectors of imputations; replacing each
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missing value by the ﬁrst component in its vector of imputations creates the ﬁrst
completed data set, replacing each missing component with the second component in
its vector creates the second completed data set and so on. Standard complete-data
methods are then used to analyse each data set. When the D sets of imputations
are random draws from the predictive distribution of the missing values under a
particular model for non-response, the D complete-data inferences can be pooled to
form one inference that properly reﬂects uncertainty due to non-response under that
model (Little and Rubin [2002]). When the imputations are from two or more models
for non-response, the combined inferences under the models can be contrasted across
models to display e sensitivity of inference to models for non-response, a particularly
critical activity when non ignorable non-response is being entertained.
4.3.3 Multiple imputation on the cardiovascular rehabilitation data
The missing data were imputed using the R package MICE (R Development Core
Team [2011], van Buuren and Groothuis-Oudshoorn [2011]) which used chained equa-
tions and a Gibbs sampler to impute plausible values where data were missing and
then used Rubin's rules to produce pooled estimates of parameters from the com-
pleted data sets. First it is necessary to ascertain whether the assumption that the
data were missing at random (including missing completely at random) was suspect.
Second, the form of the imputation model must be speciﬁed for each variable which
had data missing, including capturing known relationships between the covariates.
Next the set of variables to be included as predictors in the imputation was speciﬁed.
In this case all of those found to be signiﬁcant univariate predictors of survival were
included. If any of the variables to be imputed were sum scores or other functions
of incomplete variables, passive imputation could be implemented. The number of
iterations of the algorithm needs to be speciﬁed and the convergence of the Gibbs
sampler checked by plotting the mean and variance of the parameters against the
iteration number and checking that diﬀerent imputed values mix freely and without
trend. The number of imputed data sets to be produced needs to be speciﬁed. In
the cardiovascular rehabilitation work, the number of imputed data sets was 20, and
the number of iterations was also set to 20, which is of the order recommended in the
MICE documentation; this produced plots showing convergence of the Gibbs sample
to similar values for each imputed variable within the data sets. Setting this too low
can lead to p-values that are too low (van Buuren and Groothuis-Oudshoorn [2011]).
If θ is a vector of unknown parameters of the multivariate distribution of the com-
plete data Y , the chained equations methodology obtains the posterior distribution
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of θ by sampling iteratively from the conditional densities:
P (Y1 |Y−1, θ1)
...
P (Yp |Y−p, θp)
(4.27)
where θ1 . . . θp are the parameters of the conditional densities, Y1 . . . Yp are the p
incomplete variables and Y−j = (Y1, Y2, . . . , Yj−1, Yj+1, . . . , Yp). The plausible data
values imputed into each completed data set were drawn from a distribution speciﬁ-
cally modelled for each missing entry. The estimates for the quantities of interest, in
this case the parameters of the Cox model, were pooled into a single estimate and its
variance is estimated. For quantities that were approximately normally distributed,
within- and between-imputation variance could be given.
For the cardiac rehabilitation data predictive mean matching was selected as
the imputation model for continuous variables and for factors with 2 levels logistic
regression and with more levels, polytomous regression.
Details of the analysis results are found in Chapter 6 on page 103, and the diagnostic
plots of the multiple imputation in Chapter 9 on page 252.
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Chapter 5
Methods 2: Artiﬁcial Neural
Networks
There are two cultures in the use of statistical modeling to reach conclusions from
data. One assumes that the data are generated by a given stochastic data model. The
other uses algorithmic models and treats the data mechanism as unknown. (Breiman
[2001])
The purpose of this chapter is to give an introduction to artiﬁcial neural net-
works (ANNs), a form of machine learning, including their use in survival analysis.
The motivation for using artiﬁcial neural networks in these settings is that they have
the capacity to capture non-linearities in the relationships between the variables and
the outcomes for patients, and this may prove more appropriate than purely linear
models.
Pattern recognition encompasses a wide range of information processing problems,
such as the classiﬁcation of hand written characters, identifying faces, and medical
diagnosis and ANNs are often applied to such problems. Many humans solve these
in a seemingly eﬀortless fashion, but computer solution has proved to be immensely
diﬃcult in many cases (Bishop [1996]). ANNs have been applied in the study of
cancer, diagnosis of pulmonary embolism, lung disease, breast cancer and diﬀeren-
tiating benign from malignant pulmonary nodules (Joshi et al. [2003], Veropoulos
[2001], Fukushima et al. [2004], Eng [2002], Wu et al. [1993], Matsuki et al. [2002]).
Statistical pattern recognition is a well established ﬁeld which recognises the
probabilistic nature both of the information to be processed and of the appropri-
ate form in which the results should be expressed. The probability of the pattern
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belonging to class Ck after the pattern vector x has been observed is given by the
posterior probability P(Ck|x). Where estimation of the probability density is im-
practical, suitable alternative discriminant functions can often be determined from
the training data (Bishop [1996]). There are two separate stages in the classiﬁcation
process. The ﬁrst is inference where training data is used to determine values for the
posterior probabilities. The second stage is decision making where these are used to
make decisions such as assigning a new data point to one of the possible classes.
The high dimensionality of pattern recognition problem data makes it imprac-
tical to store every possible combination of values, so a classiﬁer must be designed to
generalise, i.e. to classify correctly a previously unseen vector. Such systems can be
described as a mapping from a set of input variables, x1, . . . , xd to output variables
yk, modelled in terms of a mathematical function containing a number of tunable
parameters whose values are determined with the help of the data. The general form
is yk = yk(x;w) where w denotes the vector of parameters, called weights in the
context of ANN models. Both regression and classiﬁcation problems can be seen as
particular cases of function approximation; in classiﬁcation problems the task is to
assign new inputs to one of a number of discrete classes or categories, whilst in re-
gression problems, the outputs represent the values of a continuous variables (Bishop
[1996]).
Machine learning can be deﬁned as follows: A computer program is said to
learn from experience E with respect to some class of tasks T and a performance mea-
sure P , if its performance at tasks T , as measured by P , improves with experience E
(Mitchell [1997]). Machine learning can be supervised or unsupervised. Supervised
machine learning is the search for algorithms that reason from externally supplied
instances to produce general hypotheses, which then make predictions about future
instances (Kotsiantis [2007]). If one supposes that (X,Y ) are random variables rep-
resented by some joint probability density P(X,Y ), then supervised learning can be
formally characterised as a density estimation problem where one is concerned with
determining properties of the conditional density P(Y |X) (Hastie et al. [2009]). In
unsupervised machine learning one has a set of N observations of a random p-vector
X having joint density P(X). The goal is directly to infer the properties of the prob-
ability density P(X) without the help of a supervisor or teacher providing correct
answers (Hastie et al. [2009]).
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5.1 Artiﬁcial Neural Networks
Figure 5.1: The Multi-layer Perceptron. (Bishop [1996])
Artiﬁcial Neural Networks belong to a class of learning methods that developed sepa-
rately in the distinct ﬁelds of statistics and artiﬁcial intelligence, based on essentially
identical models. The term ANN has come to encompass a large class of models and
learning methods. Multi-layered networks having threshold or sigmoidal activation
functions are called multi-layer perceptrons (MLP)(Bishop [1996]). An activation
(or transfer) function acts on the linear function of the input variables to give a
discriminant function. If the activation is the identity function the network collapses
to a linear model in the inputs.
The importance of neural networks in the context of practical applications
is that they oﬀer a very powerful and very general framework for representing non-
linear mappings from several input variables to several output variables, where the
form of the mapping is governed by a number of adjustable parameters. The pro-
cess of determining values for these parameters on the basis of the data is called
learning or training, and for this reason the data set of examples is generally re-
ferred to as a training set. ANN models, as well as many conventional approaches
to statistical pattern recognition, can be viewed as speciﬁc functional forms used
to represent the mapping, together with particular procedures for optimising the
parameters in the mapping. In fact, ANNs often contain conventional approaches
as special cases. ANNs are an extension of conventional techniques, which builds
on the many powerful results that the ﬁeld of machine learning oﬀers (Bishop [1996]).
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ANN models represent non-linear functions of many variables in terms of
superpositions of non-linear functions of a single variable, called hidden functions
or hidden units. The hidden units are adapted to the data as part of the training
process, so the number of such functions needs to grow only as the complexity of
the problem grows. For a given number of hidden units, the number of free pa-
rameters typically grows linearly or quadratically with the dimensionality, d, of the
input space, compared to dM growth for a generalMth-order polynomial. When the
output variables are continuous, the pattern recognition is a regression problem, and
when discrete, a classiﬁcation problem. In regression problems, the artiﬁcial neural
network approximates the regression function, whilst in classiﬁcation, the outputs of
a artiﬁcial neural network can be interpreted as approximations to posterior proba-
bilities of class membership.
MLPs with sigmoidal node functions are the most commonly used artiﬁcial
neural networks. Each hidden node produces a hyperplane boundary in the multidi-
mensional space containing the input data. The output node smoothly interpolates
between those boundaries to give decision regions of the input space occupied by
each class of interest. With a single logistic output, multilayer perceptrons can be
viewed as non-linear extensions of logistic regression and, with two layers of weights,
they can approximate any continuous function (Dybowski and Gant [2001], Bishop
[1996]).
MLPs are regression or classiﬁcation models typically represented by a net-
work diagram as in ﬁgure 5.1. Some describe these as non-linear statistical models
(Hastie et al. [2009]), whilst others argue that for a model to be statistical, assump-
tions about the variability of the data need to be made (Breiman [2001]). These
tools are especially eﬀective in high signal to noise settings where prediction without
interpretation is the goal. They are less eﬀective in problems where the goal is to
describe the physical process that generated the data and the roles of the individual
inputs. Each input enters into the model in many places, in a non-linear fashion. In
general, the diﬃculty of interpretation has limited their use in ﬁelds like medicine
where the interpretation of the models is very important.
In this study the MLP used consisted of two layers of adaptive weights with
full connectivity between inputs and hidden units, and used sigmoidal activation
functions. This architecture is capable of universal approximation, meaning that
it can approximate any continuous function to arbitrary accuracy from a compact
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region of input space provided the number of hidden units is suﬃciently large, and
provided the weights and biases are chosen appropriately (Nabney [2002]). There is
a direct correspondence between a network diagram and its mathematical function,
and general network mappings can be developed by considering more complex net-
work diagrams. In this project, attention was restricted to feed-forward networks,
which have the property that there are no feed-back loops in the network. In general,
a network is feed-forward if it is possible to attach successive numbers to the inputs
and all hidden and output units such that each unit received connections only from
inputs or units having a smaller number. Feed-forward networks have the property
that the outputs can be expressed as deterministic functions of the inputs, and so the
network represents a multivariate non-linear functional mapping. Note that if the
activation functions of all the hidden units in a networks are taken to be linear, then
for any such a network there is an equivalent network without hidden units, since
the composition of successive linear transformations is itself a linear transformation.
If the number of hidden units is smaller than either the number of input units or the
number of output units, then the linear transformation that such network generates
is not the most general possible, as information is lost in the dimensionality reduc-
tion at the hidden units.
In a network with d inputs, M hidden units and c output units, the analytic
function corresponding to the network can be expressed as follows:
The output of the jth hidden unit is formed with a weighted linear combination of
the d input values and adding a bias (i.e. constant term) to give
aj =
d∑
i=1
w
(1)
ji xi + w
(1)
j0 . (5.1)
Here w(1)ji denotes a weight in the ﬁrst layer going between input i and hidden unit
j, and w(1)j0 denotes the bias for the hidden unit j. By including an additional input
variable x0 = 1, the bias term for the hidden units can be absorbed into the weights
to give
aj =
d∑
i=0
w
(1)
ji xi. (5.2)
The activation of hidden unit j is then obtained by transforming the linear sum in
(5.2) using an activation function g1(·) to give
zj = g1(aj). (5.3)
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The outputs of the two-layer network are obtained by transforming the activations
of the hidden units using a second activation function. For each output unit, k, a
linear combination of the outputs of the hidden units is constructed. Absorbing the
bias as before gives
ak =
M∑
j=0
w
(2)
kj zj . (5.4)
The activation of the kth output unit is obtained by transforming this linear combi-
nation using a non-linear activation to give
yk = g2(ak) (5.5)
where the notation g2(ak)is used to emphasise that the activation of output units
need not be the same function as used for the hidden units. Combining (5.2), (5.3),
(5.4) and (5.5) the explicit expression for the complete function represented by the
network is
yk = g2
 M∑
j=0
w
(2)
kj g1
(
d∑
i=0
w
(1)
ji xi
) (5.6)
The sigmoid activation function is
g(z) =
1
1 + (1be
− z
a )
(5.7)
where a is the slope parameter and b shifts the curve up or down. For ﬁtting survival
functions b is set to unity (Reeves and Johnston [2008]).
The weights are at ﬁrst speciﬁed using domain knowledge or applied randomly to
the inputs if there is none, and the output compared to the target output as given
in the training data set. If the weights are near zero the operative part of the
sigmoid is roughly linear, so setting weights near zero to start means the model starts
out nearly linear and becomes non-linear as the weights increase; individual units
localise to directions and introduce non-linearities as needed. An error function is
deﬁned to measure the degree to which the prediction and target diﬀer. The credit
assignment problem is the determination of which of the hidden units should be
regarded as responsible for generating the error. When the activation functions of the
network are diﬀerentiable, the activations of the output units become diﬀerentiable
functions of both the input variables, and of the weights and biases. Evaluation
of the derivatives of the error with respect to the weights allows the weight values
which minimise the error function to be found (Bishop [1996]). The most common
algorithm for evaluating these derivatives of the error function is called error back-
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propagation. Most training algorithms involve an iterative procedure for minimising
the error function, adjusting the weights in a sequence of steps: ﬁrst evaluating the
derivatives, then use the derivatives to compute the adjustments to be made to the
weights. Then the errors are evaluated using the new weights, and the procedure
repeated. Each iteration is one training cycle. One of the simplest and most common
training algorithms is called gradient descent. In the batch version of the algorithm,
the weight vector is initialised randomly and then the vector is iteratively updated
in the direction of the greatest rate of decrease of the error. Weight changes are
accumulated over an entire presentation of the training data (an epoch) before being
applied. In the on-line or sequential version of the algorithm, the error function
gradient is evaluated for just one pattern at a time, and the weights updated after the
presentation of each training example (Bishop [1996]). The label `on-line learning'
can be misleading as it implies that learning may occur during use in the ﬁeld.
However, with both algorithms training is normally done oﬀ-line during a separate
phase with controlled data sets (Wilson and Martinez [2003]). Nevertheless, the
on-line approach does oﬀer the opportunity to update the training with a small
collection of new patterns, for example as clinical practices slowly change, without
having to delay until an entirely new data set is collected.
A network with too many weights will overﬁt the data at the global minimum of
the error function, so early stopping or weight decay regularisation is used (see page
99). However, it is better to have too many hidden units rather than too few or
the model may not have enough ﬂexibility to capture non-linearities and the extra
weights can be shrunk toward zero if appropriate regularisation is used.
Multiple minima may be present in the error function so one option is to choose a
number of starting values for the weights and select the solution giving the lowest
penalised error
5.2 Artiﬁcial Neural Networks for Survival Analysis
Recall the survival analysis equations on page 73 and equation (5.6) above and the
log likelihood equation
log L =
n∑
i=1
[∆i log(f(ti)) + (1−∆i) log(S(ti))]. (5.8)
Expressions for S(t), the survivor function and f(t), the probability density function
of survival time T , are required. A single layer artiﬁcial neural network has survival
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function
S(ti) = g2
∑
j
w
(2)
kj g1
(∑
i
w
(1)
ji xi
) (5.9)
Now if
z(ti) =
∑
j
w
(2)
kj g1
∑
j
w
(1)
ji xi
 (5.10)
so that
S(ti) = g2 (z(ti)) (5.11)
then
z(ti) = g
−1
2 (S(ti)) (5.12)
and
S′(ti) = g′2 (z(ti))z
′ (ti) (5.13)
from equation 5.11 by the chain rule and from 5.10
z′(ti) =
∑
k
g′1
∑
j
w
(1)
ji xi
w(2)j wpj . (5.14)
Deﬁne xd = t so ddt
∑
j w
(1)
ji xi = wjd giving
S′(ti) = g′2 (z(ti))
∑
j
g′1
∑
j
w
(1)
ji xi
w(2)kj w(1)jd (5.15)
and f(ti) = −S′ (ti). The use of artiﬁcial neural networks for survival analysis has
a relatively recent history (Ripley et al. [2004], Joshi et al. [2003], Joshi [2004]).
Both classiﬁcation and regression networks can be used for survival modelling. In
classiﬁcation, it is the probability of survival or time to relapse up to a given time
point that is modelled. It is possible to choose a single time point, e.g. relapse
within 5 years which is a simple binary output unit, or a series of time intervals,
such as relapse in less than one year, one to two years, two to three years, etc. The
multiple category cases may be ﬁtted using a softmax function on the outputs which
produces outputs which lie in the range [0,1] and sum to 1 so can be interpreted as
probabilities. The Softmax function (Hastie et al. [2009]) is
yk =
eak∑
k′ e
ak′
. (5.16)
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Since the probabilities must add up to 1 for N categories, only N − 1 of them can
vary independently. The natural ordering of these times can be taken into account.
In the regression model, the log likelihood is optimised (Joshi et al. [2005]) and the
probabilities of survival can be expressed as a survival curve by predicting on a vector
of times.
5.3 Optimising the Network
5.3.1 Minimising the error function
Non-linear activation functions are often used in artiﬁcial neural networks, and since
hidden and output units perform diﬀerent roles, the choice of activation function for
the output units may diﬀer from that for the hidden units. In a general feed-forward
network, each unit computes a weighted sum of its inputs in the form
aj =
∑
i
wjizi
where z is as deﬁned in equation (5.3). Suppose that the error function can be
written as a sum over all patterns in the training set of an error deﬁned for each
pattern separately,
E =
∑
n
En
and that En is diﬀerentiable function of the network variables so that
En = En(y1, . . . , yc).
The derivatives of the error function E with respect to the weights and biases in the
network can be expressed as sums over the training set of the derivatives for each
pattern separately. En depends on weight wji only via the summed input unit aj to
unit j. The derivative of En with respect to a weight wji can be obtained using the
chain rule for partial derivatives
∂En
∂wji
=
∂En
∂aj
∂aj
∂wji
. (5.17)
The required derivative is obtained by multiplying the value of ∂E
n
∂aj
for the unit at
the output end of the weight by the value of ∂aj∂wji for the unit at the input end of
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the weight. For the output units
∂En
∂ak
= g′(ak)
∂En
∂yk
(5.18)
by the chain rule on equation (5.3). For the hidden units we have
∂En
∂aj
=
∑
k
∂En
∂ak
∂ak
∂aj
(5.19)
where the sums run over all units k to which unit j sends connections, and using the
fact that variations in aj give rise to variations in the error function only through
variations in the variables ak. This leads to the back propagation formula
∂En
∂aj
= g′(ak)
∑
k
wkjg
′(ak)
∂En
∂ak
(5.20)
which allows the evaluation of errors recursively. The use of the logistic sigmoid as
an activation function is computationally eﬃcient here, since its derivative can be
expressed in the form
g′(a) = g(a)(1− g(a)). (5.21)
The dervatives of the error function with respect to the weights obtained in this
way form the Jacobian matrix of partial derivatives. The derivatives of the outputs
with respect to the inputs can also be calculated in a similar manner to form a
Jacobian matrix which estimates the contribution of the errors associated with the
input variables to the error of the output variables (Bishop [1996]). Back propagation
can also be used to obtain the second derivatives of the error with respect to the
weights to form the Hessian
∂2E
∂wji∂wlk
. (5.22)
The Hessian and its inverse plays an important role in neural computing which is
detailed in Bishop [1996]. The inverse of the Hessian H of the error with respect
to the weights can be approximated using the outer product approximation. If
R ≡ ∇wE, is the gradient of the error function and N is the number of patterns in
the data set, then the outer product approximation can be written
HN =
N∑
n=1
Rn(Rn)T (5.23)
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and the Hessian can be built up sequentially using
HN+1 = HN +R
N+1(RN+1)T . (5.24)
Then this matrix identity (Kailath [1980]) can be used to provide the inversion:
(A+BC)−1 = A−1 −A−1B(I + CA−1B)−1CA−1. (5.25)
where I is the identity matrix. Identifying HN = A, RN+1 = B, (RN+1)T = C we
have
H−1N+1 = H
−1
N −
H−1N R
N+1(RN+1)TH−1N
1 + (RN+1)TH−1N RN+1
(5.26)
This represents a procedure for evaluating the inverse of a Hessian using a single
pass through the data set. The initial matrix, H0 is chosen to be αH where α is a
small quantity. It is important to state that the outer product approximation for use
with the sum of squares error function is only likely to be valid for a network trained
on the same data set, or one with the same statistical properties as the one used to
evaluate the Hessian. For a general network mapping, the second derivative terms
will typically not be negligible. The Hessian of the error with respect to the weights
can be evaluated exactly for a network of arbitrary feed-forward topology and with
an diﬀerentiable error function using an algorithm based on back-propagation for
the evaluation of ﬁrst derivatives, detailed on page 157 of Bishop [1996].
For regression problems and for classiﬁcation problems, the purpose of net-
work training is to model the underlying generator of the data so that the best
possible predictions of the target t are made when the trained network is presented
with a new input vector x. For associative prediction problems of this kind, it is
convenient to decompose the joint probability density in the product of the condi-
tional density of the target data, given the input data and the unconditional density
of the input data thus:
P(x, t) = P(t|x)p(x). (5.27)
Many error functions can be motivated from the principle of maximum likelihood.
For training data {xn, tn}, the likelihood can be written as
L =
∏
n
P(xn, tn) (5.28)
L =
∏
n
P(tn|xn)P(xn) (5.29)
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under the assumption that each data point (xn, tn) is drawn independently from
the same distribution. It is generally more convenient to minimise the negative log
likelihood than to maximise the likelihood, and these are equivalent since the negative
logarithm is a monotonic function. Fitting an ANN by maximum likelihood is known
as `entropy' ﬁtting and is not common (Ripley and Ripley [2001], Joshi et al. [2005]).
E = −lnL = −
∑
n
ln P(tn|xn)−
∑
n
ln P(xn). (5.30)
The second term in equation (5.30) does not depend on the network parameters and
is therefore an additive constant which may be omitted from the error function.
These procedures have the advantage that they constrain the weights assigned
to the variables during learning to have values falling within the same interval.
5.3.2 Model complexity
The trained network model's ability to generalise is important for making good
predictions on new inputs; this requires model complexity to be optimised. As
with other statistical models, this requires a trade-oﬀ between bias and variance.
One way to achieve this in the artiﬁcial neural network setting is to compare the
performance of networks with a varying number of hidden units. A large data set
is advantageous here; as the number of data points grows, more complex models
can be supported, so reducing bias whilst ensuring the data constrains the model,
simultaneously reducing the variance. In practice, the data available are usually
limited. Adding a penalty term to the error function is a particular example of the
concept of regularisation (Hastie et al. [2009], Bishop [1996]) and is another way of
controlling model complexity. The general form is
E˜ = E + νΩ (5.31)
where E is the error function of choice, and ν controls the extent to which the penalty
term Ω constrains the form of the solution. One of the simplest forms of regularisa-
tion is weight decay and consists of the sum of squares of the adaptive parameters
(weights) in the network. The minimisation of the error function determines the
values for the free parameters in a network, but cannot indicate the optimal number
of such parameters, or equivalently the optimal size of the network. As with the
trade-oﬀ between bias and variance for curve-ﬁtting, the goal of training the data is
to produce a network with good generalisation performance on new input vectors,
and this is typically not the network which gives the smallest error on the training
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data. Networks with too little ﬂexibility will smooth out the structure in the data,
corresponding to high bias, whilst very complex networks will over-ﬁt the data cor-
responding to high variance. In both cases, generalisation is poor. This is where the
determination of the regularisation coeﬃcient in equation (5.31) becomes important.
A too large value for ν produces a network with large bias, whilst a too small value
allows the network to have high variance. Direct minimisation of E˜ leads to ν = 0
which is an over-ﬁtted solution. In the case of weight decay we have
Ω =
∑
i
w2i (5.32)
with the sum over all weights and biases. When used in curve ﬁtting this form of
regularisation is called ridge regression. To produce an over-ﬁtted mapping with
regions of large curvature requires large weights. Weight decay encourages weights
to be small and avoid the overﬁtting. Other alternatives include early stopping,
when training is stopped at the point where the error on a validation data set stops
falling and begins to grow. Curvature driven smoothing is another technique for
directly penalising curvature and uses second derivatives. Adding random noise to
input vectors has also been shown to lead to improvements in network generalisation
(Bishop [1996]). The most common pre-processing is linear rescaling of inputs so
that they all lie on a common scale-dividing each variable by the maximum value it
could take ensured all the variables fall in the interval zero to one. It is also possible
to rescale so that each variable has mean zero and variance one. Rescaling becomes
particularly important if weight penalty is used, since all the inputs need to be in the
same range to avoid over-penalizing the weights associated with large input values.
5.3.3 Cross validation
Cross-validation is a common mechanism for assessing the optimality of the model;
part of the data set is reserved for validating, some for testing and the remainder
used for training (Bishop [1996], Dybowski and Gant [2001], Hastie et al. [2009]).
When the network has been trained using the training set, then optimisation of the
model is made using the validation set. The eﬃcacy of the model in predicting new
cases is then reported using the independent test set. Often many partitions are used
and the accuracy of various candidate models judged on the average performance of
this procedure. The validation set is used to select ν by plotting the training and
validation errors against ν. The errors on the training set continue to fall, since that
is what the training algorithm requires. It is typical to see that, at a certain value
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of ν the error on the validation set ceases to fall and begins to rise. The value of ν
where the error is minimum on the validation set is the optimal value and is selected
for use in training the network. A similar technique can be used when varying the
number of hidden nodes.
5.3.4 The black box
One criticism levelled at neural networks is that they are black box systems by which
it is meant that the manner in which artiﬁcial neural networks derive an output value
from a given feature is not readily comprehensible, making the use of the output from
artiﬁcial neural networks unacceptable to users. Black box methods such as artiﬁ-
cial neural networks, which can be quite useful in purely predictive settings such as
pattern recognition, are far less useful for data mining (Hastie et al. [2009]). In a
model, desirable characteristics are accuracy and interpretability. Accuracy means
the model estimate of the value must be close to the true value, and interpretability
means that the input - output relationships that can be extracted from the model are
comprehensible to the intended user of the model. There are several types of inter-
pretation: how each input aﬀects the output value, as seen in regression coeﬃcients;
input-output relationships as if-then rules, as seen in tree-structured classiﬁers; how
the output value is obtained from the input vector as in the most probable conﬁgu-
ration in Bayesian Belief networks (Cooper [1990]). Interpretability is desirable if it
uncovers previously unknown but useful input-output summary, or discloses an error
in the model. If accurate prediction is what the model is required to produce, and
careful, extensive testing and ongoing monitoring provide reassurance of accuracy,
the lack of intepretability is less important than if the goal is knowledge discovery.
Interpretation of the mass of weights and connections within the network is very dif-
ﬁcult when trying to extract previously unknown but useful information from data.
This is where saliency (the relative importance of weights, Bishop [1996]) can be
used, not only for optimising network structure and performance, but also for giving
some intuition about which inputs contribute most to the accuracy of the network
predictions. There has been much eﬀort directed at learning rules from trained ar-
tiﬁcial neural networks (Dybowski and Gant [2001]) for this reason.
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5.3.5 Applying the ANNs
The artiﬁcial neural network for survival analysis used here takes as inputs the vari-
ables found to be signiﬁcant in the optimal Cox survival analysis, categorised as in
Table 6.24 on page 152. The weights were optimised using the maximum likelihood
of the function given in Equation 4.17 on page 75. The weight decay and number
of hidden nodes was optimised in MATLAB using training sets of 9/10 of the data,
selected at random, and a test set of the remaining data. After training, the log
likelihood was calculated for the test set. Hidden nodes greater than 3 could not be
supported because of lack of data, but 1, 2, and 3 hidden units were tested. The
weight decay values 1, 0.1, 0.01, 0.001, 0.0001, 0 were tested with each of the hidden
unit conﬁgurations and the optimal combination was found to be a weight decay of
0.1 and 3 hidden nodes. A vector of times (scaled by dividing by maximum time to
be between 0 and 1) was entered into the optimised network and a vector of values
between 0 and 1 returned. These are interpreted as probabilities of survival and were
compared the empirical Kaplan- Meier Survivor function and the survivor function
obtained from the Cox proportional hazards to assess model ﬁt, as shown in Figure
6.18 on page 160.
The inputs to the artiﬁcial neural network for predicting recovery from back
pain were treatment allocation plus the same variables used for building the latent
class model, listed on page 106, each score divided by the maximum to scale them
between 0 and 1. Achievement of a 3-point improvement in RMQ score, represented
as a dichotomous variable, was used as the target. The weights were optimised using
maximum likelihood using Equation 6.1 on page 125. The network architecture and
the weight decay were optimised using 10-fold cross validation scores for percentage
error and the log score given in Equation 6.2 on page 118, and those with mini-
mal values retained. Weight decays 0, 0.0001, 0.001, 0.01, 0.1 and 1 were tested
along with architectures with 1-5 hidden units. Details are given in Table 6.14 on
page 127. A network with 1 hidden unit and a weight decay of 0.1 was optimal.
The output of the model is a value between 0 and 1 with values 0.5-1 interpreted
as the model predicting recovery for this patient, and as predicting non-recovery
for the lower values. The model ﬁt is assessed by percentage accuracy on the ﬁtted
network, the log score, the sensitivity and the speciﬁcity as in Table 6.15 on page 131.
The receiver operating characteristic (ROC), or ROC curve, is a graphical
plot which illustrates the performance of a binary classiﬁer system as its discrimina-
tion threshold is varied. The ROC curve illustrates the performance of the ANN as
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the value at which predicting recovery / non-recovery is varied. There are four pos-
sible outcomes from the classiﬁcation: a recovering patient can be classiﬁed by the
model as recovering (a true positive) or not recovering (a false negative) and a non-
recovering patient can be classiﬁed as recovering (false positive) or non-recovering
(true negative). The true positive rate or sensitivity is the proportion of all the
recovering patients that are classiﬁed as recovering by the model, calculated as true
positive / (true positive + false negative). Similarly, the true negative rate or speci-
ﬁcity is true negatives / (true negatives + false positives). The ROC curve illustrates
the variation in these two quantities as the threshold value used by the model is var-
ied. A line of slope 1 indicates that the model has no discriminatory ability, and
that cases are allocated no better than at random.
In medical applications, the relative importance of avoiding false positives
and false negatives depends on the speciﬁc illness and treatment options under con-
sideration. Clearly, the ideal scenario is perfect classiﬁcation, but in real-world ap-
plications this is unlikely. When used for diagnosis, or other decision support about
treatment, correct classiﬁcation leads to correct (or best) treatment and cure, whilst
incorrect treatment can sometimes lead to serious consequences, either from failure
to give correct treatment leading to disease progression, or the suﬀering of serious
side-eﬀects without the pay-oﬀ of curing the disease. The overall error rate of the
classiﬁer is a useful measure of the performance of a classiﬁer and there are others
(Hand [2010]).
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Chapter 6
Results
This chapter sets out to describe and compare the results obtained by applying the
diﬀerent analyses outlined in Chapter 4 and Chapter 5 to the BeST data and the
the Basingstoke and Alton Data. Both data sets were introduced in Chapter 3,
The BeST data from the complex intervention for back pain were analysed
using latent class analysis (described in Chapter 4) in an attempt to ﬁnd classes
of patients for whom the response to the intervention diﬀered either positively or
negatively. The aim was to facilitate the tailoring of interventions to patients by
identifying the subgroups of patients for whom this treatment is particularly eﬀec-
tive or particularly ineﬀective. The manifest (observed) variables used to identify
the latent variable were those which the intervention was designed to tackle. The
BeST data were also subjected to a classiﬁcation artiﬁcial neural network (ANN, de-
scribed in Chapter 5), to categorise patients according to whether they experienced
signiﬁcant improvement or not, based on these same input variables. The methods
were compared for their ability to identify groups with similar outcomes. The eﬀect
of missing data was assessed using multiple imputation to complete the data sets.
Comparison was made of the analysis based on the data with the cases with missing
variables omitted, and with the missing values multiply imputed.
The Basingstoke and Alton cardiac rehabilitation data were analysed using
a Cox proportional hazards model, to identify those covariates which are signiﬁcant
predictors of long-term survival. These data were also subjected to a continuous-time
artiﬁcial neural network analysis which produced a survival curve. A comparison was
made of the two curves' ﬁt to the data and hazard rates.
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6.1 Analysis of BeST Back Pain Trial data
The Best Data was analysed by three methods, each using the same explanatory
and response variables. Logistic regression was used to predict a minimum RMQ
improvement from the explanatory variables. Latent class analysis was used to
form classes of patients using the explanatory variables, and the optimal model was
used as the explanatory variable in a logistic regression to predict a minimum RMQ
improvement. Finally, an ANN was trained using the explanatory variables and used
to predict the same minimum RMQ improvement.
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Figure 6.1: Schematic representing the analysis scheme for the BeST data set.
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6.2 Latent Class analysis of BeST Back Pain Trial data
6.2.1 Principal ﬁndings
Scores which measure the characteristics that the intervention was designed to tackle
were successfully used to classify trial participants into groups. For trial participants
who received the intervention treatment, there was an association between outcome
and class membership in the three-class model. After adjusting for age, sex and work
status in a logistic regression model, there was a marginally signiﬁcant coeﬃcient
for the interaction between treatment and membership of class 3 in the three-class
model.
6.2.2 Introduction
The BeST Trial demonstrated that a group-based cognitive behavioural approach
(CBA), delivered by a range of health professionals, had a sustained eﬀect on chronic
non-speciﬁc low back pain. This compared favourably with the range of treatments
recommended for the early treatment of persistent back pain by the National Insti-
tute for Health and Care Excellence (NICE) guidelines (NICE [2009]).
The design, intervention, and main analyses of the BeST Trial were reported in de-
tail by the trial team in (Lamb et al. [2010b]), and summarised in Chapter 3 starting
on page 44. Underwood and colleagues undertook a secondary analysis on this data
to look for eﬀect moderators (Underwood et al. [2011]) and found that neither trou-
blesomeness nor fear avoidance moderated treatment eﬀect on any of the primary
outcomes. The only moderation by baseline variables of the eﬀect of the intervention
was on the RMQ outcome: being younger and currently working both moderated
treatment eﬀect, resulting in larger improvements as a response to treatment.
The analysis approach was to ﬁrst ﬁnd the best latent class model ﬁt, and so
to ascertain the optimal number of classes for this data set. Then the relationship
between class membership and outcome for each of the intervention and control
cohorts was investigated using logistic regression, analysis of deviance and Fishers'
exact test. Finally, an adjusted logistic regression was used to control for other
variables of interest, namely age, sex and work.
6.2.3 Analysis approach
Latent class analysis was implemented on the full BeST data set using only cases
where 12-month follow-up RMQ score was available. Given the context of a cog-
105
nitive behavioural approach to the treatment of back pain, after discussion with a
clinical colleague it was agreed that the most appropriate observed variables for the
latent class modelling would be those which the intervention sought to modify. The
complete cases were used for the analysis.
The observed items that the intervention tackled are:
• SF12 question 7 i.e. `During the past 4 weeks, how much of the time has your
physical health or emotional problems interfered with your social activities,
(like visiting with friends, relatives, etc.)?' and responses are 1. All of the
time; 2. Most of the time; 3. Some of the time; 4. A little of the time; 5. None
of the time. See page 141 of Lamb et al. [2010b] (SF12_7).
• Pain self-eﬃcacy total score (PSE).
• Fear Avoidance Beliefs Questionnaire, items 2-5 relating to physical activity
(PA).
• Hospital Anxiety and Depression Scale (HADS)- using the separate scores:
HADS depression and HADS anxiety.
• Troublesomeness: moderately; very; extremely.
Each score was calculated according to its questionnaire manual detailed on page 46.
Recall that latent class analysis requires categorical variables (see page 67).
The two subscales of anxiety and depression measured by HADS were split according
to their standard interpretation, i.e. that scores lower than 8 were considered to
indicate a patient was not depressed (anxious), 8 to 10 that they were `borderline'
and over 10 that they were depressed (anxious). The HADS anxiety and depression
scales were the most informative in distinguishing between classes.
Similarly, the same cut points were adopted for PA as in the trial, i.e. a score of
under 14 was considered to indicate that a patient was not fear avoidant, whist a
score of 14 and over that a patient was fear avoidant.
There was no obvious or standard categorisation known for the remaining score,
PSE. Some time was spent undertaking sensitivity analysis, and it was decided that
medical opinion was a better guide to appropriate discretisation than optimising
on the basis of this data set, since any cut points found by the latter method may
not generalise to other data sets. It was therefore agreed, after discussion with a
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clinical colleague, to split PSE into very low, low and better than low (scores 0-
20, 21-30, 31-60) because it made no clinical sense to diﬀerentiate between high
and very high eﬃcacy patients, but the diﬀerence between low and very low may
have clinical importance in distinguishing between patient outcomes. SF12_7 was
used as it stands, i.e. with a separate category for each of the 5 possible responses.
Troublesomeness was also used in its 5 categories, noting that recruitment to the trial
required patients to have at least moderately troublesome pain, eﬀectively reducing
the categories in use to 3.
A subset was made of patients for whom all the 6 observations detailed above plus
baseline and 12-month follow-up RMQ scores were complete. The data losses were
as follows in Table 6.1.
Variable complete cases cases remaining item level case level
out of after sequential missingness missingness
original 701 (%) removal of (%) (%)
missing (%)
Fear Avoidance 662 (94.4) 662 (94.4) 34 (4.9) 5 (0.7)
Anxiety 686 (97.9) 648 (92.4) 13 (1.8) 2 (0.3)
Depression 693 (98.9) 645 (92.0) 6 (0.8) 2 (0.3)
SF12 question 7 689 (98.3) 635 (90.6) NA 12 (1.7)
Pain Self eﬃcacy 676 (96.4) 620 (88.4) 22 (3.1) 3 (0.4)
Troublesomeness 638 (91.0) 567 (80.9) NA 63 (9.0)
RMQ at baseline 700 (99.9) 567 (80.9) 0 (0.0) 1 (0.1)
RMQ 12 months 498 (71.0) 407 (58.1) 0 (0.0) 203 (29.0)
Table 6.1: Variables: cases complete in individual cases and after sequential removal. SF12_7 and
Troublesomeness are single-item scores so there is no distinction between item-level and case-level
missingness.
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Outcome was deﬁned as a 3-point or greater improvement in RMQ score at 12 months
or a score of less than or equal to 3 at baseline, maintained at 12-month follow-up,
to include those whose scores may not allow for an improvement of 3-points, but
are well (Bombardier et al. [2001], Lauridsen et al. [2006]). This is the deﬁnition
of `signiﬁcant improvement' in RMQ reported throughout this thesis. There were
407 such patients, 181 with a RMQ improvement described above, and 226 without
such an improvement. The numbers and proportions of patients in each category of
each score was given in Table 3.1 on page 51. A latent class analysis algorithm (R
package poLCA Linzer and Lewis [2011a]) was run on this complete cases data set,
and models with 2, 3, 4, 5 and 6 classes were produced. The models were evaluated
by considering the Akaike information criterion (AIC, Akaike [1974]) and Bayesian
information criterion (BIC, Schwarz [1978]) as detailed on page 78.
6.2.4 The models
Models with 2 to 6 classes were built and compared. The model with the minimum
AIC was the 4-class model while the model with the lowest BIC was the 3-class
model. For comparison, the AIC and BIC values of the 5 models is given in Table
(6.2).
Number of classes 2 3 4 5 6
AIC 4216.2 4116.8 4104.7* 4109.6 4120.6
BIC 4340.4 4305.2* 4357.2 4426.3 4501.5
Table 6.2: BIC and AIC for latent class models with 2 to 6 classes. Asterisk indicates lowest
information criterion.
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6.2.5 Patient characteristics for the three and four class models
Typical characteristics of the patients in the three classes were:
• Class 3.1: Patients in this class were generally those whose back pain caused no
interference with social activity; were not fear avoidant; had high conﬁdence in
managing despite any pain they experienced; were not clinically anxious; were
not clinically depressed and whose back pain was moderately troublesome.
• Class 3.2: Patients in this class were generally those whose back pain caused
signiﬁcant interference with social activity; were fear avoidant; had low conﬁ-
dence in managing despite any pain they experienced; were clinically anxious;
were clinically depressed and whose back pain was extremely troublesome.
• Class 3.3: Patients in this class were generally those whose back pain caused
moderate interference with social activity; were fear avoidant; had high con-
ﬁdence in managing despite any pain they experienced; were borderline or
clinically anxious; were borderline or not depressed and whose back pain was
moderately to very troublesome.
This list may give the impression that the patient characteristics were clearly de-
ﬁned for each class. However, the estimated class-conditional response probabilities
reported by the poLCA software are not 0 or 1 , and in some cases the probabilities
in two or more levels of a variable can diﬀer only slightly. For example, in the 4-class
model, Class 4 had estimated class-conditional response probabilities 0.16 for not
fear avoidant and 0.84 for fear avoidant which are clearly distinct, whilst Class 2
had 0.53 for not fear avoidant and 0.47 for fear avoidant which are roughly equal.
Taking all six predictor variables into account, with between 2 and 5 levels in each
predictor, the distributions are generally more complex than can be captured in sim-
ple descriptions. The colormaps (Figures 6.2, to 6.8) are a useful way to capture the
estimated class-conditional response probabilities. The most positive level of any
predictor (high conﬁdence, not fear avoidant, not anxious or depressed, etc.) is on
the left of the map with the levels ordered towards the most negative level on the
right.
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Figure 6.2: Three-class model: Class 1 showing the distribution of the probabilities of responses
under each score, with the healthiest patients to the left, and the least health to the right.
The colours near to the red end of the spectrum represent a high probability (near to 1) of having
this attribute given the class membership, and those near blue a low probability.
Figure 6.3: Three-class model: Class 2 showing the distribution of the probabilities of responses
under each score, with the healthiest patients to the left, and the least health to the right.
The colours near to the red end of the spectrum represent a high probability (near to 1) of having
this attribute given the class membership, and those near blue a low probability.
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Figure 6.4: Three-class model: Class 3 showing the distribution of the probabilities of responses
under each score, with the healthiest patients to the left, and the least health to the right.
The colours near to the red end of the spectrum represent a high probability (near to 1) of having
this attribute given the class membership, and those near blue a low probability.
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Typical characteristics of the patients in the four classes were:
• Class 4.1: Patients in this class were generally those whose back pain caused
little or no interference with social activity; were not fear avoidant; had high
conﬁdence in managing despite any pain they experienced; were not clinically
anxious; were not clinically depressed and whose back pain was moderately
troublesome.
• Class 4.2: Patients in this class were generally those whose back pain caused
moderate interference with social activity; could be either fear avoidant or not
fear avoidant; had low conﬁdence in managing despite any pain they expe-
rienced; were borderline or not clinically anxious; were borderline clinically
depressed and whose back pain was very troublesome .
• Class 4.3: Patients in this class were generally those whose back pain caused
moderate interference with social activity; were fear avoidant; had high conﬁ-
dence in managing despite any pain they experienced; were borderline to clini-
cally anxious; were borderline depressed and whose back pain was moderately
to very troublesome.
• Class 4.4: Patients in this class were generally those whose back pain caused
signiﬁcant interference with social activity; were fear avoidant; had low or very
low conﬁdence in managing despite any pain they experienced; were clinically
anxious; were clinically depressed and whose back pain was extremely trouble-
some.
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Figure 6.5: Four-class model: Class 1 showing the distribution of the probabilities of responses
under each score, with the healthiest patients to the left, and the least health to the right.
The colours near to the red end of the spectrum represent a high probability (near to 1) of having
this attribute given the class membership, and those near blue a low probability.
Figure 6.6: Four-class model: Class 2 showing the distribution of the probabilities of responses
under each score, with the healthiest patients to the left, and the least health to the right.
The colours near to the red end of the spectrum represent a high probability (near to 1) of having
this attribute given the class membership, and those near blue a low probability.
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Figure 6.7: Four-class model: Class 3 showing the distribution of the probabilities of responses
under each score, with the healthiest patients to the left, and the least health to the right.
The colours near to the red end of the spectrum represent a high probability (near to 1) of having
this attribute given the class membership, and those near blue a low probability.
Figure 6.8: Four-class model: Class 4 showing the distribution of the probabilities of responses
under each score, with the healthiest patients to the left, and the least health to the right.
The colours near to the red end of the spectrum represent a high probability (near to 1) of having
this attribute given the class membership, and those near blue a low probability.
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The class membership which was most probable for each individual patient was
attached to their record, and associations between outcome and group membership
were tested using Fisher's exact test, logistic regression and analysis of deviance.
Fisher's exact test, like a χ2 test, tests for an association between the rows and
columns of a table, in this instance, the class and the outcome. Fisher's exact test
is valid for all sample sizes. A small p-value suggests an association, and in this
analysis a p-value of 5% or lower was used to indicate signiﬁcance and a p-value
of between 5% and 10% was considered marginally signiﬁcant. Logistic regression
predicts the log odds of the outcome as a linear model in the predictors. The p-value
given is for the eﬀect of a unit change in the predictor on the log odds signiﬁcantly
diﬀerent from 0. Note that if the log odds is zero then the odds is 1, and there is no
diﬀerence between the chance of recovery and the chance of no recovery. The analysis
of deviance gives the reduction in residual deviance of adding each predictor variable
in turn to the logistic regression model. As with analysis of variance for ordinary
least squares regression, it is a measure of how much variability in the outcome
is explained by the predictor in question. After attaching the most probable class
membership to each case, the patient data were split into two groups according
to whether the patients had received the cognitive behavioural approach (CBA)
intervention or not, and Fisher's exact test was performed to test for an association
between class and outcome. In the case of the Three-class model, Fisher's exact
test showed an association between outcome and class (at 5% level) in the case of
the CBA (intervention) patients. The 2, 4, 5 and 6-class models did not show an
association between outcome and class under Fisher's exact test (at the 5% level) for
the CBA (intervention) patients. In the case of the best care only (control group)
patients, there was no association between outcome and class for any of the models.
The p-values for Fisher's exact test are given in Table 6.3.
Number of classes 2 3 4 5 6
Intervention 0.44 0.05* 0.20 0.32 0.07
Control 1.0 0.70 0.72 0.68 0.23
Table 6.3: Fisher's exact test for association between class membership and outcome. * Signiﬁcant
at 5% level.
The next step was to try to identify which speciﬁc classes of patients were more
likely to recover and which were less likely to recover. To do this, the models with
the best relative goodness of ﬁt were analysed more closely.
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Testing the Four-Class Model
The four-class model, having the lowest AIC, was investigated to see if patients in
some classes did better with the CBA treatment than patients of the same class who
did not receive this treatment. Analysis of deviance was used to test if an interaction
term was signiﬁcant in the logistic regression model.
In the case of the four-class model, numbers of patients in each class were as shown
in Table 6.4. Note that Class 2 had fewest patients, just 10% of the total data set,
32 in the intervention group and 10 in the control group.
Class: 1 2 3 4
Patients 210 42 101 54
Table 6.4: Patients in the four-class model. Note that the numbers of patients in this table were
from across both arms of the trial, i.e. both those who had the CBA treatment, and those who did
not, 407 altogether.
Analysis of deviance showed that treatment was signiﬁcant in explaining outcome,
but the class and interaction between class and treatment were not. This means
that receiving treatment given that a patient was in a certain class was not a clear
predictor of outcome for the four-class model.
A logistic regression model was used to predict outcome (recovery, as deﬁned on page
108) by treatment and class. The coeﬃcient for treatment was signiﬁcantly diﬀerent
from zero (p=0.004) for the control group. The coeﬃcients for class membership or
the interaction between class and outcome was not signiﬁcantly diﬀerent from zero
in the regression model.
Since the objective of the analysis was to uncover classes of patients with a common
response to the treatment, when the standard contrasts did not give the required level
of detail, new, detailed contrasts were constructed, each with one degree of freedom,
i.e. being in Class 2 is contrasted with not in Class 2, Class 3 contrasted with not
in Class 3, and so on. The contrasts were re-deﬁned to keep the model deviance
the same but split the contrasts into one-degree-of-freedom items. In this way,
membership of each class was in turn compared to membership of any of the other
classes, and the capacity to predict a signiﬁcant improvement in RMQ (recovery, as
deﬁned on page 108) assessed. The analysis of deviance showed that treatment was
signiﬁcant in predicting outcome (p=6.07× 10−5) but that class and the interaction
between class and treatment were not signiﬁcant.
The patients were split into two groups according to whether they received the CBA
intervention or not, and Fisher's exact test was performed to assess if there was
any association between class membership and outcome for each intervention group
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(results in Table 6.3). Table 6.5 gives numbers in each class in the CBA arm of
the trial. Recall that the patients were split 2:1 in favour of the intervention so that
splitting patients into groups at random should yield approximately 67% of any class
in the treatment arm and 33% in the control arm if there were no eﬀect of class.
Class Intervention Control
Recovery Recovery
Number (%) No Yes Number(%) No Yes
1 137 (65) 71 66 73 (35) 49 24
2 32 (76) 14 18 10 (24) 8 2
3 68 (67) 28 40 33 (33) 22 11
4 43 (80) 26 17 11 (20) 9 2
Table 6.5: Four-class model: Number and percentage of each class who did and did not recover in
each arm of the trial. Recovery is deﬁned in 6.2.3. Recall that the patients were split 2:1 in favour
of the intervention.
In all the above analyses, treatment is a predictor of recovery, but neither class
membership or receiving treatment given that a patient is in a certain class was a
clear predictor of outcome for the four-class model.
Testing the three-Class Model
The three-class model, having an AIC measure almost as low as the four-class model,
and a lower BIC was also investigated to see if patients in some classes did better
with the CBA treatment than patients of the same class who did not receive this
treatment.
In the case of the three-class model, numbers of patients in each class are in Table
6.6.
Class 1 2 3 All
Patients 211 52 144 407
Table 6.6: Patients in the three-class model. Note that the numbers of patients in this table were
from across both arms of the trial, i.e. both those who had the CBA treatment, and those who did
not.
Analysis of deviance showed that treatment was highly signiﬁcant (p=6.07× 10−5)
in explaining outcome and also that class was marginally signiﬁcant (i.e. signiﬁcant
at 10% level, p=0.066) in explaining outcome, but the interaction between class and
treatment was not. This means that receiving treatment given that a patient is in a
certain class was not a clear predictor of outcome for the three-class model. Logistic
regression was used to predict outcomes by treatment and class. The coeﬃcient
for treatment in the best care only arm, was signiﬁcant, but the coeﬃcient for class
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membership and for the interaction between class and outcome were not signiﬁcantly
diﬀerent from zero.
Once again, the contrasts were reﬁned into contrasts each with one degree of freedom,
and a logistic regression model ﬁtted. Treatment was signiﬁcant in the best care
only group in the logistic regression model. The analysis of deviance showed that
treatment is highly signiﬁcant in the model. It also revealed marginal signiﬁcance
for membership of Class 2 (at 10% level, p=0.065). It should be noted that Class 2
is the smallest class with 52 patients (12.8% of the whole data set).
The patients were split into two groups according to whether they received the
CBA intervention or not, and Fisher's exact test performed to assess if there was
any association between class membership and outcome for each intervention group.
Table 6.7 gives numbers in each class in the both arms of the trial.
Class Intervention Control
Recovery Recovery
Number (%) No Yes Number(%) No Yes
1 138 (65) 73 65 73 (35) 49 24
2 41 (79) 25 16 11 (21) 9 2
3 101 (70) 41 60 43 (30) 30 13
Table 6.7: Three-class model: Number and percentage of each class who did and did not recover
in each arm of the trial. Recovery is deﬁned in 6.2.3. Recall that the patients were split 2:1 in
favour of the intervention.
In all the above analyses, treatment is a predictor of recovery, and membership of
class 2 is a predictor of recovery using a 10% signiﬁcance level but receiving treatment
given that a patient is in a certain class was not a clear predictor of outcome for
the three-class model either. Class 2 had the fewest patients in it, and whilst there
is some indication that membership of Class 2 aﬀects the likelihood of recovery this
result could also be an artifact of the low numbers in the class. The proportion
of patients in Class 2 in the no-recovery category for both intervention and control
patients is much higher than the proportion in the recovery column. The diﬀerence
in proportions between those who recovered and who did not is far greater in Class
2 than in either of the other two classes, but with so few patients, we cannot rule
out that this occurred at random and is not a true eﬀect.
6.2.6 Adjusting for other variables
To investigate the inﬂuence of the important variables identiﬁed in Underwood et al.
[2011], age, sex and work were added to the logistic regression model.
Age was categorised into 5 groups of approximately equal size in the full data set of
118
701 cases:
Age group number of patients
under 40 146
40-49 147
50-59 160
60-69 150
70 and over 98
Total 701
Table 6.8: Age categories, showing the number of patients in each category of the full data set of
701 cases.
The question relating to work is: `are you currently working (either self employed or
in paid employment)?'
For all the latent class models from the two-class model up to the six-class model,
there was a signiﬁcant interaction between treatment and work in the analysis of
deviance. Treatment was signiﬁcant in every model. In the two models of interest,
the three- and four-class models, the four-class model had a marginally signiﬁcant
interaction between membership of Class 2 and treatment, both in the model with
regular contrasts and the model with reﬁned contrasts (in Class 2 compared to not
in Class 2). In the three-class model, there was a marginally signiﬁcant interaction
between membership of Class 3 and treatment, again both in the regular contrast
model and the reﬁned contrast model. This suggests that, having adjusted for age,
sex and work status, work modiﬁes the eﬀect of treatment (see Table 6.11.
These analyses support the ﬁndings of Underwood and colleagues, who found that
working moderated the treatment eﬀect, resulting in larger improvements as a re-
sponse to treatment. In addition, for the two models of interest, there is some
indication that class membership moderated treatment eﬀect, although the evidence
for this is modest.
It is of interest to investigate whether the variables age, sex or work status were
represented equally within the classes or whether there is a pattern of the working
people, who were marginally more likely to recover, also being the majority con-
stituents of the classes most likely to recover, i.e. Class 3 in the three-class model
and Class 2 in the four-class model.
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Variables used for Class 1 Class 2 Class 3 Class 4 All
identifying classes
SF127 1 * 0 0 1 8 9
SF127 2 4 9 4 28 46
SF127 3 21 21 74 15 131
SF127 4 56 7 11 1 75
SF127 5 128 5 11 2 146
Not Anxious 155 21 0 0 176
Borderline 44 20 58 1 123
Clinically Anxious 11 1 43 53 108
Not Depressed 204 14 3 0 257
Borderline 6 27 60 21 114
Clinically depressed 0 1 2 33 36
Not troublesome 3 0 0 0 3
Moderately 120 12 49 13 194
Very 79 21 42 17 159
Extremely 8 9 10 24 51
Fear Avoidant 76 19 71 45 211
Not Fear Avoidant 134 23 30 9 196
Pain Self eﬃcacy Very Low 0 6 0 20 26
Low 0 33 0 29 62
Moderate and above 210 3 101 5 319
Outcome variables Class 1 Class 2 Class 3 Class 4 All
RMQ Signiﬁcant improvement 90 20 51 19 180
No Signiﬁcant Improvement 120 22 50 35 227
RMQ † mean baseline 6.62 10.87 9.08 14.08 8.47
RMQ † mean 12 months 4.31 8.42 6.68 12.27 6.30
Variables (adjusted model) Class 1 Class 2 Class 3 Class 4 All
Age under 40 35 8 25 7 75
40-49 42 9 23 13 87
50-59 48 7 22 19 96
60-69 56 10 24 13 103
70 and over 29 8 7 2 46
Female 113 22 75 36 246
Male 97 20 26 18 161
Working 125 14 54 15 208
Not working 84 28 47 38 197
missing 1 0 0 1 2
Table 6.9: Patient Characteristics in the four-Class latent class model
* SF12 question 7 `How much of the time does your pain interfere with social activities?' 1= all of
the time, 2=most of the time, 3=some of the time, 4=a little of the time, 5= none of the time.
† Roland Morris Disability Questionnaire. RMQ score takes integer values 0 to 24, with lower score
indicating less disability.
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Variables used for Class 1 Class 2 Class 3 All
identifying classes
SF127 1 * 0 8 1 9
SF127 2 2 29 15 46
SF127 3 19 11 101 131
SF127 4 60 2 13 75
SF127 5 130 2 14 146
Not Anxious 155 1 20 176
Borderline 43 1 79 123
Clinically Anxious 13 50 45 108
Not Depressed 206 0 51 257
Borderline 5 16 93 114
Clinically depressed 0 36 0 36
Not troublesome 3 0 0 3
Moderately 122 11 61 194
Very 79 16 64 159
Extremely 7 25 19 51
Fear Avoidant 76 44 91 211
Not Fear Avoidant 135 8 53 196
Pain Self eﬃcacy Very Low 2 19 5 26
Low 2 26 34 62
Moderate and above 207 7 105 319
Outcome variables Class 1 Class 2 Class 3 All
RMQ Signiﬁcant improvement 89 18 73 180
No Signiﬁcant Improvement 122 34 71 227
RMQ † mean baseline 6.35 13.71 9.69 8.47
RMQ † mean 12 months 4.21 12.02 7.31 6.30
Variables (adjusted model) Class 1 Class 2 Class 3 All
Age under 40 36 8 31 75
40-49 43 13 31 87
50-59 48 17 31 96
60-69 55 12 36 103
70 and over 29 2 15 46
Female 113 36 97 246
Male 98 16 47 161
Working 127 16 65 208
Not working 83 35 79 197
missing 1 1 0 2
Table 6.10: Patient Characteristics in the three-Class latent class model
* SF12 question 7 `How much of the time does your pain interfere with social activities?' 1= all of
the time, 2=most of the time, 3=some of the time, 4=a little of the time, 5= none of the time.
† Roland Morris Disability Questionnaire. RMQ score takes integer values 0 to 24, with lower score
indicating less disability.
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Variable Class & Treatment model Age Sex and Work
Std Std
Coeﬀ error p-value Coeﬀ error p-value
Best care only -0.71 0.24 0.004** -0.28 0.73 0.70
Cognitive behavioural approach -0.11 0.49 0.17 -0.42 0.44 0.34
Class 1 - - - 0 - -
Class 2 -0.79 0.82 0.34 -1.25 0.91 0.17
Class 3 -0.12 0.41 0.77 -0.36 0.46 0.44
Treatment * Class 1 - - - 0 - -
Treatment * Class 2 0.46 0.89 0.61 0.99 0.99 0.31
Treatment * Class 3 0.62 0.49 0.21 0.94 0.54 0.08 •
Age under 40 - - - 0 - -
Age 40-49 - - - 0.67 0.68 0.32
Age 50-59 - - - 0.45 0.66 0.49
Age 60-69 - - - 0.07 0.71 0.91
Age 70 and over - - - -0.48 0.97 0.62
Male - - - -0.65 0.42 0.12
Female - - - 0 - -
In Work - - - -0.64 0.55 0.24
Not in Work - - - 0 - -
CBA* under Age 40 - - - 0 - -
CBA* Age 40-49 - - - -0.82 0.78 0.29
CBA* Age 50-59 - - - -0.61 0.77 0.42
CBA* Age 60-69 - - - -0.22 0.83 0.79
CBA* Age 70 and over - - - 0.32 1.10 0.77
CBA*Female - - - 0 - -
CBA* Male - - - 0.38 0.49 0.43
CBA*Not in work - - - 0 - -
CBA*in work - - - 1.53 0.63 0.02 ?
Table 6.11: Logistic Regression Model Coeﬃcients
Signiﬁcance codes: • signiﬁcant at α = 0.1, ? signiﬁcant at α = 0.05, **signiﬁcant at α = 0.01
These tables reveal that, in the four-class model, Class 2 is very small, 42 patients
out of 407 which is just 10.3%. It is likely, therefore, that the marginal association
between Class 2 and treament for this model is an artefact of the small number of
observations, and may not be a genuine eﬀfect. In the three-class model, 144 patients
are in Class 3, 35% of the observations, which is what would be expected if patients
were allocated into three groups at random. It is much less likely, therefore, that the
marginal association between membership of Class 3 and treatment is an artefact of
the distribution of patients between classes.
Scores which measure the characteristics that the intervention was designed
to tackle were successfully used to classify trial participants into three and four
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Class Work No Work missing Total
Recovery Yes No Yes No Yes No
Class 1 59 66 30 54 0 1 210
Class 2 9 5 11 17 0 0 42
Class 3 30 24 22 25 0 0 101
Class 4 8 7 10 28 1 0 54
Table 6.12: Work and recovery in classes for the 4-class model.
Class Work No Work missing Total
Recovery Yes No Yes No Yes No
Class 1 67 60 29 54 0 1 211
Class 2 8 8 9 26 1 0 52
Class 3 38 27 35 44 0 0 144
Table 6.13: Work and recovery in classes for the 3-class model.
groups. For trial participants who received the intervention treatment, there was an
association between outcome and class membership in the three-class model. After
adjusting for age, sex and work status in a logistic regression model, there was a
marginally signiﬁcant interaction between treatment and membership of Class 3 in
the three-class model, suggesting that Class 3 patients respond to the treatment
diﬀerently than Class 2 and Class 1 patients, but with the caveat that the sample
size is small. Underwood et al concluded that although BeST is one of the larger
trials of back pain treatment, it is still too small reliably to detect moderation if it
exists (Underwood et al. [2011]).
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6.3 Artiﬁcial Neural Network analysis of the BeST data
This is a comparison of artiﬁcial neural network, latent class analysis and logis-
tic regression for determining which patients beneﬁt from a cognitive behavioural
approach to treatment for non-speciﬁc low back pain Barons et al. [2013b].
6.3.1 Principal ﬁndings
Using the same 7 variables as for the latent class analysis, a classiﬁcation ANN
and an ordinary logistic regression were more accurate in classifying patients with
respect to recovery than a logistic regression using Latent Class membership as
the predictor. The best log score performances were by the ANN and the latent
class logistic regression, whilst the best sensitivity was shown by the ANN, and for
speciﬁcity, latent class logistic regression was highest. The best overall performance
was the ANN, with the best performance in 3 of the 4 measures and providing both
sensitivity and accuracy. The ANN is the best candidate of these three models for
decision support for allocating patients to the cognitive behavioural approach to the
treatment of back pain.
6.3.2 Introduction
The aim of this study was to compare three methods for using patient character-
istics as predictors of a 3-point or greater improvement in the RMQ score between
baseline and 12-month follow-up. A classiﬁcation ANN was compared to two logistic
regression models, one using the variables directly, and the other using the classes
derived from the latent class analysis as predictors. All three models were subjected
to 10-fold cross validation and the averaged accuracy performance was reported.
In each of the three approaches, the same seven variables were used as in the
construction of the latent class models above. These were selected on the basis that
they measure the attributes which the cognitive behavioural approach was designed
to inﬂuence. The outcome measure was the RMQ score change by 12-month follow-
up. The predictor variables were PSE, SF12_7, HADS (anxiety and depression
scales separately) and troublesomeness. The 407 cases with complete data, detailed
in Table 6.10, were used for the analyses.
As described in Chapter 5, artiﬁcial neural networks are a form of machine
learning (Mitchell [1997]). A feed-forward artiﬁcial neural network with a single
hidden layer was used, and the number of hidden nodes was varied from 1 to 5 to
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optimise using the percentage error and the log score comparison metrics described
below. The logistic function was used for both activation and output functions. The
inputs were scaled ∈ [0, 1] by dividing each score by the maximum score, and weight
decays 0, 0.0001, 0.001, 0.01, and 0.1 were tested. 10-fold cross validation was carried
out and the percentage error and the log score calculated to determine the optimal
network and for comparison with the other two models.
For comparison with the ANN and the latent class analysis, which are capable
of capturing non-linearity, a linear logistic regression was used to predict outcome
using all the six predictors listed. This was also used to predict outcome in a 10-fold
cross validation, and the log score was calculated for these models.
6.3.3 Comparison metrics
All analyses were carried out in R statistical software (R Development Core Team
[2011]). The artiﬁcial neural network was built using the the R package nnet (Ven-
ables and Ripley [2002]) which had a logistic activation function and with a logistic
output activation selected. The optimisation of weights was carried out by selecting
the entropy option which is maximum conditional likelihood ﬁtting, or equivalently
for the case with a binary output, minimising the Kullback-Leibler distance (Ven-
ables and Ripley [2002]).
E =
∑
p
∑
k
[
tpk log
tpk
ypk
+ (1− tpk) log
(1− tpk)
(1− ypk)
]
(6.1)
where tp is the target (recovery ∈ [0, 1]), and yp is the model's output for the pth
patient and k is the number of classes. The percentage error - the total percentage
of patients assigned to the wrong outcome, is reported, making no distinction be-
tween sensitivity errors and speciﬁcity errors (false positives or false negatives) and
averaged over the 10-fold cross validation. In this application, it is desirable to be
able to identify all those for whom the treatment will be eﬀective, even at the risk
of allocating some to this programme who were unlikely to beneﬁt, since there are
no known or suspected contraindications. The log score is calculated:
∑
p
∑
k
−tpk log ppk (6.2)
Clearly, whenever the outcome is no recovery (tpk = 0) then there is zero contribu-
tion to this sum, so the log score reported is for the positive outcomes only and is
calculated using Equation 6.2. A lower log score indicates greater ability to identify
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those who will recover; it will predict a high probability of recovery for a patient who
actually recovered. The behaviour of log score is illustrated by plotting probability
of recovery from 0.1 to 1 against log score.
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Figure 6.9: As average probability of recovery varies, there is signiﬁcant change in the value of
the log score, for example as average probability of recovery rises from 0.5 to 0.6, the log score
reduces from 124.8 to 91.9.
This shows that even a small change in the mean probability of recovery predicted
by any of the models, for the recovered patients, inﬂuences the log probability score.
It follows that the log score is also sensitive to outliers; a single value much lower or
higher than the rest will also adjust the log score. This demonstrates that the log
score is a useful measure in this context.
The two logistic regression models were subjected to 10-fold cross validation using the
R package DAAG (Maindonald and Braun [2012]), and the log score was calculated
for each.
Artiﬁcial neural network
Log score was minimised when there were two hidden nodes for all networks, except
the network with weight decay set at 0.1, where the one hidden node conﬁguration
had the lowest log score. When weight decay = 0.1, the network with 4 hidden
nodes also provides a lower log score than either 3 or 5 hidden nodes. Percentage
error (misclassiﬁcation during cross validation) is minimised in the networks with
one hidden node for all values of the weight decay. The distribution of probabilities
of recovery assigned by the ANN model (with one hidden node and weight decay 0.1)
to the patients who did recover is shown in the histogram (Figure 6.11). A perfect
plot would have the entire mass at 1. This plot shows that the bulk of the predicted
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Figure 6.10: This plot shows how the log score varies as the number of patients with probability
of recovery much smaller than the remainder rises. For example, if 1 patient had a probability of
0.1 and average probability of recovery for the remaining 179 is 0.5, and then the log score rises
from 124.8 to 126.4. If two patients have probabilities of 0.1, the log score is 127.9, if three then
129.6.
probabilities were 0.5 and above, which indicates why the log score is reasonably
good at 145.5 and the prediction error is 38.8% (sensitivity 0.58, speciﬁcity 0.63).
Hidden nodes 1 2 3 4 5
Weight decay
0 % error 40.5 41.3 42.3 45.5 43.2
Log Score 150.0 145.8 154.3 154.6 166.7
0.0001 % error 39.8 42.8 43.9 44.9 45.5
Log Score 149.9 147.9 155.7 158.4 171.6
0.001 % error 39.8 42.5 42.8 45.2 44.9
Log Score 150.9 149.6 154.7 157.8 164.2
0.01 % error 40.8 41.5 42.5 43.7 44.9
Log Score 149.3 144.5 152.4 154.3 161.4
0.1 % error 38.8 41.0 42.0 43.5 43.5
Log Score 145.5 146.8 149.1 148.5 152.1
Table 6.14: Evaluation of number hidden nodes required for optimal neural network.
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Figure 6.11: Histogram of the probabilities of recovery for cases that did recover, as predicted by
the artiﬁcal neural network with one hidden node and weight decay 0.1.
Probabilities of recovery in LR
Recovery probabilities predicted by logistic regression
co
u
n
t
0.0 0.2 0.4 0.6 0.8 1.0
0
10
20
30
40
50
60
Figure 6.12: Histogram of the probabilities of recovery for cases that did recover, as predicted by
the standard logistic regression.
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Figure 6.13: Histogram of the probabilities of recovery for cases that did recover, as predicted by
the latent class logistic regression.
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Here is for ROC curve for the ﬁtted ANN. The diagonal line is the line of no
discrimination, and since the ANN line is above this, the model is shown to have
some discrimination capability. As with the other measures, the ROC curve also
shows that the model has room for improvement. Since there are no known side-
eﬀects of attending CBA, it is more important in this application to capture those
patients likely to beneﬁt, at the cost of treating some who are unlikely to recover.
Without a method for making such a prediction, all patients are likely to be treated
and costs will be higher still.
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Figure 6.14: ROC curve for illustrating the balance of errors as the threshold at which the
boundary between classiﬁcations used by the model is varied.
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Model Prediction Error % Log Score Sensitivity Speciﬁcity
LCA+ LR (3-class) 42 146.5 0.33 0.82
LR 38.8 170.5 0.46 0.72
ANN (1 hidden unit w-decay 0.1) 38.8 145.5 0.58 0.63
Table 6.15: Comparison of all analysis methods
Logistic Regression
The ﬁrst logistic regression we consider is the standard logistic regression model
using the same explanatory variables as the ANN. 10-fold cross validation gave a
prediction error of 38.8%, and a log score of 170.5 (sensitivity 0.46, speciﬁcity 0.72).
Next the latent class model with three classes was used. The latent class model was
built using 6 variables, then the class membership and the treatment were used as
predictors in a regression model. The 10-fold cross validation prediction error was
42.0% and the log score was 146.5 (sensitivity 0.33, speciﬁcity 0.82).
The distribution of probabilities of recovery assigned by the logistic regression
models to the patients who did recover is shown in the histograms (Figures 6.12 and
6.13). The distribution of probabilities assigned to the patients who did recover by
the ordinary logistic regression have a few very high values and a higher proportion
of the probabilities below 0.5 than in the case of the ANN. This ordinary logistic
regression had the highest log score. The latent class logistic regression model had
probability distribution for the patients who did recover which is skewed towards
the larger values, with the bulk of the probabilities falling in the 0.5 and 0.6 bins.
It had fewer very low probabilities than the ordinary logistic regression and also no
high probabilities. The log score for this model is only slightly higher than the log
score for the best ANN model, indicating that these two models outperform ordinary
logistic regression.
The overall accuracy is highest for the ANN and the ordinary logistic regres-
sion, with the latent class logistic regression misclassifying 13 more patients than the
other two models. The logistic regression is the only linear model, and had the lowest
error rate but the highest log score. The other two models allow for non-linearity.
The latent class logistic regression model uses 6 of the variables to assign patients to
classes, followed by using the class membership and the treatment as predictors of
outcome in a logistic regression. This is superior to the ordinary logistic regression in
sensitivity but poorer in overall accuracy. The second non-linear model is the ANN
using the same 7 variables as inputs. This performs as well as the logistic regression
with respect to accuracy, but is superior in the log score. The ANN performs as well
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as the latent class logistic regression in terms of log score, but is superior in overall
accuracy.
We hypothesise that by using techniques that can account for non-linearities and
seeing improvement suggests that linear models do not describe the connection be-
tween the cognitive domain and the experience of back pain well. We have shown
that the artiﬁcial neural network provides the best combination of overall error rate
and sensitivity, and would be the best candidate of these three models for decision
support for the cognitive behavioural approach to treatment of lower back pain.
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6.4 Analysis of the Basingstoke and Alton cardiac reha-
bilitation cohort data
These data were analysed by two methods. The Cox proportional hazards model,
which is a standard survival analysis method, was used and optimised to ﬁnd the
best subset of explanatory variables for all-cause and cardiovascular survival. This
subset of explanatory variables was used to ﬁt an ANN and used to predict mortality.
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Figure 6.15: Schematic representing the analysis scheme for the BeST data set.
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6.5 The Cox Model for Long-Term Survival After a Car-
diovascular Event
The long-term mortality of an unselected cohort of patients who have experienced a
coronary event or procedure was investigated, to identify factors which were associ-
ated with longer term survival.
6.5.1 Principal ﬁndings
Predictors of long-term survival (> 5 years) in patients who have had a coronary
event or procedure were not identical to the predictors of short-term survival. After
adjusting for age, sex and medications, ﬁtness remains a strong predictor of long-
term survival from both all-cause and cardiovascular mortality. When changes in
ﬁtness during the rehabilitation period were taken into account, an improvement to
high ﬁtness is associated with the same beneﬁts as having started with high ﬁtness.
6.5.2 Introduction
Recall that access was granted to data on a cohort of patients recruited between 1st
January 1993 and 31st December 2002 through the Basingstoke and Alton (Hamp-
shire, UK) cardiac rehabilitation programme with follow-up to 30th March 2011.
The cohort is unselected, includes all NHS referrals, and participants have now been
followed for between one day and 18 years and three months providing 11,871 person-
years of follow-up. Recruitment to the cohort was undertaken typically 2 to 6 weeks
after their index coronary event (Bethell et al. [2009], West et al. [2011]). NHS
patients in the area served by the rehabilitation centre were routinely referred to
this programme following an acute myocardial infarction, episode of unstable angina
or revascularisation. The only other inclusion criterion for the study was that the
patients had registered with the cardiac rehabilitation programme. This resulted in
an unselected cohort of 2,714 patients. Data collection was undertaken by one per-
son (ST) for each patient, at recruitment and on graduation from the programme,
ensuring consistency over time (Turner [2007]). The Oﬃce for National Statistics
provided data on dates and causes of death. All patients who attended the pro-
gramme and had baseline ﬁtness measured were included in the analysis. Data
collected included whether the programme was completed, diagnosis, co-morbidity,
family history, occupation, date of birth, age, sex, smoking history, resting heart
rate, cholesterol level, triglycerides level, post code, and, from 1998, height. At
both recruitment and on graduation records were made of each patient's weight,
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blood pressure, ﬁtness, anxiety and depression (as measured by Hospital Anxiety
and Depression Scale (Bjelland et al. [2002],Turner [2007])), current smoking habit
and medications (ACE inhibitor, aspirin, beta blocker, statins). There were devel-
opments in protocols for secondary prevention medications during the period of the
study (Turner [2007]). At the start of the study, around 80% of those attending the
Basingstoke and Alton rehabilitation programme were prescribed aspirin, 20% pre-
scribed ACE inhibitor and beta blocker, and almost none prescribed statins. Statin
prescriptions climbed dramatically to almost 60% in the two years to 1996, to 85%
in the following 4 years, and then more slowly to a steady 95% from 2002 onwards.
Beta blocker prescription rose from 20% to 30% between 1993 and 1998 and then
to 60% in the 2 years to 2000, remaining between 50% and 60% for the duration of
the study. Similarly, ACE inhibitor prescription rose slowly between 1993 and 1998
and then experienced a strong increase, so that by 2002, over 80% of patients were
prescribed ACE inhibitors. Aspirin prescription rose steadily from over 80% at the
start of the study to almost 100% by 2001. The patients recruited during the last
4 years of enrolment almost all had prescriptions for aspirin and statins, 80% had a
prescription for ACE inhibitor and between 40% and 50% had prescriptions for all 4
secondary prevention medications. A plot showing the changes in use of secondary
prevention can be found on page 184 of Turner [2007]. It might be expected that
these patients had a longer life expectancy post-event than those recruited under the
earlier regime.
6.5.3 Calculated variables
Changes in weight, ﬁtness, anxiety and depression were calculated from the entry and
exit values for each individual. Since height was not routinely recorded throughout,
BMI was available for only 889 patients. Baseline weight was categorised into under
75kg, 75-90kg, and over 90kg and labelled A, B and C respectively for brevity. The
index of multiple deprivation was ascertained from post code, occupation was coded
under 9 headings (see Table 6.22), and age was categorised into under 50, 50-59,
60-69 and 70 and over. The Modiﬁed D'Hoore Co-morbidity Index is designed to as-
sess non-coronary co-morbidity speciﬁcally in the out-patient cardiac rehabilitation
environment, rather than the acute setting (D'Hoore et al. [1996]), and was calcu-
lated for each patient based on the recorded co-morbidities (see table 3.2 on page 58).
Up to August 1995, ﬁtness was measured on a bicycle ergometer with ECG
monitoring and measurement of estimated peak workload. After that date, exercise
tests were performed on a treadmill, using either the Bruce protocol (Bruce et al.
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[1973]) or, for frail or elderly patients, the modiﬁed Bruce protocol (Bruce [1973]).
Peak exercise tolerance was expressed as the predicted oxygen uptake (V O2 max)
in ml/kg/minute, from the known oxygen cost of bicycling at diﬀerent workloads
(Astrand and Rodahl [1986]). The treadmill test used the same endpoints as for
bicycle tests and V O2 max predicted on the assumption that each one minute of
the Bruce protocol uses one MET (metabolic equivalent - or 3.5ml O2/kg/min) and
that the ﬁrst three stages of the modiﬁed Bruce protocol each use one MET. V O2
max<15ml/kg/min was categorised as low ﬁtness, V O2 max>22ml/kg/min as high
ﬁtness with the remainder as medium (established for cardiac rehabilitation by Ka-
vanagh et al. [2002] Kavanagh et al. [2003]).
The researchers who collected the data report that the exercise test protocol for the
treadmill tests was either the full Bruce or the modiﬁed Bruce protocol, with the
latter used for frailer patients as it starts more gently. With the treadmill set at a
constant 1.7 mph, the gradient is increased from 10% (full Bruce) or 0% (modiﬁed
Bruce) every 3 minutes to a maximum gradient of 22%. The metabolic equivalents
(METs) are calculated from the number of minutes until the patient had reached
85% of their predicted heart rate maximum for their age or developed symptoms
which precluded the test's continuation using the standard conversion that 1 minute
of the Bruce protocol used one MET, and the ﬁrst two stages of the modiﬁed Bruce
protocol use 1 MET each. (Turner [2007]). Each MET is equivalent to 3.5ml/kg/min
so V O2 max Max is estimated as 3.5(1+x), with x being the number of minutes and
the additional 3.5ml/kg/min representing the resting metabolic rate.
Treadmill testing using the Bruce protocol is used for both diagnosis and prognosis
in patients at risk of coronary disease. Symptoms of Ischemia prompt a diagnosis
of disease. Prognosis is estimated using exercise duration, exercise hypotension, ex-
ercise hypertension chronotropic incompetence, heart rate recovery and ventricular
ectopy. Exercise duration is a good measure of functional capacity and a longer du-
ration indicates a lower probability of mortality from coronary disease or any other
cause, including in healthy subjects and retains its prognostic value after adjusting
for age and sex (Miller [2008]). Lower exercise duration can be an indicator of lower
ﬁtness or more severe cardiovascular disease.
Depression and anxiety were categorised into none, borderline and depressed
or anxious using a Hospital Anxiety and Depression Scale score below 8 to suggest
no depression (anxiety), 8-10 to suggest borderline and a score over 10 to suggest
clinical depression or clinical anxiety (Bjelland et al. [2002]).
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In the main analysis, baseline categories of ﬁtness, depression and anxiety
were used as predictors. Since the inﬂuence of an improvement in ﬁtness, depression
or anxiety categories on survival is of interest, and whether these depend on baseline
categories, variables Fitness, Anxiety and Depression were deﬁned so that a scale
of 1 to 7 captured each starting category and improvement or deterioration (see
Table 6.23 ). Very few patients started in the highest ﬁtness category and then
deteriorated over the course of the programme (5 men) so these were combined with
the `no change' category. There were no patients who deteriorated having started in
the mid-ﬁtness category, so this category was omitted. Survival time was deﬁned as
the period between the date the participant joined the programme and the date of
death.
Statistical analysis
In the survival analyses both all-cause mortality and cardiovascular mortality were
considered, with non-cardiovascular deaths treated as censored in the latter anal-
ysis. Cox proportional hazards models (Collett [2003], Cox [1972]) were used to
model both all-cause and cardiovascular survival, beginning from the subset of vari-
ables that were found to be signiﬁcant predictors (at 5% level) of all-cause mortality
after preliminary univariate analyses as the baseline model. A backward stepwise
selection algorithm was employed to ﬁnd the model with minimum AIC (Akaike
[1974]), retaining age and sex as the minimum model. The high calibre practice at
the rehabilitation programme gives us conﬁdence that there was no loss to follow-up.
All analyses were carried out in R statistical software (R Development Core Team
[2011]).
Missing data
The Cox proportional hazards model was used on the complete cases. There were
1,529 cases (56.3%) of the 2,714 available which were complete in all 36 variables
which were signiﬁcant in the univariate analysis and became the starting point for
the deﬁnitive analysis. There were 1,029 cases (38%) which were complete in these
variables and also had observations of ﬁtness, depression and anxiety at the end of the
programme. To address the issue of missing data in order to assess the credibility of
a model built using only the complete cases (Little and Rubin [2002]), hazard ratios
from the complete-case analysis were compared with those from an analysis of all
data (2,714 cases) after replacement of missing values with imputed data. Multiple
imputation was performed in the R package MICE (Multivariate Imputation using
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Chained Equations, R Development Core Team [2011]), providing 20 completed data
sets with values imputed where they were missing. The optimised model was then
built with each of these 20 data sets, and pooled estimates of model coeﬃcients and
variances calculated using the rules devised by Little and Rubin (Little and Rubin
[2002]) for comparison. There were no known reasons to believe that the data were
missing other than at random, except in the case of the end ﬁtness data. Reasons
for end ﬁtness to be missing included referral for cardiac surgery and poor health,
suggesting that time to death for these individuals might diﬀer from those with end
ﬁtness observations. A t-test showed that the mean time to death was not the same
for those with and without an end ﬁtness measurement (P<0.001)
A total of 2,054 patients completed the programme (Turner [2007]); the main reasons
for not completing were patient preference, referral for cardiac surgery, poor health
or death. Those without complete end ﬁtness data included those who were taken to
a diﬀerent heart rate at the ﬁnal ﬁtness test, most of whom were on a beta blocker
for which the dose had been changed or who were tested at a diﬀerent time of day,
and those who were tested using a diﬀerent test protocol.
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Figure 6.16: Patient recruitment and eligibility. *The number of patients with missing data in
individual variables of interest varied, with ﬁtness after the programme missing in 48.5% of cases,
and the remaining variables ranging between 0 and 29.4 % . Details of variables and numbers and
percentage of missing observations are in Table 6.18 on page 146.
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The mean follow-up for those with complete data was 11 years 4 months.
Detailed characteristics of patients are shown in Table 3.3. Women (13.7%) had
a higher mean age. The largest age group, for both sexes, was 60-69 years. The
most common reason for referral to the programme was acute myocardial infarction
(51.1%). Nearly half the women had never smoked compared to just under one third
of the men and close to a third of both sexes had recently given up smoking. Around
half of all patients had a family history of coronary heart disease and over 70% were
free from non-coronary co-morbidity, although a higher proportion of the women had
diabetes. The men had a higher mean ﬁtness than the women and the percentage of
men in the high-ﬁtness category at recruitment was 3 times that of the women; most
of the women were in the low-ﬁtness category. At graduation, 67% of the men and
34% of the women were in the high-ﬁtness category, with one ﬁfth of the patients
having improved from the mid-ﬁtness category. Median ﬁtness was improved by a
similar amount in both sexes, and high ﬁtness was the largest group at graduation.
There was little evidence of clinical depression in this cohort, and most of
those whose scores suggested a borderline category improved by graduation, as did
almost all of the few whose scores at recruitment suggested clinical depression. There
was more anxiety, although the rates were not high. Again, the majority who began
in the borderline category improved, as did a signiﬁcant proportion of those starting
in the clinical anxiety category, but the proportion of women who remained in the
clinical anxiety class was 3 times that of the men.
The maximum recorded co-morbidity score was 7 (very high) but only 2.6%
of participants had a co-morbidity score of 3 or more (D'Hoore et al. [1996], see
Table 3.2 on 58).
Survival
During the course of the study and follow-up of the 1529 participants, 385 died, and
of those deaths 192 (49.9%) were from cardiovascular causes.
Two Cox proportional hazards models were constructed from these data, the primary
model used baseline only measures of ﬁtness, depression and anxiety, for which there
were 1,529 complete cases available. The secondary model used baseline and change
ﬁtness, depression and anxiety as described in Table 6.23 for which 1,029 cases were
available. Table 6.16 details all the signiﬁcant predictors in the primary propor-
tional hazards model of all-cause mortality. In this primary model, age was the most
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Figure 6.17: Kaplan-Meier survival curves for all cause and cardiovascular mortality for the
primary model, the cohort with complete baseline data, 1529 cases. The plot is for the entire
observation time and the dotted lines are the 95% conﬁdence intervals.
important predictor of all-cause mortality, with risk increasing with age. In this
cohort, the next most important predictor was ﬁtness category at recruitment, with
the ﬁttest patients having lowest risk. Risk increased with co-morbidity, and both
aspirin and statins prescriptions reduced risk. Myocardial infarction was the diag-
nosis carrying the greatest risk, along with myocardial infarction with percutaneous
coronary intervention, angina and other cardiac diagnoses. Coronary artery bypass
graft and angina were much lower risk diagnoses. Female sex carried a lower risk
of mortality, as did a lower resting heart rate. Systolic blood pressure was also a
risk indicator. ACE inhibitor prescription was associated with higher risk, perhaps
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because this prescription is given to the high risk cases.
All-cause survival model
complete cases Imputed data
model model
Model Term Hazard Conﬁdence Pooled
Ratio Interval Hazard
lower .95 upper .95 Ratio
Age category under 50 1 - - 1
50-59 2.13 1.17 3.88 2.02
60-69 3.84 2.15 6.88 3.08
70+ 7.94 4.38 14.39 6.07
Fitness:
High baseline 1 - - 1
Mid baseline 1.56 1.16 2.09 1.76
Low baseline 2.60 1.86 3.60 2.76
D'Hoore
Co-morbidity
score None 1 - - 1
1 (least) 1.23 0.91 1.66 1.17
2 1.42 1.08 1.86 1.48
3 1.35 0.68 2.66 1.87
4 (most) 4.50 2.13 9.50 2.67
Statins Yes 0.72 0.57 0.89 0.74
No 1 - - 1
Aspirin Yes 0.53 0.35 0.79 0.63
No 1 - -
Diagnostic
Category MI 1 - - 1
CABG 0.69 0.54 0.89 0.69
PCI 0.54 0.32 0.89 0.68
MI + PCI 0.85 0.44 1.67 0.82
Angina 0.87 0.54 1.39 0.79
Other cardiac 0.99 0.44 2.23 0.94
Sex Male 1 - - 1
Female 0.73 0.54 0.98 0.62
Systolic blood
pressure before 0.995 0.991 0.999 0.998
Ace inhibitor Yes 1.26 1.01 1.57 1.19
No 1 - - 1
Resting heart rate 1.007 1.000 1.014 1.006
Table 6.16: All-cause survival model, ordered by importance of variables to the model, using
baseline only ﬁtness, anxiety and depression categories (1,529 cases, 385 deaths). Pooled hazard
ratios are from multiple imputation of missing data. MI is Myocardial Infarction, CABG is coronary
artery bypass graft, PCI is percutaneous coronary intervention.
141
Cardiovascular survival model: baseline ﬁtness
complete cases Imputed data
model model
Model Term Hazard Conﬁdence Pooled
Ratio Interval Hazard
lower .95 upper .95 Ratio
Fitness: High baseline 1 - - 1
Mid baseline 1.69 1.11 2.60 2.16
Low baseline 4.00 2.54 6.30 4.12
Statin Yes 0.45 0.33 0.61
No 1 - -
Age category under 50 1 - - 1
50-59 1.59 0.76 3.32 1.53
60-69 2.68 1.32 5.43 2.42
70+ 4.10 1.98 8.48 3.83
Diagnostic
Category Myocardial Infarction (MI) 1 - - 1
Coronary Artery Bypass 0.60 0.42 0.85 0.62
Graft (CABG)
Percutaneous Coronary 0.26 0.09 0.70 0.49
Intervention (PCI)
MI + PCI 1.05 0.42 2.62 0.73
Angina 0.85 0.46 1.56 0.71
Other cardiac 0.72 0.23 2.29 1.01
Aspirin Yes 0.48 0.28 0.80 0.56
No 1 - - 1
Sex: MALE 1 - - 1
FEMALE 0.65 0.43 0.99 0.53
Ace inhibitor Yes 1.42 1.04 1.94 1.37
No 1 - - 1
Table 6.17: Optimised Cardiovascular survival model, ordered by importance of variables to the
model, using only baseline values for ﬁtness, depression and anxiety (1,529 cases 192 cardiovascular
deaths). Pooled hazard ratios are from multiple imputation of missing data.
The cardiovascular mortality model is detailed in Table 6.17. Fitness cate-
gory at baseline was the strongest predictor of cardiovascular mortality, with higher
ﬁtness associated with lower risk. A prescription for statins cut the risk of cardiovas-
cular mortality by more than half in this cohort. Age was the next most signiﬁcant
predictor of mortality, with risk increasing with age as expected. As with all-cause
mortality, a diagnosis of myocardial infarction carried the highest associated risk of
mortality, with MI+PCI, angina and other cardiac diagnoses equally high. Female
sex was associated with lower risk, and a prescription for ACE inhibitor with higher
risk.
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In the cohort having complete data including end depression, anxiety and ﬁt-
ness (the secondary model), age was still the strongest predictor of risk for all-cause
mortality (Table 6.24). The next most important predictor was the combination
of ﬁtness category at recruitment, and whether they improved or maintained that
ﬁtness, with highest risk attributed to those who began in the low-ﬁtness category.
There was no statistically signiﬁcant diﬀerence (assessed at the 5% level) between
those who began in the mid-ﬁtness category and improved to high ﬁtness and those
who began in the high-ﬁtness category and maintained high ﬁtness. However, those
who did not improve suﬃciently to move up from the mid-ﬁtness category had sig-
niﬁcantly higher risk; improvement to a mid-ﬁtness from low-ﬁtness category did not
signiﬁcantly reduce risk, although a signiﬁcant diﬀerence in risk is evident between
low and medium ﬁtness for the patients whose category did not change. Having a
prescription for statins or having a prescription for aspirin was each associated with
a lower risk of mortality. A prescription for ACE inhibitors was associated with a
higher risk of mortality and females had lower all-cause mortality.
The cardiovascular mortality model for the cohort having complete data in-
cluding end depression, anxiety and ﬁtness is detailed in Table 6.25. A prescription
for statins was the most powerful predictor of cardiovascular mortality with those
having a prescription having one third the risk of those without. Once again, ﬁtness
was important, low baseline and failure to improve being powerful predictors of car-
diovascular mortality. After ﬁtness, age was important with those over 70 years at
higher risk of cardiovascular death. Aspirin was associated with lower risk, as was
being female.
Imputed data
The hazard ratios derived from the pooled imputed data (shown in Tables 6.16 and
6.17), were very similar to those from the complete cases model, both in size and
direction, and fall within the conﬁdence intervals given for the model estimates.
This suggests that the analysis that used only the complete cases did not produce
substantailly diﬀerent results on account of removing the cases with incomplete data.
There were 889 cases which were complete in baseline BMI as well as baseline ﬁtness,
depression and anxiety as in the primary model, and both all-cause and cardiovas-
cular mortality models were derived for these, to test the importance of BMI. In
neither case did BMI remain in the optimised model.
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Main ﬁndings
Attaining a ﬁtness level of V O2 max>22ml/kg/min (deﬁned here as high ﬁtness) in
the early months following a cardiac event or procedure is associated with improved
long-term survival in those who have experienced a coronary event or procedure.
(A useful comparison is that a young, untrained male would typically have a ﬁtness
level of V O2 max 35-40 ml/kg/min and a cycling athlete V O2 max 80 ml/kg/min.)
High ﬁtness at recruitment to the rehabilitation programme was likely to reﬂect high
ﬁtness before a coronary event or procedure, but there was no statistically signiﬁcant
diﬀerence between patients who improved from moderate ﬁtness at recruitment to
high ﬁtness at graduation and those who maintained high ﬁtness from recruitment,
for those who completed the programme. Secondary prevention medications were
also strongly associated with improved long-term survival in both all-cause and car-
diovascular mortality. In particular, a prescription for statins or a prescription for
aspirin were associated with lower risk of both all-cause and cardiovascular mortality.
A prescription for ACE inhibitors was associated with higher mortality, but those on
ACE inhibitors were the high risk cases. Patients having a CABG surgery and PCI
have a signiﬁcantly higher long-term survival from cardiovascular mortality than do
patients with a myocardial infarction or angina.
Fitness for life confers signiﬁcant potential beneﬁts for those who may go on
to experience a coronary event or procedure. Promotion of ﬁtness after a coronary
event or procedure, even for those already moderately ﬁt, had potential for improved
life expectancy.
The key role of medications in the early weeks after a cardiac event or proce-
dure on reducing long term mortality both from cardiovascular causes and all-causes
in patients experiencing a cardiac event or procedure had been demonstrated previ-
ously (Unal et al. [2004]) and in this model. We have no follow-up information on
the adherence or changes to medication after graduation from the programme, so do
not know how long patients continued with their medication. Given this, the strong
eﬀect of secondary preventative medication is striking.
The protective eﬀect of female sex extends both to cardiovascular causes of
death and to all-causes in cardiovascular patients, contrary to some other ﬁndings
(Dallongevillle et al. [2010]). Weight does not appear to aﬀect all-cause or cardio-
vascular mortality in cardiovascular patients, which is consistent with other studies
(Romero-Corral et al. [2006], Shahian et al. [2012]). A prescription for ACE in-
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hibitors at entry to the programme were closely related to a high risk level and were
associated with increased risk of cardiovascular mortality. When ﬁtness is measured
and included in the survival analysis, BMI ceases to be a predictor of all-cause or
cardiovascular mortality.
Numbers and percentages of the individual variables that were missing in the
2714 cases which met the inclusion criterion of having a baseline ﬁtness measurement
were shown in Table 6.18.
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Variable description Missing %
id Unique identiﬁer 1 0.04
Illness date Date of the index event 0 0
Entry date Date entered the programme 0 0
Graduate date Date graduated from the programme 0 0
Death date Date of death 0 0
Diagnosis ‡ A number from 1 to 8 where
1 is myocardial infarction (MI),
2 is coronary artery bypass grafting (CABG),
3 is percutaneous transluminal coronary
angioplasty(PCI)with or without stenting,
4 is angina pectoris (AP),
5 is valve surgery (VS),
6 is other cardiac conditions
e.g. cardiomyopathy, ischaemic and
non-ischaemic heart failure (OC),
7 is non-cardiac conditions (NC) and
8 is myocardial infarction with percutaneous
transluminal coronary angioplasty as a single
episode of care, (MI+PCI). 0 0
Family History ‡ Family history, yes / no 0 0
Age ‡ Age in years 0 0
age category ‡ Age in categories: 1 is under 50, 2 is 50 to 59,
3 is 60 to 69 and 4 is 70 0 0
Sex ‡ Sex 0 0
Cholesterol Cholesterol measurement at recruitment 537 19.8
Triglycerides Triglycerides measurement at recruitment 787 29.0
Diabetes ‡ patient has diabetes, yes / no 0 0
Comorbidity List of comorbidities in free text 0 0
Height Height in Metres 1161 42.8
Weight ‡ Weight in kilogrammes at recruitment 20 0.7
Weight after ‡ Weight in kilogrammes at graduation 799 29.4
weight category before ‡ A is deﬁned as under 75kg,
75-90kg as overweight,
and over 90kg as C. 20 0.7
Table 6.18: Missing Data (continued next page)
‡indicates this variable was a signiﬁcant predictor of mortality in a single-variable model.
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Variable description Missing %
sbp before ‡ Systolic blood pressure at recruitment 15 0.6
dbp before Diastolic blood pressure at recruitment 26 1.0
sbp after ‡ Systolic blood pressure at graduation 742 27.3
dbp after Diastolic blood pressure at recruitment 763 28.1
V O2 before ‡ Fitness at recruitment in V O2 max 0 0
V O2 after ‡ Fitness at graduation in V O2 max 1316 48.5
V O2 category before ‡ Fitness category at entry 0 0
V O2 category after ‡ Fitness category at exit 1316 48.5
anxiety before Anxiety measured at recruitment
using the hospital anxiety and depression .
scale (HADS). A score between 8 and 10
indicates borderline anxiety,
whilst over 10 suggests clinical anxiety. 89 3.3
anxiety after ‡ Categorisation by HADS at graduation 748 27.6
depression before ‡ Categorisation by HADS at recruitment 89 3.3
depression after ‡ Categorisation by HADS at graduation 749 27.6
over all health before Patient's perception of overall health at entry
- one of six domains from the Dartmouth Coop /
Wonca charts used to assess functional
health and quality of life.
Only patients joining after April 1996 were
assessed in this way 773 28.5
over all health after 1 (excellent) to 5(poor) patient's perception of
overall health at graduation 1275 47.0
life before patient perception of life in general
at recruitment 773 28.5
life after at graduation 1275 47.0
feelings before patient perception of feelings
at recruitment 773 28.5
feelings after at graduation 1275 47.0
painful tension before patient perception of
painful tension at recruitment 775 28.6
painful tension after painful tension at graduation 1276 47.0
physical ﬁtness before patient perception of
physical ﬁtness at recruitment 775 28.6
physical ﬁtness after physical ﬁtness at graduation 1274 46.9
social support before patient perception of social support
available to them at recruitment 775 28.6
social support after at graduation 1274 46.9
Table 6.19: Missing Data continued.
‡indicates this variable was a signiﬁcant predictor of mortality in a single-variable model.
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Variable description Missing %
risk category before ‡ Risk category at recruitment 101 3.7
(high, medium, low)
risk category after ‡ Risk category at exit 730 26.9
Smoking history ‡ coded 0 to 4 where 0 is never smoked,
1 is not smoked for 10 years or more,
2 is not smoked for between 1 and 10 years,
3 is recent quitter, and 4 is current smoker. 3 0.1
aspirin before ‡ Prescription for aspirin at recruitment, yes / no 1 0.04
aspirin after ‡ Prescription for aspirin at graduation 671 24.7
ace before ‡ Prescription for ACE inhibitor at recruitment 1 0.04
ace after ‡ Prescription for ACE inhibitor at graduation 671 24.7
bb before ‡ Prescription for beta blockers at recruitment 1 0.04
bb after ‡ Prescription for beta blockers at graduation 673 24.8
statin before ‡ Prescription for statins at recruitment 9 0.3
statin after ‡ Prescription for statins at graduation 678 25.0
full secondary
prevention before Prescription for aspirin and ACE inhibitors
and beta blockers and statins at recruitment 1 0.04
full secondary
prevention after ‡ Prescription for aspirin and ACE inhibitors
and beta blockers and statins at graduation 1 0.04
resting heart rate ‡ resting heart rate at entry 7 0.3
hrateafter ‡ Heart rate after exercise 681 25.1
exercise sessions number of exercise sessions attended
to graduation or drop-out 105 3.9
imd2004score ‡ Index of multiple deprivation derived
from post code 114 4.2
combined total
comorbidity ‡ D'Hoore comorbidity score 0 0
occupation code ‡ Occupational Code 1-9: Managers &
senior oﬃcials, Professional occupations,
Associate professional, Administrative &
secretarial, Skilled trade,
Personal service, Sales & customer, Process,
plant & machines, Elementary occupations 293 10.8
completer category‡ 1 is completed the programme,
2 is started but did not complete, 3 is never started. 0 0
Table 6.20: Missing Data continued.
‡indicates this variable was a signiﬁcant predictor of mortality in a single-variable model.
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For the 1,029 cases with complete end ﬁtness, anxiety & depression data see
Table 6.21.
Variable Male Female Total
Number 895 (86.9%) 134 (13.1%) 1,029 (100%)
Mean years of follow-up (sd) 11.6 (3.9) 11.2 (3.8) 11.5 (3.9)
Mean age in years (sd) 61.1 (9.3) 63.1 (9.0) 61.3 (9.3)
N % N % N %
Age group under 50 years 104 11.6 14 10.5 118 11.5
Age group 50-59 years 275 30.7 29 21.6 304 29.5
Age group 60-69 years 336 37.6 52 38.8 388 37.7
Age group 70 years and over 180 20.1 39 29.1 219 21.3
Diagnostic Category
Myocardial Infarction (MI) 456 50.9 73 54.5 529 51.4
Coronary Artery Bypass
Graft (CABG) 269 30.1 34 25.4 303 29.4
Percutaneous Coronary
Intervention (PCI) 81 9.1 12 9.0 93 9.0
MI + PCI 36 4.0 3 2.2 52 5.1
Angina 41 4.6 11 8.2 13 1.3
Other cardiac 12 1.3 1 0.7 39 3.8
Smoking history
Never smoked 249 27.8 63 47.0 312 30.3
Not for 10 years+ 285 31.9 19 14.2 304 29.6
Not for 1-10 years 34 3.8 4 2.9 38 3.7
Recent quitter 273 30.5 40 29.9 313 30.4
Current smoker 54 6.0 8 6.0 62 6.0
D'Hoore Co-morbidity score
None 663 74.1 89 66.4 752 73.1
1 (least) 111 12.4 14 10.5 125 12.1
2 102 11.4 27 20.2 129 12.5
3 12 1.3 3 2.2 15 1.5
4 (most) 7 0.8 1 0.7 8 0.8
Diagnosis of diabetes 92 10.3 22 16.4 114 11.1
Family history of CHD 424 47.4 67 50.0 491 47.7
Weight at baseline
A under 75kg 286 32.0 93 69.4 379 36.8
B 75-90kg 418 46.7 25 18.7 443 43.1
C over 90kg 191 21.3 16 11.9 207 20.1
Table 6.21: Baseline values for patients at recruitment to the programme: secondary analysis -
1,029 patients
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Variable Male Female Total
N % N % N %
ACE inhibitor No 479 53.5 54 40.3 533 51.8
ACE inhibitor Yes 416 46.5 80 59.7 496 48.2
Aspirin No 31 3.5 10 7.5 41 4.0
Aspirin Yes 864 96.5 124 92.5 988 96.0
Statin No 338 37.8 43 32.1 381 37.0
Statin Yes 557 62.2 91 67.9 649 63.0
Beta blockers No 573 64.0 80 59.7 653 63.5
Beta blockers Yes 322 36.0 54 40.3 376 36.5
Occupation
Managers & senior oﬃcials 152 17.0 11 8.2 163 15.8
Professional Occupations 98 10.9 7 5.2 105 10.2
Associate Professional 105 11.7 17 12.7 122 11.8
Administrative & secretarial 75 8.4 41 30.6 116 11.3
Skilled trade 250 27.9 7 5.2 257 25.0
Personal service 14 1.6 16 11.9 30 2.9
Sales and customer 18 2.0 10 7.5 28 2.7
Process, plant & machines 110 12.3 10 7.5 120 11.7
Elementary occupations 73 8.2 15 11.2 88 8.6
Table 6.22: baseline values of patients at recruitment to the programme continued: secondary
analysis - 1,029 patients
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Variable Male Female Total
N % N % N %
Fitness
High baseline, no change 397 44.3 18 13.4 415 40.3
High baseline, deteriorate 5 0.6 0 0 5 0.5
Mid baseline, improve 203 22.7 28 20.9 231 22.5
Mid baseline, no change 151 16.9 25 18.7 176 17.1
Mid baseline, deteriorate 0 0 0 0 0 0
Low baseline, improve 86 9.6 20 14.9 106 10.3
Low baseline, no change 53 5.9 43 32.1 96 9.3
Depression
Not depressed, no change 780 87.2 107 79.9 887 86.2
Not depressed, deteriorate 14 1.6 2 1.5 16 1.5
Borderline, improve 62 6.9 15 11.2 77 7.5
Borderline, no change 8 0.9 2 1.5 9 0.9
Borderline, deteriorate 2 0.2 0 0 3 0.3
Depressed, improve 26 2.9 7 5.2 33 3.2
Depressed, no change 3 0.3 1 0.7 4 0.4
Anxiety
Not anxious, no change 607 67.8 73 54.4 887 86.2
Not anxious, deteriorate 40 4.5 10 7.5 16 1.5
Borderline, improve 99 11.1 17 12.7 77 7.5
Borderline, no change 45 5.0 10 7.5 9 0.9
Borderline, deteriorate 9 1.0 0 0 3 0.3
Anxious, improve 68 7.6 11 8.2 33 3.2
Anxious, no change 27 3.0 13 9.7 4 0.4
Median ﬁnal estimated
V O2 ml/kg / min 25.3 18.1 24.5
(10th, 90th percentiles) (16.3, 35.0) (10.4, 26.8) (15.2, 35.0)
Median change from baseline in
V O2 ml/kg / min 3.3 2.6 3.2
(10th, 90th percentiles) (0.5, 8.1) (0.0, 7.95) (0.3, 8.1)
Table 6.23: Change from baseline for patients at graduation from the programme - 1,029 patients
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Table of models with baseline and end ﬁtness, depression and anxiety
All-cause survival model
complete cases Imputed data
model model
Model Term Hazard Conﬁdence Pooled
Ratio Interval Hazard
lower .95 upper .95 Ratio
Age category under 50 1 - - 1
50-59 1.66 0.86 3.22 2.12
60-69 2.48 1.31 4.69 3.05
70+ 5.54 2.90 10.61 5.80
Fitness: High baseline, no change 1 - - 1
Mid baseline, improve 1.29 0.86 1.93 1.52
Mid baseline, no change 2.32 1.59 3.38 2.39
Low baseline, improve 2.84 1.87 4.31 2.84
Low baseline, no change 3.78 2.40 5.94 3.80
Aspirin Yes 0.38 0.24 0.59 0.63
No 1 - - 1
Ace inhibitor Yes 1.45 1.12 1.88 1.29
No 1 - - 1
Sex Male 1 - - 1
Female 0.64 0.44 0.92 0.60
Statins Yes 0.74 0.57 0.97 0.72
No 1 - - 1
Table 6.24: Optimised all-cause survival model for secondary analysis, ordered by importance of
variables to the model. Pooled hazard ratios are from multiple imputation of missing data.
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Cardiovascular survival model
complete cases Imputed data
model model
Model Term Hazard Conﬁdence Pooled
Ratio Interval Hazard
lower .95 upper .95 Ratio
Fitness: High baseline, no change 1 - - 1
Mid baseline, improve 1.08 0.58 2.00 1.61
Mid baseline, no change 2.19 1.26 3.80 2.86
Low baseline, improve 3.40 1.86 6.20 3.18
Low baseline, no change 5.10 2.67 9.76 5.23
Statin Yes 0.43 0.29 0.63 0.52
No 1 - - 1
Age category under 50 1 - - 1
50-59 1.16 0.52 2.60 1.61
60-69 1.83 0.84 3.98 2.47
70+ 3.31 1.47 7.43 3.82
Aspirin Yes 0.39 0.22 0.71 0.60
No 1 - - 1
Sex: Male 1 - - 1
Female 0.50 0.29 0.87 0.51
Ace inhibitor Yes 1.58 1.08 2.30 1.39
No 1 - - 1
Diagnostic Myocardial Infarction (MI) 1 - - 1
Category Coronary Artery Bypass 0.63 0.41 0.98 0.65
Graft (CABG)
Percutaneous Coronary 0.20 0.04 0.83 0.47
Intervention (PCI)
MI + PCI 1.18 0.36 3.86 0.77
Angina 0.96 0.49 1.89 0.73
Other cardiac 1.02 0.25 4.19 0.93
Table 6.25: Optimised Cardiovascular survival model for secondary analysis, ordered by impor-
tance of variables to the model. Pooled hazard ratios are from multiple imputation of missing
data.
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6.6 Artiﬁcial Neural Network for Modelling Long-Term
Survival After a Cardiovascular Event
Artiﬁcial neural networks are a novel approach to modelling survival after a cardiac
event. A Cox proportional hazards modelling approach has been used above with
the data from the Basingstoke and Alton cardiac rehabilitation centre. These results
show the comparison of the two approaches.
6.6.1 Principal ﬁndings
Both the Cox proportion hazards model and the ANN model produce survival esti-
mates which were a good ﬁt to the Kaplan-Meier estimate of survival from the data.
The Cox model is constrained by its proportional hazards assumptions, and so the
hazard over time is always proportional to the baseline hazard. The ANN is free from
this constraint, and whilst for some covariates (e.g. statins, ﬁtness) a proportional
hazard is modelled, for others (e.g. ACE inhibitors, age) the hazard over time varies
diﬀerently between categories of the covariate.
The comparison of hazard rates produced by the Cox and ANN models has shown
the ability of the ANN to model hazard rates that vary over time in ways not con-
strained by a proportional hazards assumption and has produced some revealing
variations in modelling this data set, which provide a basis for hypothesis generation
and potential for tailoring interventions more closely to individual patients.
6.6.2 Introduction
The 6 variables found to be signiﬁcant in the ﬁtted Cox model (i.e. age, sex, ﬁtness
and medications ACE inhibitor, aspirin and statins) were used as inputs in a feed-
forward artiﬁcial neural network with a single hidden layer comprising three hidden
nodes (multi-layer perceptron). The network was regularised using weight decay with
a parameter of 0.5. Optimisation was by minimisation of the log likelihood, and car-
ried out in MATLAB R© using scripts adapted from those developed by Johnston and
Reeves (Reeves and Johnston [2008]) and oﬀered in the book Intelligent and Adaptive
Systems in Medicine edited by Keith Burnham and Olivier Haas. The interface be-
tween MATLAB R© and the R statistical software (R Development Core Team [2011])
was via the R package R.matlab. The hazard rate for the ANN model was calculated
using the equation 4.13. The Cox model was ﬁtted using R statistical software (R
Development Core Team [2011]) and the hazard rate calculated by multiplying the
baseline hazard by the relevant coeﬃcients using the fact that the exponential func-
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tion obeys the basic exponentiation identity, ex+y = ex×ey so that when calculating
the hazard rate from the baseline hazard rate hi(t) = e(β1x1i+β2x2i)ho(t) can be cal-
culated by the baseline hazard multiplied by the relevant exponentiated coeﬃcients,
both drawn from the ﬁtted Cox model thus: hi(t) = eβ1x1i×eβ2x2iho(t), See page 73.
Two aspects of the model were explored here, the ﬁt to data and the diﬀerences in
the model hazard rates.
Fitness was in 5 categories labelled 1,3,4,6,7 which represent the 5 combinations of
before and after rehabilitation ﬁtness categories seen in the data set; the combina-
tions of baseline category and improvement represented by category 2 and 5 were
not in the data set (see Table 6.23 on page 151). Age was in 4 categories (under 50
Years, 50-59, 60-69 and 70 and over) labelled 1 to 4 respectively, sex was labelled
1 for male and 2 for female, and the medications were 1 if prescribed, 0 otherwise.
Altogether there were 320 possible combinations of these 6 variable categories. Each
of the 320 was represented by a 6-ﬁgure number and 159 of the possibilities were to
exist in the data set. These are shown in Tables 6.26, 6.27, & 6.28 starting on page
156, with details of the number of deaths from all causes observed in each variable
category combination. Variable category combinations are indicated by a 6-ﬁgure
number giving the categories of the variables in the sequence: age, sex, ﬁtness, and
medications ACE inhibitor, aspirin and statins, so that 311011 represents age cate-
gory 3 (60-69), male, high ﬁtness at start and end of rehabilitation, no prescription
for ACE inhibitor, a prescription for aspirins and also for statins.
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Variable Combination Alive Dead Variable Combination Alive Dead
111000 1 0 211111 48 2
111010 16 1 213000 1 0
111011 22 1 213001 0 1
111110 4 0 213010 19 3
111111 23 2 213011 12 1
113000 1 0 213101 0 1
113010 13 1 213110 7 1
113011 3 0 213111 14 3
113101 1 0 214000 1 3
113110 2 0 214010 10 3
113111 4 0 214011 2 3
114010 2 0 214110 2 3
114011 0 1 214111 7 1
114110 2 1 216010 2 0
116101 0 1 216110 0 2
116110 1 1 216111 7 3
121000 1 0 217010 0 1
121011 2 0 217110 0 1
121111 2 0 217111 0 1
123001 1 0 221010 1 0
123011 1 0 221011 1 0
123110 1 0 221110 1 0
123111 1 0 221111 1 0
124010 1 0 223010 1 0
124011 1 0 223011 3 2
124110 1 0 223100 1 0
124111 0 1 223110 0 1
126110 0 1 223111 1 1
211000 1 0 224001 0 1
211001 1 1 224010 3 0
211010 35 3 224110 1 0
211011 52 4 224111 3 0
211110 13 0 226000 1 0
Table 6.26: Combinations of variables with numbers of patients in the data set alive or dead.
The combination label is made up from the values of the categorical variables in the sequence age,
sex, ﬁtness, ACE inhibitor, aspirin, statin, so that 311011 represents age category 3 (60-69), male,
high ﬁtness at start and end of rehabilitation, no prescription for ACE inhibitor, a prescription for
aspirins and also for statins.
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Variable Combination Alive Dead Variable Combination Alive Dead
226011 1 0 321110 1 0
226111 1 0 321111 4 0
227011 2 0 323000 1 0
227111 2 0 323010 2 0
311001 1 0 323011 1 0
311010* 22 7 323110 2 0
311011* 29 9 323111 2 0
311101 0 0 324000 0 1
311110 3 4 324010 1 0
311111 52 4 324011 1 0
313001 1 0 324110 1 0
313010* 15 10 324111 2 0
313011 14 0 326011 4 0
313110 5 3 326110 0 2
313111 28 4 326111 5 1
314000 2 0 327010 1 1
314010* 18 8 327011 7 0
314011 13 4 327101 0 1
314100 0 1 327110 2 1
314101 1 0 327111 3 4
314110 1 6 411010 4 1
314111 16 5 411011 7 4
316000 0 0 411110 2 1
316010 1 5 411111 16 4
316011 6 1 413000 0 1
316101 1 1 413010 4 3
316110 4 2 413011 2 6
316111 4 2 413110 4 0
317010 1 1 413111 10 3
317011 4 4 414010 1 8
317110 0 1 414011 8 6
317111 6 2 414110 1 5
321011 1 0 414111 4 4
Table 6.27: Combinations of variables with numbers of patients in the data set alive or dead
(continued). The combination label is made up from the values of the categorical variables in the
sequence age, sex, ﬁtness, ACE inhibitor, aspirin, statin, so that 311011 represents age category 3
(60-69), male, high ﬁtness at start and end of rehabilitation, no prescription for ACE inhibitor, a
prescription for aspirins and also for statins.
* The combinations with an asterisk are shown in the survival plots
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Variable Combination Alive Dead Variable Combination Alive Dead
416000 0 1 423011 2 1
416010 3 3 423111 2 1
416011 3 4 424010 1 1
416100 0 1 424011 1 0
416101 1 1 424111 1 3
416110 1 4 426010 0 1
416111* 11 8 426110 0 1
417010 0 5 426111 0 1
417011 3 3 427000 0 1
417100 0 1 427010 0 2
417110 0 5 427101 0 1
417111* 7 7 427110 0 4
421110 1 0 427111 8 3
421111 1 1
Table 6.28: Combinations of variables with numbers of patients in the data set alive or dead
(continued). The combination label is made up from the values of the categorical variables in the
sequence age, sex, ﬁtness, ACE inhibitor, aspirin, statin, so that 311011 represents age category 3
(60-69), male, high ﬁtness at start and end of rehabilitation, no prescription for ACE inhibitor, a
prescription for aspirins and also for statins.
* The combinations with an asterisk are shown in the survival plots.
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6.6.3 Model ﬁt to data
Both the Cox and ANN models produce survival curves which were comparable to
the Kaplan-Meier estimate of the survivor function obtained from the data.
The Kaplan-Meier estimates of the survivor function are shown in Figure 6.18 for
the variable category combinations in the data set that have at least 7 deaths and
so provide suﬃcient information to make a useful comparison between the Kaplan-
Meier curve and the model survival curves. These variable category combinations
have between 14 and 38 cases observed in the data and are asterisked in the Tables
6.26, 6.27, & 6.28. These cases all fell in the 60+ age brackets, were all male and all
have a prescription for aspirin. They have a variety of ﬁtness categories and other
medication regimes. Both the Cox proportional hazards model and ANN model
estimates of the survivor curve for those same variable category combinations are
also shown. The conﬁdence intervals on each model's survival curves shown are 95%
conﬁdence intervals. Both models clearly produce survival curves that were a good
ﬁt to the Kaplan Meier estimate from data, and their conﬁdence intervals overlap.
The ability of the ANN to produce a more ﬂexible model is clearly seen in each plot.
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Figure 6.18: Survival plots showing the Kaplan-Meier estimate from the data, the Cox propor-
tional hazards model and the ANN model for data subsets with 7 or more deaths, marked with an
asterisk in the Tables 1, 2, and 3. 95% conﬁdence intervals for each model are also shown.
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6.6.4 Model predictions compared
For the 6 cases where there is the most data (marked with an asterisk in the Tables
6.26, 6.27, & 6.28), the contrasts between the hazard rates for the levels of each
variable were plotted in turn, so that the hazard rate for males is plotted against
females, each medication against not taking that medication, ﬁtness levels and age
categories against each other. The item being varied is indicated in the subset label
by an asterisk in the place of its category level, so that 3*1011 indicates the hazard
rate plot comparing males and females who were aged 60-69, had no prescription for
ACE inhibitor, and did have a prescription for both aspirin and statins.
The contrasts between male and female are shown in in Figures 6.19 and 6.20
on page 162. The hazard rates on the right of each ﬁgure show the Cox proportional
hazards model, and on the left the hazard rate given by the ANN model. Note
that the hazard rates for the Cox proportional hazards model were produced by
multiplying the baseline hazard rate by their relevant exponentiated coeﬃcients in
the optimised Cox model, and so were constrained to be proportional to each other
in line with the model assumptions. This is seen in the case of the male / female
contrasts, in that female hazard rates follow the same course over time and were
always lower than the male hazard. The ability of the ANN model to capture non-
linearity means that the hazard rates were not constrained to be proportional and
can vary independently from each other. In the male / female contrasts, the hazard
rates for the 60-69 age group were the same for males and females at early times,
whereas at later times, the male risk was seen to rise sharply. In the 70+ age group,
the female hazard rate was consistently lower than the male rate, and reading these
together it should be noted that, with a mean follow-up time of 11.5 years (max
18 years 3 months), the cases recorded as being in the 60-69 age group at baseline
would have mostly have reached the 70+ age group by the end of follow-up.
Contrasting the hazard rates produced by the Cox proportional hazards and
ANN models for statins compared with no statins (Figures 6.21 and 6.22 on page
164), a very similar picture emerges. Both cases with and without a prescription for
statins have a similar hazard rates at early times, and the hazard rate for the no
statins cases rises steeply at later times for the 60-69 age group (when they will be
70+). Once again, the behaviour of the hazard rate curves for the 70+ age group
is diﬀerent. It is the same regardless of statins status and is much steeper than the
younger age group. The ANN hazard plot suggests that the model switches from an
exponential curve to a logistic curve between the two age categories when considering
statins.
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Figure 6.19: Hazard rate Males and Females. The Cox proportional hazards model is shown
on the right of the ﬁgure, and the ANN model on the left. The hazard rate for the Cox model
is calculated by multiplying the baseline hazard by the relevant exponentiated model coeﬃcients,
and the ANN hazard rate is calculated using equation 4.13. The combination label is made up
from the values of the categorical variables in the sequence age, sex, ﬁtness, ACE inhibitor, aspirin,
statin, so that 311011 represents age category 3 (60-69), male, high ﬁtness at start and end of
rehabilitation, no prescription for ACE inhibitor, a prescription for aspirins and also for statins. *
asterisked position is the variable being compared, e.g. male and female.
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Figure 6.20: Hazard rate Males and Females. The Cox proportional hazards model is shown
on the right of the ﬁgure, and the ANN model on the left. The hazard rate for the Cox model is
calculated by multiplying the baseline hazard by the relevant exponentiated model coeﬃcients, and
the ANN hazard rate is calculated using equation 4.13. The combination label is made up from the
values of the categorical variables in the sequence age, sex, ﬁtness, ACE inhibitor, aspirin, statin,
so that 41777 represents age category 4 (70+), male, low ﬁtness at start and end of rehabilitation, a
prescription for ACE inhibitor, a prescription for aspirins and also for statins. * asterisked position
is the variable being compared, e.g. male and female.
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Figure 6.21: Hazard rate statins and no statins. The Cox proportional hazards model is shown
on the right of the ﬁgure, and the ANN model on the left. The hazard rate for the Cox model
is calculated by multiplying the baseline hazard by the relevant exponentiated model coeﬃcients,
and the ANN hazard rate is calculated using equation 4.13. The combination label is made up
from the values of the categorical variables in the sequence age, sex, ﬁtness, ACE inhibitor, aspirin,
statin, so that 311011 represents age category 3 (60-69), male, high ﬁtness at start and end of
rehabilitation, no prescription for ACE inhibitor, a prescription for aspirins and also for statins. *
asterisked position is the variable being compared, e.g. male and female.
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Figure 6.22: Hazard rate statins and no statins. The Cox proportional hazards model is shown
on the right of the ﬁgure, and the ANN model on the left. The hazard rate for the Cox model is
calculated by multiplying the baseline hazard by the relevant exponentiated model coeﬃcients, and
the ANN hazard rate is calculated using equation 4.13. The combination label is made up from the
values of the categorical variables in the sequence age, sex, ﬁtness, ACE inhibitor, aspirin, statin,
so that 41777 represents age category 4 (70+), male, low ﬁtness at start and end of rehabilitation, a
prescription for ACE inhibitor, a prescription for aspirins and also for statins. * asterisked position
is the variable being compared, e.g. male and female.
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The power of the ANN model to model non-linearity is clearly seen in com-
paring the plots of hazard rates for cases with and without a prescription for ACE
inhibitors (Figures 6.23 and 6.24 on page 167). In the Cox model, the coeﬃcients for
ACE inhibitors are larger than 1, indicating that a prescription of ACE inhibitors
was associated with higher risk (probably because ACE inhibitors were prescribed
for the high risk cases, such as heart failure). This feature is also captured in the
ANN model hazard rate curves, where a prescription for ACE inhibitor produces
a higher hazard rate. The only diﬀerence between cases indicated by 311*10 and
311*11 is that the latter had a prescription for statins. The hazard rate is signiﬁ-
cantly modiﬁed, making the hazard rate for ACE and No ACE the same for early
times, with hazard rate for No ACE increasing in later times. In the cases 311*10,
313*10 and 314*10, the changing ﬁtness levels make no diﬀerence to the fact that
having a prescription for ACE inhibitor gives a much steeper and higher hazard rate.
However, in the 70+ age group 416*11 and 417*11, the hazard rate is very similar
regardless of ACE prescription status, and is more similar to the higher ACE pre-
scription curve for the younger age category, suggesting that increased age negates
the lower risk of no ACE prescription.
In the contrast between aspirin and no aspirin prescription (Figures 6.25 and
6.26 on page 169) the hazard rate of the ANN model for those with an aspirin
prescription is much lower than those without an aspirin prescription for the 60-69
age group, but the diﬀerence disappears for the 70+ age group, despite that group
also having a prescription for statins, which aﬀects the time course of the hazard
rate in the younger, ﬁtter group 3110*1, by removing the upward turn at later times
for those with an aspirin prescription (red dashed line). It is noteworthy that for the
70+ age group with the lowest ﬁtness, there is a small but clearly discernible beneﬁt
for the hazard rate with a prescription for aspirin, not seen in the ﬁtter 70+ cases.
Age (Figures 6.27 and 6.28 on 171) is an important predictor of risk in the
Cox proportional hazards model, and the hazard rate plots for this model show the
proportional hazards between age classes, with the 70+ age group having the largest
multiplicative factor and so a much steeper increase in hazard rate over time. The
ANN model also captures this feature, producing a proportional-like hazard for the
3 younger age groups, which were more similar to each other than in the Cox model,
and a steeper hazard curve over time for the cases in the 70+ age category at the
beginning of the observations. This pattern was repeated for all the sample variable
category combinations, with a slight modiﬁcation in the case of the lowest ﬁtness
categories, where the 60-69 age group showed a steep increase in hazard rate at later
times, when it would be entering the 70+ age category.
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Figure 6.23: Hazard rate ACE inhibitor and No ACE inhibitor. The Cox proportional hazards
model is shown on the right of the ﬁgure, and the ANN model on the left. The hazard rate for the
Cox model is calculated by multiplying the baseline hazard by the relevant exponentiated model
coeﬃcients, and the ANN hazard rate is calculated using equation 4.13.
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Figure 6.24: Hazard rate ACE inhibitor and No ACE inhibitor. The Cox proportional hazards
model is shown on the right of the ﬁgure, and the ANN model on the left. The hazard rate for the
Cox model is calculated by multiplying the baseline hazard by the relevant exponentiated model
coeﬃcients, and the ANN hazard rate is calculated using equation 4.13.
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Figure 6.25: Hazard rate aspirin and no aspirin. The Cox proportional hazards model is shown
on the right of the ﬁgure, and the ANN model on the left. The hazard rate for the Cox model is
calculated by multiplying the baseline hazard by the relevant exponentiated model coeﬃcients, and
the ANN hazard rate is calculated using equation 4.13.
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Figure 6.26: Hazard rate aspirin and no aspirin. The Cox proportional hazards model is shown
on the right of the ﬁgure, and the ANN model on the left. The hazard rate for the Cox model is
calculated by multiplying the baseline hazard by the relevant exponentiated model coeﬃcients, and
the ANN hazard rate is calculated using equation 4.13.
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Figure 6.27: Hazard rate in diﬀerent age groups (age at recruitment). The Cox proportional
hazards model is shown on the right of the ﬁgure, and the ANN model on the left. The hazard rate
for the Cox model is calculated by multiplying the baseline hazard by the relevant exponentiated
model coeﬃcients, and the ANN hazard rate is calculated using equation 4.13.
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Figure 6.28: Hazard rate in diﬀerent age groups (age at recruitment). The Cox proportional
hazards model is shown on the right of the ﬁgure, and the ANN model on the left. The hazard rate
for the Cox model is calculated by multiplying the baseline hazard by the relevant exponentiated
model coeﬃcients, and the ANN hazard rate is calculated using equation 4.13. Fix the headings in
two plots *16111 and *17111
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Figure 6.29: Hazard rate in diﬀerent ﬁtness categories. Change the labels to 13467 . Fitness is in
5 categories labelled 1,3,4,6,7 which represent the 5 combinations of before and after rehabilitation
ﬁtness categories seen in the data set: high ﬁtness at start of rehabilitation maintained (1), mid
ﬁtness at start improved to high ﬁtness (3), mid ﬁtness at start maintained (4), low ﬁtness at start
improved (6), low ﬁtness at start and end (7).
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Fitness (Figure 6.29 on page 173) shows a proportional hazard rate for both
the Cox model, where it is constrained to be proportional, and in the ANN model
where it is not. There were, however, still clear diﬀerences between the models.
The sharp rise in the hazard rate at later times seen for cases 31*010 is not seen
in 31*011, where the only diﬀerence is a prescription of statins for the latter. The
oldest age group also had a steeper rise in hazard rate over time than the 60-69 age
group in every ﬁtness group. The spread in the 70+ age group is is also greater than
the 60-69 age group.
The comparison of hazard rates produced by the Cox and ANN models has
shown the ability of the ANN to model hazard rates that vary over time in ways not
constrained by a proportional hazards assumption and has produced some revealing
variations in modelling this data set, which provide a basis for hypothesis generation
and potential for tailoring interventions more closely to individual patients.
A full discussion of the results presented in this chapter is given in Chapter
7.
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Chapter 7
Discussion
This chapter begins with a discussion of complexity science and health care as a
complex system. This is followed by the results in the context of the literature
which is divided into the same four subdivisions in the results and literature review,
namely LCA for the BeST data, ANN for the BeST data, long-term survival after
a cardiac event using a Cox model and ANN for survival modelling. Following this
discussion, each of the research aims stated in the introduction have been revisited
and evaluated. The chapter closes with a discussion of further research directions.
7.1 Complexity Science
The New England Complex Systems Institute introduces Complexity Science thus:
`Complex Systems is a new ﬁeld of science studying how parts of a system give
rise to the collective behaviors of the system, and how the system interacts with its
environment. Social systems formed (in part) out of people, the brain formed out of
neurons, molecules formed out of atoms, the weather formed out of air ﬂows are all
examples of complex systems. The ﬁeld of complex systems cuts across all traditional
disciplines of science, as well as engineering, management, and medicine. It focuses
on certain questions about parts, wholes and relationships. These questions are
relevant to all traditional ﬁelds.' (The New England Complex Systems Institute
[2013]).
7.2 Complexity in health care
It is well-established that health care and health itself are complex systems (Plsek
and Greenhalgh [2001], Wilson and Holt [2001], Plsek and Wilson [2001], Fraser and
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Greenhalgh [2001], Topolski [2009]). In a series of 4 articles on Complexity Science
and its relevance to health care in 2001, the British Medical Journal deﬁned complex
adaptive systems: `A complex adaptive system is a collection of individual agents
with freedom to act in ways that are not always totally predictable, and whose actions
are interconnected so that one agent's actions changes the context for other agents.
Examples include the immune system, a colony of termites, the ﬁnancial markets
and just about any collection of humans (for example, a family, a committee, or a
primary health care team).' (Plsek and Greenhalgh [2001]).
There follows an overview of complexity in various aspects of health and health care
and how ideas from Complexity Science have been used to address the challenges in
the health care system. At the end of this chapter is a statement of the aims of this
research.
7.2.1 The Complexity challenge
Conventional models of the universe and its subsystems as machines with simple
rules and absolutely predictable and controllable outcomes, have been the frame-
work for understanding medicine and health care as evidenced by the orientation
of medicine around organ-based disciplines and physiological processes and organi-
sation around linear, hierarchical relationships and rules (Plexus [2003]). The shift
from a bio-mechanical view of the body followed the realisation that no part is con-
stant, independent or predictable; complex systems typically have fuzzy boundaries,
membership of sub-systems can change and agents can simultaneously be members
of several systems (work, family, hobby, communities, for example). Conventional,
reductionist scientiﬁc thinking assumes that we shall eventually ﬁgure it all out and
resolve the unresolved issues, whilst Complexity theory accommodates uncertainty
and inherent tension between diﬀerent parts of the system (Plsek and Greenhalgh
[2001]). Complex systems often exhibit non-linear behaviour and sensitive depen-
dence on initial conditions, such that small diﬀerences in the initial variables leads
to large diﬀerences in outcomes. This makes complex systems fundamentally unpre-
dictable over time. Despite this lack of predictability, it is often possible to make
generally true and practically useful statements about a complex system. Attractors
are patterns of behaviour within a complex system. A health care example is the
tendency of psychotherapy patients to accept counsellor's advice when it is framed in
ways that enhance their core sense of autonomy, integrity and ideals. Order, innova-
tion and progress can emerge within a complex system without them being imposed
from outside, e.g termite colonies, driving conventions and behaviour patterns in
repeated meetings. Whilst a surgical theatre team performing a routine procedure
176
might think in mechanistic terms and fall into agreed roles, few situations in mod-
ern health care have such a high degree of certainty and agreement about procedure
and, for those, rigid protocols may not be appropriate. It is claimed that mechanistic
thinking is no longer appropriate in health care and that ﬂexible responses based on
autonomy and creativity should be embraced (Plsek and Greenhalgh [2001]).
7.2.2 Complexity and clinical care
The complexity of both biological and social systems are said to be the reason few, if
any, human illnesses can be said to have a single cause or cure. Glycaemic control in
a diabetes patient is an example of this inherent complexity. The management of the
condition based on simple cause-and eﬀect understanding of insulin and blood glucose
levels led to more hypoglycaemia episodes than an approach which emphasized the
patients' own intimate knowledge of their own proﬁles and body rhythms and their
experimentation with practical responses to variations (Wilson and Holt [2001]).
Another complex systems approach to modelling glucose levels in diabetes found a
diﬀerence in how the levels were correlated at diﬀerent time points between people
with diabetes and those without (Khovanova et al. [2012]). Where lifestyle changes
are needed to improve health, the patients' readiness to change is a key element
of success, and it is suggested this readiness comes when the system is far from
equilibrium, and a new attractor can be accommodated (Wilson and Holt [2001]).
The wider context of other advice which the patient may receive or seek, whether
from a social network, internet source, alternative therapy etc. has been explored
and, for example, there is evidence that social networking is changing people's health-
related experience through the emergence of on-line expert patient groups and the
discovery of community around particular health conditions, which exhibit both
complementarity and competition with the patient-doctor encounter (Griﬃths et al.
[2012]).
7.2.3 Complexity in leadership and management
Leadership and management, including in health care, depends largely on productive
interaction. However, the organisation and management of health care is enacted as
if a well functioning organisation were akin to a large, well-oiled machine. This leads
to the imposition of separate budgets and targets for primary, secondary and social
care which promotes an internal focus for each part (Plsek and Wilson [2001]). One
example is the target to administer thrombolytic drugs to eligible patients within 60
minutes of the onset of a myocardial infarction (heart attack) which is confounded
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with a target for administration within 30 minutes of arrival at hospital, with am-
bulance response times and also any delay by the patients in calling for help, so
that the patient may miss out on full intended beneﬁt despite the individual targets
being met. It is suggested that Complexity-based organisational thinking leads to
whole-system goals and pooled resources which generate relationships among the
stakeholders which provoke creative ideas organisation. A complex adaptive systems
framework could improve outcomes in transitions between health care settings, in-
cluding hospital discharge, which was found to be associated with high re-admission
and adverse event rates in the newly-discharged (Geary and Schumacher [2012]).
Where the organisation as a machine paradigm is in place, initiating change is seen
as akin to a replacement part being ﬁtted, and resistance to change tackled with
the hammer of strong leadership, sanctions, or strict budget controls (Plsek and
Wilson [2001], Johnson et al. [2010]). Instead, it was suggested, a complex systems
approach considers resistance to be the pull of a diﬀerent attractor, such as a desire
to focus on an under-served patient group. Understanding the context and attitude
in which change is attempted can oﬀer strategies to adapt without loss of focus on
what is done well. Variation within a complex organisation arises out of interac-
tion between diﬀerent factors. The strict elimination of all variation is an appeal
to the machine metaphor and will have the byproduct of stiﬂing innovation. In the
nursing home context, complexity-type management led to better patient outcomes
(Anderson et al. [2003]). In the US health care system, multi-scale complex systems
analysis suggests that the overall system can be dramatically improved by establish-
ing two separate but linked health care systems with distinct organisational forms:
one a high-eﬃciency system performing large-scale repetitive tasks such as screening
tests, inoculations, and generic health care, and the other a high-complexity system
treating complex medical problems of individual patients (Bar-Yam [2006]).
7.2.4 Complexity and medical education
As the government and managers seek to deliver a health care system that is ever
safer, constantly up to date, and focuses on patients' changing needs, medical ed-
ucation needs to deliver not only competence (knowledge, skills and attitude) but
also capability (the ability of an individual to adapt to change, generate new knowl-
edge, and continue to improve their performance). Capability cannot be taught or
passively assimilated, but requires existing competencies to be adapted and tuned
to new circumstances (Plsek and Wilson [2001]). In the modern information age,
an expert is someone who knows how to access knowledge eﬃciently and can form
conceptual links between seemingly unrelated areas. Learning how things are inter-
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connected is often more useful than learning about the pieces for applying learning
to new contexts, but this is not a strength of traditional curricula. Checklist-driven
approaches to clinical care become useful only after the problem has been thor-
oughly understood; the acquisition of understanding requires intuition and imagi-
nation (Weiss et al. [2011]). Education that makes use of insights from complex
systems e.g. through storytelling and group problem-based learning helps build on
these distinctly human capabilities (Plsek and Wilson [2001]).
7.2.5 Health as a complex system
Health is traditionally deﬁned in western medicine as absence of disease, and life
deﬁned in terms of death (Topolski [2009]). As the nineteenth century biomedical
model of health replaced theories of humours and spirits, it was itself expanded by
Engel's 20th century biopsychosocial model. The experience of health results from
many diﬀerent interconnected factors, changes in which can have a non-linear eﬀect
on the whole, leading to the conclusion that Engel's model can be further improved
using the concepts from Complex Systems science. This new model asserts that
living systems are open to their environment (e.g.weather, Parsons et al. [2011]),
and borrows the language of statistical physics in describing ageing (Topolski [2009])
and illness (Burton et al. [2010]) as increase in entropy and decrease in complexity.
This model describes a log-normal distribution of maximum health potential with
a minimal sum of health for survival. The theoretical maximum health potential
is modiﬁed by the inﬂuence of surroundings on the six paired parameters which
describe health, vis. physical and environmental, emotional and social and cognitive
and semiotic which sum to describe the experience of health and well-being. This
Complexity science based model unites the concepts of identiﬁable pathologies and
subjective illness in one conceptual model.
7.2.6 The complex individual
Griﬃths et al. [2010] state that `This notion of the individual has much in com-
mon with that of the complex system: open systems with emergent properties and
transformational potential. The emergent property of a complex system is the qual-
ity that indicates its nature as a whole, and cannot necessarily be predicted or
explained by detailed examination of the parts of the system. There is constant
interaction within a complex system and between the system and its environment,
and so constant change. The nature of this change might be small adjustments or
adaptations, but the system remains qualitatively similar; however, change might
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be transformational and, if this occurs, the system becomes qualitatively diﬀerent.
The nature or quality of the system is the emergent property of the system at that
time. Complexity science is concerned with describing and explaining the patterns
of change of a system, both the transformations and the adjustment and adaptation
between transformations. This social theory on the nature of the individual and
complex systems suggested that we could consider individuals as complex systems
with emergent properties (what we have referred to above as how a person is overall,
her or his qualitative state) that are constantly changing, and that the pattern of
change might be important. An individual's pattern of adjustment and adaptation,
and any transformations, could result from all he or she does and all that happens
to him or her over time. '
This description attempts to capture some of the reasons why individuals do not
respond uniformly to stimuli (Thorogood et al. [2006]). For example, the stigma
of depression intersects with responses to depression: some people get more de-
pressed, but for others stigma makes them get up and prove themselves (Boardman
et al. [2011]). Similarly, alcohol has both positive and negative health eﬀects: same
exposure, diﬀerent outcomes. In a linear model, the coeﬃcients of these may be
both positive and negative and so tend toward zero, despite the eﬀect being sig-
niﬁcant. Human development is also a complex process (McGonigle-Chalmers and
Kusel [2012], McGonigle-Chalmers et al. [2008]) and human interactions are key to
health and disease (Danon et al. [2012], Dong et al. [2012], Centola [2011], House
[2011], Centola [2010], Christakis and Fowler [2008], Fowler and Christakis [2008],
Centola [2007], Christakis and Fowler [2007], Centola et al. [2005]).
On every scale, health and health care are complex systems and yet most
of the quantitative analysis relating health care to outcomes uses linear models. A
2010 review collated more than 100 articles about complex adaptive systems think-
ing in health care and related sectors (Health-Foundation [2010]) and noted a lack
of empirical research.
Having established that health care is a complex system which has non-linear
interactions between its constituent parts, the overarching aim of this research was
to explore whether using non-linear models can better model health care and so
capture the information contained in health care data sets of complex interventions.
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7.3 Latent Class Analysis of BeST Back Pain Trial Data
Many studies have used classiﬁcation techniques to distinguish between categories of
patients with low back pain (LBP), and the treatment-based classiﬁcation schemes
have been described in the literature review. Tailoring on the basis of classiﬁcation
in some studies lead to a reduction in pain, whilst others showed no evidence that
tailoring treatment on the basis of classiﬁcation was eﬀective. In the vast majority
of cases, the classiﬁcation was made based on clinicians' observations of increased
and decreased pain under varying postural conditions of the patient, and only a
few on patient-reported measures. There were a few schemes which used statistical
methods such as the k-means algorithm to form clusters based on means of various
measures. The k-means method requires that a distance between two measurement
of something is meaningfully deﬁned. In the case of a sum score like HADS, it is
not clear how meaningful the mean of the score is, or how to take a mean of the
categorical version of the variable (e.g., clinically depressed, borderline, normal), so
k-means was not considered suitable for this investigation. In contrast, latent class
analysis (LCA) is a model-based approach (as described on page 64) which does not
require such a distance metric. Two papers were found that described the use of
LCA in relation to back pain. In one, the use of LCA for the classiﬁcation of LBP
time courses was found to produce descriptive classes, but these were not linked to
treatments or outcomes (Dunn et al. [2006]). The other LCA model linked patient
characteristics to quality of life (36-Item Short Form Health Survey, SF-36, Version
1), rather than pain and disability changes (Beales et al. [2012]). These last two
studies are the most similar to the BeST LCA study detailed here in that they used
some of the same measures, but they were not attempting to associate outcome with
a treatment based on these patient characteristics.
The need to ﬁnd classiﬁcation schemes which can direct treatment and improve both
pain and disability, elucidated in Fairbank et al. [2011], has yet to be fully satisﬁed.
An important contribution has been made in the BeST LCA study presented in this
thesis, in using the patient characteristics that the treatment was designed to tackle
to derive classes of patients, and relating these classes to pain and disability out-
comes. The results starting on page 105 show that it is possible to identify distinct
classes of patients using LBP interference with social activities, pain self-eﬃcacy,
fear avoidance beliefs relating to physical activity, depression, anxiety and perceived
troublesomeness. In a cognitive behavioural approach (CBA) to tackling these char-
acteristics in people with non-speciﬁc LBP, there is some evidence that at least a
predeﬁned minimum level of reduction in pain and disability is more likely to be
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enjoyed by one class than the others.
Additionally, in a model adjusted for class membership, age, gender and employment,
an association between outcome and work status was found which was also found
independently by a separate secondary analysis of the same data looking for poten-
tial eﬀect moderators using the same outcome measures (Underwood et al. [2011]).
Underwood's work tested three hypotheses that were deﬁned at the design stage of
the trial: that treatment beneﬁt would be greater in those with more troublesome
back pain; that the treatment eﬀect would be greater in those with high levels of fear
avoidance; that the treatment beneﬁt would be greater in those with subacute low
back pain (≤ 3 months) than those with chronic low back pain. For those analyses,
the Bonferroni correction was applied and the signiﬁcance assessed at α= 0.025. In
addition, they investigated baseline demographic data to identify potential predictors
or moderators of outcome, using 2-sided tests with statistical signiﬁcance assessed at
α= 0.05. The ﬁndings were that univariate analyses showed that age, employment,
beneﬁts, and the MVK disability score were predictors of change from baseline of
RMQ, MVK disability and MVK pain. It was also discovered that troublesomeness,
duration, baseline RMQ, and baseline MVK pain predicted outcome in some but
not all three measures. A stepwise selection model was tested and found signiﬁcant
interactions only when using RMQ as the outcome. Speciﬁcally, being younger and
employed were eﬀect modiﬁers. Doubt is expressed in Underwood's paper whether
this is a true moderation eﬀect.
In the BeST LCA presented here, although treatment predicts recovery in the 4-
class model, no association can be found between class membership and recovery or
receiving treatment given membership of any of the classes in the logistic regression
analyses of the unadjusted model or in the analysis of deviance. In the model ad-
justed for age, gender and employment, however, there was a marginally signiﬁcant
coeﬃcient for the interaction between membership of Class 2 and treatment with the
CBA intervention in the logistic regression models, suggesting that after adjusting
for age, gender and work status, membership of Class 2 is associated with recovery
for those receiving CBA. In this 4-class model, Class 2 is populated with patients who
were moderately aﬀected on all dimensions (details on page 112). The signiﬁcance of
Class 2 was not replicated in the analysis of deviance for the adjusted model, which
showed treatment to be highly signiﬁcant, and the interaction of treatment and work
to be signiﬁcant. Looking at Table 6.9 (page 120), it is clear that both Class 2 and
Class 4 have at least twice as many members not working as working, and that Class
1 has 50% more in the working category than not working, so the link between class
and work is evident. In Table 6.12 it is clear that of those in work, approximately
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half recovered and half did not (bearing in mind that allocation to treatment is 2:1
in favour of the CBA intervention), whilst in the not-working group, the majority
did not recover. This is seen particularly in classes 1 and 4, where approximately
twice as many did not recover as did recover. Whilst the signiﬁcance of results re-
lating to Class 2 and Class 4 might be artifacts of low numbers in those classes, the
same cannot be said for Class 1 or Class 3 suggesting that the results with respect
to work are robust, and are conﬁrming results obtained by alternative methods in
Underwood et al. [2011].
In the 3-class model, treatment is a predictor of recovery throughout. Addi-
tionally, membership of Class 2 is marginally signiﬁcant in analysis of deviance in
the unadjusted model, indicating the possibility of a diﬀerent response to treatment
for the patients in Class 2. However, Class 2 of the three-class model is also the
smallest class with just 52 patients (12.8% of the data set) and therefore any results
for this class might be highly dependent on the precise mix of characteristics of the
individuals allocated to Class 2, and may, therefore, not replicate in a diﬀerent data
set. Recall that in this data set, those in Class 2 of the 3-class model are the patients
with the severest symptoms (details on page 109). The indication that membership
of Class 2 aﬀects the likelihood of recovery may be related to the severity of the
symptoms individuals are experiencing, or an artefact of the low numbers in the
class. The lack of signiﬁcance for the interaction term indicates that receiving treat-
ment given a patient belongs to a certain class is not a clear predictor of outcome.
Fisher's exact test showed an asociation between class membership and recovery for
those in the treatment arm of the trial, which was not mirrored for those in the
best care only (control) arm of the trial, suggesting a diﬀerent response to treatment
between the two arms of the trial which is class-dependent. In the adjusted model,
the interaction between treatment and work is signiﬁcant in the analysis of deviance,
both for the regular and for the reﬁned contrasts. Furthermore, in the reﬁned con-
trast model, membership of Class 2 was again marginally signiﬁcant, although the
interaction of Class 2 and treatment was not. Once again, in the adjusted model the
interaction of treatment and work is highly signiﬁcant. The same patterns can be
seen in Table 6.13 as in Table 6.12, namely that whilst among the people in work,
recovery was evenly distributed between recovery and no recovery, the majority of
people out of work did not recover, with Class 2 having three times as many who
did not recover as did. This could explain why the analysis uncovered work status
and Class 2 membership both to be important. Whilst there is some indication that
membership of Class 2 aﬀects the likelihood of recovery, caution must be exercised
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for reasons stated above.
Whilst the number and characteristics of classes yielding the models with
minimum AIC and BIC scores was robust, during the analysis it became clear that
the regression coeﬃcients in the linear models relating class membership to outcome
were sensitive to changes in a few patient cases, and therefore the conclusions drawn
from these analyses may be fragile. It is clear that dividing 407 patient cases into 3
or 4 classes will yield classes which may be small and therefore in danger of having
atypical proﬁles. There is no detail given in the BeST trial report (Lamb et al.
[2010b]) as to why there is so much of the follow-up RMQ missing. If the original
701 patients all had a follow-up RMQ score, the results from these analyses would
be more reliable.
An important contribution has been made in identifying classes of patients
with LBP based on the patient characteristics that the CBA treatment was designed
to tackle. These classes have been related to outcomes in adjusted and unadjusted
models. There are also some hints that using the patient characteristics that the in-
tervention was designed to tackle has identiﬁed classes within the patient population
that have diﬀering responses to CBA. A previously identiﬁed association between
outcome and work status, which was found independently using alternative methods,
has been also identiﬁed by these analyses. This work has the potential to identify
those for whom a cognitive behavioural approach (CBA) is eﬀective or ineﬀective
and so guide the choice of treatments to those most suitable for individuals.
7.4 Artiﬁcial Neural Network Analysis of the BeST Data
The use of ANNs for predicting the outcome of treatment for back pain, using base-
line measures of the patient characteristics the intervention is designed to tackle,
has explored a gap in the literature. For patients oﬀered a cognitive behavioural
approach to back pain, this technique would be able to provide a good estimate of
whether a 3-point improvement on the RMQ is likely to be achieved for an individ-
ual, given their baseline characteristics. If a similar prediction were available for the
other back pain treatment options, then these could be combined into a useful tool
for allocating a given patient to the most appropriate treatment based on their base-
line characteristics. Having established that back pain has a non-linear relationship
with some covariates such as frequency of physical activity in univariate analysis,
using techniques that can account for non-linearities is a reasonable approach. The
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fact that these non-linear models were shown to display improved performance over
linear models suggests that linear models do not describe the connection between the
cognitive domain and the experience of back pain well. The values of the sensitivity
and speciﬁcity for the ANN are in line with those produced by Ripley et al. (Ripley
et al. [2004]).
Given prevalence of LBP, numbers in this trial were small, especially after we require
the data to be complete in the explanatory and the response variable, RMQ improve-
ment. It would be useful to be able to replicate the technique on other and especially
larger data sets to eliminate the possibility of an atypical result based on a small
data set. Perhaps more data would discount the beneﬁts of non-linear modelling we
see here, or perhaps conﬁrm it, but much more data would be needed before strong
claims can be made. It is also possible that using the measures of the mechanism of
treatment are not the best predictors and future work could test the other variables
available in this data set and others to see if these have greater predictive power in
linear or non-linear models. Nevertheless, in this type of health care application,
which uses scores from self-reported questionnaires, it could be argued that the data
will always be complex and that the levels of performance we see here are unlikely
to be surpassed simply by collecting more data.
We have shown that the artiﬁcial neural network provides the best combination of
overall error rate and sensitivity, and would be the best candidate of the three mod-
els tested for decision support for the cognitive behavioural approach to treatment
of lower back pain.
7.5 The Cox Model for Long-Term Survival After a Car-
diovascular Event
This analysis of the Basingstoke and Alton data set contributes to the body of re-
search seeking to identify risk factors for long-term mortality in coronary patients.
The majority of the trials included in systematic reviews have followed up partic-
ipants for two years or less, whilst this observational study has followed up for up
to 18 years. This length of follow-up is unusually long for studies on patients ex-
periencing a cardiac event or procedure (Heran et al. [2011]). Other studies that
did follow up for more than 5 years, limited participants to men under the age of
65 without diabetes or signiﬁcant comorbidity, whilst this study includes men and
women of all ages and all does not exclude diabetes or other comorbidities. Such
limitations have compromised the generalisability of the systematic reviews (Turner
[2007]). Most studies did not include ﬁtness or anxiety and depression as possible
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explanatory variables, whilst this study included both, and also change in ﬁtness dur-
ing the rehabilitation programme. Diﬀerences between cardiovascular mortality and
all-cause mortality were not considered in the majority of these studies, and there
was little consideration of secondary prevention medications as predictors of survival.
The three long-term studies detailed on page 31 are diﬀerent from this study
in important ways: they had only male participants under 65 years old, only those
who had suﬀered MI, and excluded those with signiﬁcant comorbidity. In all cases,
there was an exercise dose that was ﬁxed, and ﬁtness was not measured, in contrast
with the Basingstoke and Alton data set where ﬁtness was measured at entry and
exit, and the programme for any individual lasted as long as it took for a given level
of exercise capacity to be reached. In addition Dorn et al. excluded those failing
to complete the initial 6-week low-level exercise programme, further reducing the
similarity between their study cohort and patients typically seen in cardiac rehabil-
itation (Dorn et al. [1999]).
The strengths of this study are the large, unselected cohort with an average
11.5 years of follow-up for those with complete observations. The data were collected
in routine clinical practice and collected by one person, Dr Sally Turner, giving con-
ﬁdence in the quality of the data and relevance to NHS practice. The problem of
potential of bias in the model due to the missing data has been dealt with using an
established method (namely multiple imputation and pooling) and the robustness
of the model conﬁrmed. These patients, including a proportion women that is typ-
ical for studies in this area, already have coronary heart disease, and there is very
little literature for this class of patient. The beneﬁts of a single NHS centre study
with consistent staﬃng and programme is that there is consistent delivery of the
programme between patients. Over the course of the study, two diﬀerent methods
of estimating ﬁtness (V O2max) were used, but only patients whose ﬁtness at the
beginning and end are measured in the same way are included. One weakness of
the Basingstoke and Alton data set is that physical ﬁtness was assessed indirectly
using predicted, not measured, oxygen uptake. However, these method of ﬁtness
assessment are typical of the pragmatic methods used in such NHS settings.
Another limitation was the use of the same ﬁtness categories for all patients, and
this is likely to underestimate the beneﬁcial eﬀects of ﬁtness for women (Kavanagh
et al. [2002], Kavanagh et al. [2003]). Patients who never attended, or attended at
least once but did not have a baseline measure of ﬁtness are included in the popu-
lation of patients typically experiencing a cardiac event or procedure, and excluding
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these cases from the analysis diminishes the generalisability of the results. Some
of these individuals will have been the most frail patients, and excluding them also
explains the initial period of no deaths seen in the Kaplan Meier plot (Figure 6.17).
However, our study showed that ﬁtness level in the early weeks after a cardiac event
or procedure was equally important for cohorts with a wider range of initial ﬁtness,
a wider age range, signiﬁcant co-morbidities and that included women.
In the survival analysis of the Basingstoke and Alton data set presented in
this thesis, ﬁtness category was a signiﬁcant predictor of all-cause mortality and car-
diovascular mortality, whether the baseline measurement was used alone or whether
it was used alongside ﬁtness category improvement. This is a much more appropri-
ate variable than simple exercise dose since it is well known that individuals' dose
response for exercise varies widely (Scharhag-Rosenberger et al. [2010], Savage et al.
[2009]). It has previously been found that improvement in ﬁtness during a CR pro-
gram was associated with decreased mortality in those with low ﬁtness alone (Martin
et al. [2011], Vanhees et al. [1995]). The change in peak V O2max during the training
period of cardiac rehabilitation was found to predict cardiovascular mortality and
lower resting heart was linked to cardiovascular survival (Fox et al. [2007], Fox et al.
[2008]).
BMI was not available in the a large part of the Basingstoke and Alton data
set, so weight was categorised in such a way as to represent normal, overweight
and obese categories in an average-height person in a typical UK group with this
gender mix. Whilst alone weight category was a signiﬁcant predictor of mortality,
in the presence of other variables, including ﬁtness category, it ceased to be signiﬁ-
cant. Moreover, when the 889 cases which did have complete data in baseline BMI
(and other variables of interest) were modelled, BMI was not retained in the model
as a signiﬁcant predictor of either all-cause or cardiovascular mortality, but ﬁtness
was signiﬁcantly related to mortality. This ﬁnding was consistent with other liter-
ature, for example, the GOSPEL study, and intensive intervention that decreased
CV mortality plus nonfatal myocardial infarction (MI) and stroke, included vari-
ous lifestyle targets alongside its ﬁxed-dose exercise prescription, including healthy
Mediterranean diet and BMI ≤ 25. There were other studies linking BMI with sur-
vival, and whilst some considered BMI and exercise the majority did not consider
both BMI and ﬁtness (Li et al. [2006], Willett et al. [1995]). The health eﬀects of
BMI adjustment (weight loss) were found to be complex, possibly composed of op-
positely acting processes, and in need more research (Sorensen et al. [2005]). In a
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systematic review of cohort studies, the authors concluded that better outcomes for
cardiovascular and total mortality seen in the overweight and mildly obese groups
could not be explained by adjustment for confounding factors. They suggested these
ﬁndings could be explained by the lack of discriminatory power of BMI to diﬀeren-
tiate between body fat and lean mass (Romero-Corral et al. [2006]).
The all-cause mortality rate of ﬁt, obese men was found to be not signiﬁcantly diﬀer-
ent from that of ﬁt, lean men and that unﬁt men with low waist girths had greater
risk of all-cause mortality than did ﬁt men with high waist girths (Lee et al. [1999]).
Others found that BMI, as a predictor of all-cause mortality risk in women, may be
misleading unless cardiorespiratory ﬁtness (CRF) is also considered. (Farrell et al.
[2002], Kodama et al. [2009]). It is clear that the relationship between BMI, ﬁtness
and survival is not well-established.
The Basingstoke and Alton data set study found that ﬁtness and improve-
ment in ﬁtness within the early months after a coronary event or procedure predict
long term survival of patients. One ﬁfth of the patients in this study who com-
pleted the programme and therefore had an end ﬁtness measurement, moved from
mid-ﬁtness to high ﬁtness and these had as good a long-term outcome as those who
had begun in the highest ﬁtness category, and a better prognosis than those who
began in the mid-ﬁtness category and did not improve. There was also a group who
moved from the low ﬁtness to the mid-ﬁtness category and had improved survival
over those who did not. The Basingstoke and Alton CR programme diﬀered from
other programmes because the exercise training continued for each individual until
they were able to perform a physical exercise session without a break, i.e. until they
attained a measure of stamina, then their ﬁtness was measured, making no assump-
tions about dose-response.
Recall that lower V O2 max estimated from a treadmill test can indicate lower
ﬁtness or more severe cardiovascular disease and a higher risk in the AACVPR (see
pafe 136. Those patients whose ﬁtness category is low and who do not improve may
be those whose cardiovascular disease is more severe. Exercise regimes aimed at
improving ﬁtness category should also take account of their disease severity.
The largest age group for both genders in this study was 60-69 years, with
536 (35.1%) of the patients with complete baseline data aged over 65, who would
have been excluded from other studies on age grounds , and similarly for the many
participants with comorbidities. And yet these patients are typical of those present-
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ing for CR after a cardiac event or procedure, and it is valuable to have information
on risk factors and especially strategies for modifying risk factors which apply to
them.
In the Basingstoke and Alton cohort, secondary prevention medications con-
tribute signiﬁcantly to improved long-term survival in both all-cause and cardiovas-
cular mortality, as expected for short-term mortality (Liakopoulos et al. [2012],Vale
et al. [2011a], Perez et al. [2009]), with the exception of ACE inhibitors which were
associated with lower life expectancy. As discussed previously, ACE inhibitors are
prescribed to those in high risk categories (Skinner and Cooper [2011]), and this as-
sociation is probably a reﬂection of underlying poor health; there was a correlation
in the Basingstoke and Alton data set between a prescription for ACE inhibitors and
high risk category. There is no information on how long the medications were used,
suggesting that the eﬀect is very strong.
In the Basingstoke and Alton data set, diagnosis is a signiﬁcant predictor of
cardiovascular mortality and of all-cause mortality when ﬁtness at baseline only is
used as an explanatory variable. When ﬁtness plus change in ﬁtness category is used,
diagnosis is not a signiﬁcant predictor of mortality suggesting that change in ﬁtness
category is correlated with diagnosis. In the other models, patients having coronary
artery bypass surgery and percutaneous coronary intervention have a signiﬁcantly
higher long-term survival from cardiovascular mortality than do patients with a my-
ocardial infarction or angina. This accords with Buckley et al. where prognosis to
death or cardiac outcomes for patients with angina alone was similar to those with
previous acute MI or revascularisation, while health status was poorer (Buckley and
Murphy [2009]).
Smoking is known to be a factor in the development of heart disease, so it
might be expected to be a predictor of mortality in those who have had a cardiac
event or procedure (Ketonen et al. [2008], Hardoon et al. [2008]). In the Basingstoke
and Alton data set, current smoking habit data showed nearly half the women had
never smoked compared to just under one third of the men and close to a third of
both genders had recently given up smoking. Whilst current smoking habit was a
predictor of mortality when used alone, it ceased to be a signiﬁcant part of the model
in the presence of other variables. This may be because current smoking habit is a
`snapshot' at a point in time and does not give all the information about long-term
behaviour. Initial cessation of smoking is quite common in CHD patients. However,
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approximately 50% of those who stop smoking begin smoking again within 1 year
after the event (Barth et al. [2004]). Another possibility is that smoking is correlated
with ﬁtness, and having controlled for ﬁtness, smoking is no longer an independent
predictor of mortality. Recent epidemiologic studies show evidence for a link between
smoking behaviour and depression (Schmitz et al. [2003]).
There was little evidence of clinical depression in the Basingstoke and Al-
ton cohort, and most of those whose HADS scores suggested either depressed or a
borderline category improved by graduation. Depression and anxiety were each pre-
dictors of long-term mortality in univariate models, but neither was signiﬁcant in the
multivariate model. Depression is known to be associated with short-term mortality.
Dickens et al. investigated the association of depression with mortality following
MI in 588 subjects and followed up their cases for up to 8 years. Depression was
not associated with cardiac mortality, whether depression was detected immediately
before MI, 12 months after MI or at both time points. They concluded that the asso-
ciation between depression and post-MI mortality is complex, possibly being limited
to depression immediately after MI (Dickens et al. [2007]). A recent meta-analysis
found that the presence of depressive symptoms after myocardial infarction was not
uncommon and was associated with a 2-fold to 2.5-fold increased risk of impaired
cardiovascular outcome within 2 years (van Melle et al. [2004]). They concluded that
the potential mechanisms linking depression and impaired cardiovascular prognosis
were still poorly understood. First, unhealthy behavior of depressed MI patients
(diminished compliance, smoking, unhealthy diet, inactivity) was found to be im-
portant. Second, evidence was found to be growing that physiological mechanisms
were involved. Finally, physicians also prescribed signiﬁcantly less thrombolysis, as-
pirin, ACE inhibitors, and BB to MI patients with comorbid depression. Therefore,
deﬁcits in quality of medical care may explain, in part, the excess mortality experi-
enced by patients with depression after MI. Another meta-analysis found results on
the long-term impact of clinical depression to be rather limited and further research
to be necessary to obtain more stable eﬀects on the impact of depressive disorders
on mortality in CHD patients (Barth et al. [2004]). The ENRICHD RCT sought to
investigate the eﬀect of treating depression and low perceived social support on mor-
tality and recurrent MI after a ﬁrst MI (Berkman et al. [2003]). 1,084 women and
1,397 men were randomised between usual care and individual and group cognitive
behavioural therapy during the ﬁrst 6 months after MI. The intervention improved
depression and social isolation, but did not increase event-free survival at mean 29
months follow-up. The relative improvement in the psychosocial intervention was
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less than expected because of substantial improvement in the usual care group. It
is known that the natural history of depression following acute coronary syndrome
(ACS) is variable (Haas [2006]). It is not clear, therefore, whether the improvement
in depression and anxiety seen in the Basingstoke and Alton cohort is part of the
natural history of the illness or due to treatment, exercise or the support of the
group at the exercise and education sessions. Nevertheless the improvement is wel-
come, and with much longer follow-up, conﬁrms that depression is not associated
with long-term mortality. Another study found that depression predicts failure to
complete cardiac rehabilitation (Casey et al. [2008]), and this was also evident in the
Basingstoke and Alton cohort (Turner [2007])
With 13.7% of patients female, the Basingstoke and Alton cohort was fairly
typical of the patients seen in CR. As discussed above, the majority of trials have
included only men, leading some researchers to conclude that coronary heart dis-
ease in women is under diagnosed, under treated, and under-researched (Mikhail
[2005]). Women account for less than 30% of the participants in most studies and
trials in cardiology making it diﬃcult to draw conclusive evidence on managing car-
diovascular disease in women. Despite diﬀerences between the sexes in risk factors,
presentation, and response to treatment, women continue to receive similar treat-
ments to men on the basis of trials that include mainly male participants (Mikhail
[2005]). One review article concluded that the pathogenesis of CHD was very similar
for men and women. Yet, diabetes, HDL and triglycerides levels were found to have
a greater impact on CHD risk in women compared to men. In addition, there were
indications that risk factors such as smoking, family history and inﬂammation char-
acterized as C-reactive protein, had a more negative inﬂuence on CHD in women
than in men. On the other hand the evidence showing that lipoprotein(a) was a
cardiovascular risk factor seems to be stronger in men than in women. The majority
of cardiovascular risk factors showed no important diﬀerences between the genders
(Roeters van Lennep et al. [2002]). The EUROASPIRE III survey (in 22 European
countries in 2006-2007) identiﬁed 8,966 consecutive patients (25.3% women) who had
had a coronary event or revascularisation before the age of 80. The results showed
that despite similarities in medication exposure, women were less likely than men
to achieve BP, LDL-cholesterol and HbA1c targets after a coronary event. This gap
did not appear to narrow between 1994 and 2007 (Dallongevillle et al. [2010]). In
an investigation into the eﬀect of doctor and patioent gender, Adams et al. found
doctors appeared less aﬀected by patient gender but both male and especially female
doctors took more account of male patients' age, and considered more age-related
191
disease possibilities for men than women. Findings highlighted the need for better
integration of knowledge about female presentations within accepted CHD risk mod-
els, and did not support the contention that women receive better-quality care from
female doctors (Adams et al. [2008]).
A postcode-based index of multiple deprivation was recorded for the Bas-
ingstoke and Alton cohort. Health may be expected to be generally better in an
auent area such as this than in a deprived geographical area, so these results may
not be fully generalisable to other regions. A study analysing recent socioeconomic
trends in coronary heart disease mortality in England found both death rates and
the number of deaths were lowest in the most auent quintile and the pace of fall
was also faster than in the most deprived quintile. Overall, about half of the decrease
in death rates was attributable to improvements in uptake of medical and surgical
treatments. The contribution of these to the deaths averted was very similar across
all quintiles. Risk factor changes accounted for approximately a third fewer deaths in
2007 than occurred in 2000, but were responsible for a smaller proportion of deaths
prevented in the most auent quintile compared with the most deprived. However,
the beneﬁts of improvements in blood pressure, cholesterol, smoking, and physical
activity were partly negated by rises in body mass index and diabetes, particularly
in more deprived quintiles (Bajekal et al. [2012]). Occupation was recorded for the
Basingstoke and Alton cohort, but was not a signiﬁcant predictor of mortality in the
multivariate model. In a prospective occupational cohort study of 17,186 male civil
servants aged 40-69 years between 1967 and 1970 in the UK (the Whitehall study),
employment grade was used as a proxy for socioeconomic position. Men with low
employment grades generally had less favourable risk proﬁles than those with high
grades. Systolic blood pressure, glucose, and proportions of current smokers and
non-insulin dependent diabetes patients were higher in the low employment grade
group than in the high grade group. However, total cholesterol concentrations were
slightly greater in the high grade group than in the low grade group. During the
15-year follow-up, 1,262 men died from coronary heart disease and low employment
grade and all risk factors were associated with high mortality (Kivimäki et al. [2008]).
Promotion of ﬁtness after a coronary event or procedure may extend life
expectancy. Monitoring of patients at risk of a coronary event and intervention
where appropriate to prevent myocardial infarction may improve life expectancy.
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7.6 Artiﬁcial Neural Network for Modelling Long-Term
Survival After a Cardiovascular Event
The ANN and Cox models both produced survival probabilities for mortality in car-
diovascular patients consistent to with the Kaplan-Meier estimate and with each
other (page 160), in line with the ﬁndings of Joshi and Reeves (Joshi et al. [2005])
and Ripley et al. (Ripley et al. [2004]) in their studies on cancer. The use of Kaplan-
Meier curves for comparison is standard practice and there are recent proposal to
correct for case-mix where this is appropriate (MacKenzie et al. [2012]).
Whilst Ripley gave exemplar hazard functions for each of the 7 models studied,
neither Ripley nor Joshi showed or discussed the hazard rates produced by their
respective ANN models in relation to their data. In the new work presented here,
using the models' ability to predict a ﬁxed length of time has been avoided as a basis
of comparison. Cox models are not designed to estimate the probability of survival
at a ﬁxed time, they are intended to show the dependence of the survivor curve on
the explanatory features (Ripley and Ripley [2001]). When used for prediction they
are able to predict the whole survivor curves and it is not surprising that they are
less well able to predict a single point on that curve than the methods designed to
predict just one point. Furthermore, censoring biases will always favour the ANN as
it estimates the probability of survival to a ﬁxed time conditional on the patient still
being under follow-up, and not the unconditional probability estimated by survival
analysis or by a clinician. Ripley et al. use the deviance as a measure of ﬁt (the
sum of minus twice the logarithms of the predicted probability of the event over all
the patients in the training set) which provides a more sensitive measure of ﬁt than
the success rate, especially in the survival analysis models where the exact time of
death is used.
The comparison between the Cox proportional hazards and the ANN hazards is
given on pages 162 to 173. The Cox model is constrained by its proportional haz-
ards assumption, but the ANN is free to vary over time and between levels of the
covariates, allowing the development of hypotheses which can be used in further
investigations. The contrast between male and female hazards in the ANN model is
negligible, when other variables are held constant, in all but the two groups with the
oldest age and lowest ﬁtness. Here, there is a small increase in hazard for the males,
but the hazards are proportional, as with the Cox model. In addition, the hazard
increases more quickly over time for these elderly, unﬁt patients. This suggests that
the eﬀect of gender itself on the hazard is proportional but modiﬁed by age or by
ﬁtness or both. Statins appears to have little or no eﬀect on the hazard. There is a
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slight upturn at late times for the patients without a Statins prescription, but this
is a slight diﬀerence. Consistently with the hazard split by age, the shape of the
hazard is diﬀerent for the older, less ﬁt patients, increasing more sharply over time,
but in this case the the curves lie on top of each other, suggesting that hazard is not
diﬀerent for those with and without a prescription for Statins. The same cannot be
said for those with and without an ACE inhibitor prescription, except in the case of
the older, less ﬁt patients. In the younger patients, the hazard is increased markedly
for those having an ACE inhibitor prescription, and increases more quickly at later
times. The exception is the patients also having a prescription for Statins; com-
pared to those who do not, and with all other variables held constant, the hazard
is the same for those with and without ACE inhibitor prescriptions, except at very
late times when the hazard for those with a prescription have a rapidly increasing
hazard. This suggests that the eﬀect of a prescription for ACE inhibitors on hazard
is modiﬁed by a prescription for Statins, including for older patients. It may also
be modiﬁed by age or or both. Aspirin also shows a clear diﬀerence in the hazard
as modelled by the ANN, between those who have and those who do not have a
prescription. In this case, having a prescription lowers the risk, and for the slightly
younger, ﬁtter patients, the risk remains largely unchanged over time. For those
without a prescription for Aspirin, the hazard proﬁle is very similar to that of the
oldest, least ﬁt patients, for whom Aspirin has little or no modifying eﬀect on the
hazard. Having a prescription for Statins does not alter the hazard for having or
not having a prescription for Aspirin, suggesting that Statins and Aspirin act inde-
pendently. The eﬀect of Aspirin on the hazard may be modiﬁed by age or ﬁtness
or both. When the hazard for each of the 4 age categories is investigated, the ANN
models shows those who are over 70 years of age at baseline to have a higher hazard
than the other 3 categories, which are approximately the same, regardless of Statins.
Fitness does not seem to have an eﬀect on hazard, except for the least ﬁt categories
where at late times, those age 60-69 years at baseline have a sharp increase in hazard.
This suggests that there is something akin to a step change in hazard for those who
are least ﬁt when they reach around 70 years of age. Finally, ﬁtness seems to have
a proportional relationship with hazard in the ANN model, with the diﬀerences in
hazard being greatest for the over 70s, although by no means large. This suggests
there is an interaction between age and ﬁtness.
It seems to be an open question whether the eﬀects of ﬁtness diﬀer measurably for
the over 70s, although the ability maintain ﬁtness gains in the over 70s does seem
limited (Oerkild et al. [2012]). According to this ANN model, the hazard for the
older and least ﬁt patients is qualitatively diﬀerent than than of the other patients,
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and either age or ﬁtness or both seem to aﬀect the eﬀect of medications and gender.
Moreover, it seems that age and ﬁtness aﬀect each other. This warrants additional
investigation if interventions suitable for patients of all demographic groups are to
be developed.
The hazards under the ANN model, when all other covariate are kept con-
stant, are proportional for gender, statins and ﬁtness, but not for age, ACE inhibitors
or aspirin. This suggests that using a model able to capture non-linear relationships
has revealed nuances that the linear model cannot. These hypotheses have been
drawn using subsets of the data where there is a reasonable number of patients. It
happens that all such subsets have male patients, since this cohort was overwhelm-
ingly male. This contrasts with the previous work; Joshi & Reeves had 1,160 females
to 786 (41%) males in malignant melanoma and Ripley all female (breast cancer).
Furthermore, Joshi used diﬀerent cut-points for the male and female patient age
categories, determined by on Martingale residuals of the Cox model.
An ANN approach has successfully been extended to a non-cancer data set
and hazard rates produced by the model have been examined and hypotheses gen-
erated.
7.7 Concordance with Research Aims and Objectives
The research aims were set out on page 13, and in this section each objective has
been revisited and the extent to which it has been achieved has been evaluated.
Discussion on how the results would need to be extended to the point where policy
would be informed has also been described.
7.7.1 Can latent class analysis identify sub-sets of patients within a
cohort of patients recruited to a clinical trial for non-speciﬁc
low back pain?
Using a probabilistic model, classes of patients have been identiﬁed within the BeST
cohort. From a number of competing models, it was possible to identify two models
with substantially better ﬁt than the others. The models have proved to be robust
against minor re-speciﬁcation of cases. This contributes to the existing work seeking
to understand the diﬀerent responses of patients to the same treatment by dividing
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them into groups. This is a ﬁrst step in the attempt to take a population-level result
and apply it to groups of individuals sharing relevant characteristics.
7.7.2 Is it possible to use linear models and the classes identiﬁed
by the latent class analysis to tailor interventions for non-
speciﬁc low back pain to patients?
Having identiﬁed sub-populations (classes) within the LBP population in the BeST
trial, the next question was `did the patients in diﬀerent classes respond diﬀerently
to the CBA treatment?'. This was tackled by using logistic regression to predict
outcomes using class membership and treatment allocation as predictors. A second
logistic regression was used to predict outcomes using class membership, age, sex and
work status, since other work suggested these might be important. It proved diﬃcult
to establish with any certainty that the classes of patients responded diﬀerently to
the CBA complex intervention. Whilst an association between class membership
and outcome for those who received the complex intervention was evident, it was
not possible to discern whether the association for any given class was positive or
negative (whether a particular class was more likely or less likely to achieve the
speciﬁed improvement). It was not possible, either, to identify which speciﬁc class
or classes responded diﬀerently to the complex intervention in terms of outcome.
This is not unusual in complex systems. As already discussed to the introduction,
complex systems often exhibit non-linear behaviour and sensitive dependence on
initial conditions making them unpredictable over time.
7.7.3 How do the performances of the linear and non-linear models
compare for the prediction of patient outcomes following a
cognitive behavioural approach intervention for non-speciﬁc
low back pain?
The linear logistic regression based on class membership alone was compared to
a logistic regression using the same variables as the LCA used to model classes
and these were both compared to an ANN which also used the same variables for
prediction. Over all, the non-linear ANN performed better in terms of accuracy of
prediction, sensitivity and log score than either of the linear models. These models
could each be used to inform a clinician's advice to a patient about the likely eﬃcacy
for them of the BeST CBA intervention. In such an application, the ANN is likely
to be more useful, but ANNs lack interpretability. If the clinician wished, or was
required, to justify their advice, the lack of interpretability would make this diﬃcult.
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7.7.4 What is the potential for these linear and non-linear models
to inform policy on the treatment of non-speciﬁc low back
pain?
The BeST trial showed that the CBA intervention was eﬀective on average, and
the LCA work has attempted to answer the question `for whom is it eﬀective?'. If
a model is to be used to to inform policy or aid clinical decision making, it needs
to be accurate and easy to understand. As they stand at present, the accuracy of
the models introduced here is around 60%. Whether this is good enough depends
on the alternatives and the cost of a misclassiﬁcation. In the narrow application of
allocating patients to CBA treatment for their back pain, it could be argued that
the alternative is to allocate all patients to CBA treatment, since it was eﬀective on
average. In that case, any of these models might provide an improvement, although
the non-linear model had the highest accuracy of the three. In an ideal scenario,
there would be a single tool which identiﬁed the particular treatment, out of the ar-
ray of options available, which would be optimal for the patient at hand. The STarT
tool (Hill et al. [2011]) has made a step in this direction by identifying broad types
of treatment best suited to patients who fall into 3 categories for risk of chronicity.
STarT is available on the web and around 75 clinicians, in a variety of countries
and settings, have indicated that they are using the tool with a variety of treatment
approaches (STarT [accessed 18/05/13]).
Accuracy of the models could be improved with more data, particularly the
question about the associations between class membership and outcome. One ap-
proach would be to combine data from diﬀerent data sets. There is a project under-
way at the University of Warwick to collect anonymised data of therapist-delivered
intervention for low back pain, called Low Back Pain Repository project. There is
precedent for this kind of approach: researchers combined data from 2 large trials
(making 40,000 cases) and were able to deﬁne 28 sub-groups and contribute valuable
insight on beneﬁts and risks of aspirin after ischaemic stroke for small subgroups
of patients for whom the individual trials did not contain enough cases to arrive at
ﬁrm conclusions (Chen et al. [2000]). The diﬃculties of diﬀerent studies deﬁning
diﬀerent outcome measures is being addressed by the Core Outcome Measures in
Eﬀectiveness Trials (COMET) initiative launched in 2010. COMET facilitates the
development of agreed standardised minimum sets of outcomes to be measured and
reported in all clinical trials, audits of practice or other forms of research for a spe-
ciﬁc condition. Outcomes in a particular study are not restricted to those in the
core outcome set, but there is an expectation that the core outcomes will also be
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collected and reported to allow the results of trials and other studies to be compared,
contrasted and combined as appropriate (Williamson et al. [2012]).
7.7.5 Using a linear model, what predicts long-term survival after
a cardiac event or procedure, at population level?
Using a Cox model, a linear model for survival, it was discovered that ﬁtness cate-
gory, secondary prevention medications (statin, aspirin and ACE inhibitor), diagno-
sis, age and sex were associated with cardiovascular mortality after a cardiac event or
procedure at population level. All cause mortality was associated with these same
variables, and in addition, co-morbidity and systolic blood pressure. It was also
found that after adjusting for ﬁtness, BMI was not associated with either cardiovas-
cular or all-cause mortality after a cardiac event or procedure. Since the Cox model
is a linear model, its parameters have a straightforward interpretation as hazard
ratios, which can be used to predict the likely survival experience of an individual
one the value of their variables is known.
7.7.6 Can a non-linear artiﬁcial neural network be used to model
long-term survival after a cardiac event or procedure?
The particular form of ANN selected for use in this study had previously been used
on a Cancer data set, and was selected for ease of comparison. As with the cancer
data set, this ANN was able to model survival. and the concordance of the survival
probability distribution produced with the Kaplan-Meier estimate was as good as
that of the Cox model
7.7.7 How do linear and non-linear models compare in modelling
the survival and hazard of a population who have experienced
a a cardiac event or procedure?
The concordance of the survival probability distribution produced by the ANN with
the Kaplan-Meier estimate was as good as that of the Cox model,
When the Cox and ANN survival models produced hazard rates for subsets of in-
dividuals who all shared the same values of explanatory variables, the Cox model
was constrained by its proportional hazards assumption, but the ANN had no such
constraint. Where the hazards modelled were those for groups of patients whose
explanatory variables diﬀered only in one variable, hypotheses about the eﬀects of
diﬀerent explanatory variables and interactions between them could be formed, as
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described above. This is the ﬁrst time an ANN survival model has been used in this
way.
7.7.8 What is the potential for this research to inform policy for
those who have experienced a a cardiac event or procedure?
Cardiovascular disease is a well-studied disease. Nevertheless, its context is con-
stantly changing, with new forms of clinical management and deﬁnitions, such as
the redeﬁnition of myocardial infarction in the year 2000 and in 2012 (Thygesen
et al. [2012]). The hypotheses generated using the ANN could be tested, given suﬃ-
cient cases, and the remarks made above about the pooling of data hold for this case,
too. There is a cardiac surgery register (Bridgewater et al. [2010]), but its focus is
quality and short term survival and not all the patients in cardiac rehabilitation will
have had surgery.
Hip to waist ratio and BMI are not independent of ﬁtness and whenever the prog-
nostic power of the former is suspected, cardiorespiratory ﬁtness should always be
measured to discriminate between these indicators. Caution should be exercised in
attributing causation to BMI and advice to adjust BMI to reduce reduce mortality in
cardiovascular patients is not supported by this research. However, the promotion
of ﬁtness to reduce mortality in Cardiovascular patients is well supported by this
research.
7.8 Future research
The research presented here has some limitations which provide opportunity for
further research. Whilst the use of non-linear models did provide additional insight,
their eﬃcacy in tailoring interventions to patients has not yet reached the point of
informing policy or useful application in clinical practice.
7.8.1 BeST back pain trial
The BeST study, with 701 participants, is described as a large-scale randomised
controlled trial (Lamb et al. [2010a]). Whilst this study size was appropriate for the
demonstration of long-term eﬀectiveness and cost eﬀectiveness of CBA intervention
at population level, it has (especially with only 407 with complete observations)
constrained the usefulness of the division of the patient population into classes us-
ing LCA. In this respect, the ANN was a more successful non-linear model, since
its superior ability to predict recovery makes it a candidate for use in aiding clinical
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decisions about the treatment most likely to be eﬀective for a given individual. How-
ever, with an accuracy of 61% its usefulness is limited. Larger data sets would enable
the assessment of these non-linear models for use clinically. Larger data sets might
include similar sized data sets with fewer missing values, or data sets with similar
levels of missingness and more participants. As has been discussed previously, it can
be hard to establish with certainty that missing data are missing at random, and
biasses can be introduced in data sets with missing observations.
LCA and ANNs are more frequently used in very large data sets (Mitchell
[1999]) where the use of standard statistical analyses becomes problematic: small
eﬀects can be found with very large sample sizes and it is important to recognize
that a statistically signiﬁcant ﬁnding may not be meaningful or useful. Variance
diminishes as the sample size increases, but bias stays constant and when the bias
is large, a small truly random sample or randomized study can be more valuable.
One very large database of observational clinical data is the Clinical Practice Re-
search Datalink (CPRD, formerly the General Practice Research Database, GPRD)
which makes available anonymised data from the GP Practices which are registered
with it. There is also an NHS Data linkage service at the Health and Social care
Information Centre which is able to link CPRD data and Hospital Episode Statistics
(HES) data in a suitably anonymised form, or to link study-collected data or dis-
ease register data with CPRD and HES data. HES is a data warehouse containing
details of all admissions, outpatient appointments and A&E attendances at NHS
hospitals in England, collected during a patient's time at hospital and is submitted
to allow hospitals to be paid for the care they deliver. The use of general medical
or administrative data sources must be approached with caution, however, since its
primary purpose is not research but administration and the needs for accuracy may
diﬀer in the details between these two purposes. For this reason, any study using
these kinds of data needs to include a practitioner who can give appropriate insight
into the likely accuracy of the variables, data quality control and reasons for missing
data. The UK's national health service puts it in a unique position with respect to
the possibility of unselected medical data, but it should be remembered that CPRD
and HES data is observational, and the usual cautions with respect to bias in obser-
vational studies apply (Hammer et al. [2009]).
The increasing adoption of core outcome measures in eﬀectiveness trials
(COMET) is making it easier to combine the results of several trials in a speciﬁc dis-
ease group, since the agreed measures are reported alongside the researchers' other
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outcomes. The repository above can take advantage of the fact that standard out-
come measures have been proposed for low back pain research (Dayo et al. [1988]),
speciﬁcally: bothersomeness or severity and frequency of LBP; RMQ or Oswestry
Disability questionnaire (Roland and Fairbank [2000], Maughan and Lewis [2010]);
SF-12 or EuroQoL; days of work absenteeism, cut down activities and bed rest; and
a single question on overall satisfaction. However, the ability to undertake sub-group
analysis on such data may not be straightforward, and the cautions issued for sub-
group analysis in Cochrane review meta-analyses should be heeded (Higgins and
Green [2011]). There may not be suﬃcient detail given in diﬀering studies to be
certain that the patients truly belong in the same sub-group, which may bias the
analysis. It is important to consider whether the diﬀerences between sub-groups are
clinically plausible, are supported by other evidence, or support diﬀerent recommen-
dations.
The Low Back Pain Repository project to collect anonymised data of therapist-
delivered intervention for low back pain, currently has more than 9,000 cases in
the repository and the aim is to reach 10,000. One challenge here is that, despite
standard outcome measures having been proposed for low back pain research, even
when the same or similar patient characteristics and outcomes were measured, the
instruments for measuring them are not all the same, and very few measure trou-
blesomeness. The repository divides the measures into domains, and some work to
understand how these individual measures relate to each other will be needed. It
will be interesting to discover how troublesomeness is related to the other measures.
If it proves possible to model a proxy to troublesomeness, it will be possible vali-
date these result on trials with troublesomeness recorded and also on these proxy
outcomes. In addition not all interventions have been the same, so uncovering the
similarity and diﬀerences of patient responses to disparate interventions may be chal-
lenging. Another challenge is the heterogeneity in the follow-up times and how these
might be robustly rescaled to match. Since the data is anonymised, there is no way
to know whether the same individual is represented multiple times in diﬀerent trials,
and to date the age distribution has not matched that in the population at large.
Nevertheless, there is signiﬁcant opportunity for validating a classiﬁcation approach
in such a large database.
The burden of data collection on both study participants and researchers can
have an eﬀect of the rates of missingness, so it may be better to collect those vari-
ables known to be informative and make eﬀort to avoid missing data, than to try to
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collect everything and risk much missingness. Exploration of the repository or other
data sets present an opportunity to reveal what the minimal eﬀective data collection
would be to inform future research.
Research into a classiﬁcation approach to tailoring interventions to patients
with low back pain using LCA would be aided by a more extensive data set. Method-
ological advances which allow multiple imputation and robust pooling for non-linear
models would like LCA and ANN would help to make best use of the relatively small
data sets which are able to be collected during back pain intervention trials.
7.8.2 Basingstoke & Alton cardiac rehabilitation
Currently there is not a core outcome set in place for cardiac arrest clinical trials but
there is a COMET initiative underway to rank the importance of potential outcome
measures with the use of a Delphi process for all key stakeholder groups and to host
a consensus meeting involving all key stakeholders to ﬁnalise a core outcome set
(Collaboration [Accessed 25/05/2013]). Another source of data are disease registers.
There is an adult cardiac surgery register (Bridgewater et al. [2010]), but not all
patients who have a cardiac event or procedure have surgery. The purpose of the
cardiac register is to measure the quality of care of adult cardiac surgery in the UK
and provide information for quality improvement and research, so it may nor be ideal
for investigation into long-term survival for a more general population of patients
who have had a cardiac event or procedure.
For the ANN survival analysis, Bayesian methods for learning could be ap-
plied as they have been in other studies. Deﬁning a suitable prior may reveal more
detail, especially since a Bayesian approach might help overcome some of the limi-
tations of a small data set (Eleuteri et al. [2007b], Taktak et al. [2008]). This ANN
analysis has relied on identifying prognostic factors using the Cox model as in Joshi
et al. [2005], but variable selection can be done using the ANN (Bourdès et al. [2007]),
and in Biglarian et al. [2010] ANNs were compared to a Weibull model for deter-
mining prognostic factors in gastric cancer patients. The normalised importance
was the measure of signiﬁcance for the ANN and the p-value for the Weibull model.
The markers were broadly the same, but order of signiﬁcance was diﬀerent. The
performance as measured by correct prediction was superior in the ANN, but both
models were good (≥ 74% for death, survival and total). In the work of Eleuteri &
Taktak, automatic relevance determination was used, a Bayesian method described
in Bishop [1996] capable of determining the relative importance of input variables,
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and allowing the inclusion of a large number of inputs without fear of overﬁtting
(MacKay [1994]). It is also possible to assess the saliency of each weight by setting
to zero and examining the change in the cost function. A number of feature-salience
ranking techniques are discussed in Wang et al. [2000].
Development of good methods for interpreting ANNs could make them far
more useful: a common problem is that users, and particularly clinicians, are quite
reasonably reluctant to trust important decisions to systems they do not understand
(Plate et al. [2000]). Illustrating with a data set on squamous-cell lung cancer, Plate
et al. showed that plotting the eﬀect on the output of a particular input variable
for some selection of points in the input space can reveal which variables contribute
to the output and even indicate interactions. There have been attempts to interpret
the output of an ANN using rule extraction from the trained network, and there
is a survey of these methods in Saad and WunschII [2007]. In addition, the ROC
framework has been extended to evaluate performance of time-to-event data and a
framework developed to represent the operation of ANNs as low-order Boolean rules
that can be checked against domain expert knowledge (Lisboa et al. [2007])
It has recently been shown that another form of machine learning, support vector
machines (SVM), can be adapted to perform survival analysis (Lama et al. [2011]).
The basic SVM is a classiﬁcation machine, but relevance vector machines (RVM)
is an extension with a Bayesian learning algorithm providing posterior probabilistic
outputs. Using a partial logistic framework, Lama et al. used SVMs to analyse data
from a head and neck cancer trial.
Missing data is often a challenge in real-world applications. In an ANN-based
decision support system, missing values in a key variable were substituted using the
mean value, a random value, nearest neighbour or a neural network estimate and were
compared to omitting the variable in training the decision support ANN (Pesonen
et al. [1998]). The imputation methods gave broadly similar accuracy and omitting
the variable from the input of the decision support ANN also gave acceptable results.
Machine learning, including ANNs, can be used as techniques for providing imputed
values before analysis (Jerez et al. [2010]).
Research into long-term survival following a cardiac event or procedure could
be extended by using larger data sets and by extending the ANN approach into a
Bayesian framework. Visualisation and interpretability of outputs is vital in order
to make non-linear models acceptable for use in health care settings, especially if
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used in decision support for treatment choices.
7.9 Summary
In the case of patients with non-speciﬁc low back pain, a cognitive behavioural ap-
proach was previously found to be eﬀective on average and cost eﬀective. The work
in this thesis has shown that it is possible to use the patient characteristics that the
intervention was designed to tackle to divide the patient cohort into classes. There
is some evidence that there is a diﬀerential response to the intervention, although
the evidence here is not robust. However, the ability of these methods to pick out
the same eﬀect modiﬁers as independent work on the same data set gives some ev-
idence that the methods are ﬁnding true eﬀects. One avenue of conﬁrmatory work
could be the use of the back pain repository to test out the hypothesis that classes
of patients can be identiﬁed such that class membership is associated with diﬀering
outcomes following a cognitive behavioural approach. The same methodology could
be used to evaluate the division of patients into classes and investigate association
with outcome for other interventions.
Artiﬁcial neural networks have been applied to predicting outcomes based on the
same characteristics that the cognitive behavioural intervention was designed to
tackle. Compared to a logistic regression on these variables, and compared to a
logistic regression using class membership based on these variables, predictions from
the ANN were superior. The same methodology could be used to evaluate the likely
response of patients to other interventions, and move towards a tailoring of inter-
ventions for patients that may increase the rate of recovery from ﬁrst-treatments by
distinguishing which of a range of treatments is most likely to be eﬀective for a given
individual.
In the case of patients recovering from a cardiac event or procedure, the standard sur-
vival analysis has shown that ﬁtness is an invaluable prognostic indicator for both
cardiovascular and all-cause mortality. Furthermore, when ﬁtness is measured as
V O2max, then BMI is no longer statistically signiﬁcant as a prognostic factor. The
fact that BMI ceased to be a signiﬁcant predictor of prognosis when ﬁtness was mea-
sured in cardiac rehabilitation has important implications for other areas of medicine
where BMI is a prognostic factor. It is important that proper distinction is made
between correlated variables like BMI and ﬁtness to ensure that patients are given
correct advice. If prognostic value ascribed to BMI is actually the eﬀect of ﬁtness,
but this was not measured, it may go some way to explaining the obesity paradoxes
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being seen in (Ryan [2005], von Haehling et al. [2011]), as people attempting to lose
weight typically increase their activity leading to an improvement in ﬁtness, inde-
pendent of any weight loss. In future work, whenever BMI and hip to waist ratio
are measured, ﬁtness should also be measured so that the correct factors can be
identiﬁed and appropriate health advice can be given and optimal interventions may
be designed.
An ANN has been successfully used to model survival in this cardiovascular re-
habilitation cohort. The predicted survival by this method was a good ﬁt to the
Kaplan-Meier estimate, and more ﬂexible than the Cox model ﬁt. The hazards over
time for individual covariates have been explored (as in Lisboa et al. [2009]) giving
rise to testable hypotheses. These results suggest that the eﬀect on the hazard of
ACE inhibitors is modiﬁed by Statins and that the response of unﬁt patients over
the age of 70 years is diﬀerent from their ﬁtter counterparts in the age range 60-69
years. Extensions to this work would ideally include a larger data set where each
of the sets of variable combinations was adequately represented, particularly women
and the age groups under 60 years about which the ANN approach can say little.
In addition more detail may allow the testing of the hypotheses about interactions
between variables. A Bayesian approach could be taken and variable selection could
be performed within the ANN framework instead of adopting the variables selected
in the optimal Cox model. Other machine learning techniques, such as radial basis
function networks could be explored.
In the following chapter, conclusions are drawn on the value of using non-
linear models to explore complex health care data sets.
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Chapter 8
Conclusion
It is well-established that health care and health itself are complex systems and they
are therefore expected to behave in a non-linear manner. Many of the conventional
models used for health care data are linear. The aim of this research was to explore
whether using non-linear models could better model health care and so capture the
information contained in health care data sets. In order to achieve this goal, this
research compared linear models with non-linear models for two health care data
sets of complex interventions. This research has attempted to contribute to an in-
crease in understanding of the complex interaction within people, within complex
interventions and between people and the interventions, particularly in pursuit of
decision support in tailoring interventions to patients and generation of hypotheses.
Latent class analysis was able to identify classes of patients with similar char-
acteristics to each other and these classes were related to the patients response to a
complex intervention for low back pain. It was not possible to identify with certainty
the speciﬁc responses (positive or negative) of particular classes, which limited the
use of the classiﬁcation for tailoring interventions to patients. Tailoring decisions
were best supported by the use of an artiﬁcial neural network, since its ability to
predict likely outcome for an individual was superior to the other models investi-
gated. The ability of these models to inform policy on the allocation of treatments
for low back pain was limited by the modest accuracy and missing data. Neverthe-
less, it was demonstrated that this approach has potential, and that the non-linear
models oﬀered more accurate predictions than the linear model.
After a cardiac event or procedure cardiovascular mortality in the long-term
is predicted by age, sex, ﬁtness, secondary prevention medications and speciﬁc diag-
nosis of cardiac event or procedure. All-cause survival in this population is predicted
206
by these same variable with the addition of co-morbidity and systolic blood pressure.
There was a diﬀerent survival time for those who completed and did not complete
the rehabilitation programme. For those who did complete the rehabilitation, ﬁtness
gained during the programme predicted increased survival times, and ﬁtness was a
more signiﬁcant predictor of survival than BMI. using the same explanatory vari-
ables, the non-linear artiﬁcial neural network model was able to predict the survival
probability as well as the linear model. The non-linear model of hazard rate gave
rise to a number of hypotheses about interactions between covariates which may
aﬀect, which were nor obtainable from the linear model. These models are not yet
suﬃciently robust to inform policy, but if visualization of the model outputs was
developed and the hypotheses generated were tested, then these models could be
used. The non-linear model oﬀered new hypotheses that are pertinent to tailoring
interventions to patients using phenotype, rather than genotype.
The conclusion drawn is that non-linear models are useful in the analysis of
complex health care data sets because of their ability to capture some of the com-
plexity of the data that cannot be captured by linear models.
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9.2 Diagnostic plots
9.2.1 Survival models with imputed data
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9.2.2 Plots of the multiply imputed variable distributions
For key variables with substantial proportion of missing data, the distributions of
the observed and imputed values are shown in ﬁgures 9.1 to 9.12.
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Figure 9.1: Distribution of observed and imputed values for weight at baseline for the cardiovas-
cular rehabilitation cohort.
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Figure 9.2: Distribution of observed and imputed values for weight at graduation for the cardio-
vascular rehabilitation cohort.
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Figure 9.3: Distribution of observed and imputed values for systolic blood pressure at baseline
for the cardiovascular rehabilitation cohort.
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Figure 9.4: Distribution of observed and imputed values for systolic blood pressure at graduation
for the cardiovascular rehabilitation cohort.
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Figure 9.5: Distribution of observed and imputed values for ﬁtness category at graduation for
the cardiovascular rehabilitation cohort.
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Figure 9.6: Distribution of observed and imputed values for anxiety at graduation for the cardio-
vascular rehabilitation cohort.
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Figure 9.7: Distribution of observed and imputed values for aspirin prescription at graduation
for the cardiovascular rehabilitation cohort.
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Figure 9.8: Distribution of observed and imputed values for ACE inhibitor prescription at grad-
uation for the cardiovascular rehabilitation cohort.
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Figure 9.9: Distribution of observed and imputed values for beta blocker prescription at gradua-
tion for the cardiovascular rehabilitation cohort.
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Figure 9.10: Distribution of observed and imputed values for statin prescription for the cardio-
vascular rehabilitation cohort.
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Figure 9.11: Distribution of observed and imputed values for deprivation at baseline for the
cardiovascular rehabilitation cohort.
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Figure 9.12: Distribution of observed and imputed values for occupation at baseline for the
cardiovascular rehabilitation cohort.
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9.2.3 Diagnostic plots for the proportional hazards assumption
These are plots of the Schoenfeld residuals versus log(time) for each of the predictors
in the model including a lowess smoothing curve. See page 80 for an introduction.
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Figure 9.13: Schoenfeld residuals versus log(time)for ACE inhibitor, Aspirin and Statin prescrip-
tions.
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Figure 9.14: Schoenfeld residuals versus log(time). Diagnosis 1 is myocardial infarction, 2 is
coronary artery bypass graft, 3 is percutaneous coronary intervention, 4 is angina, 8 is myocardial
infarction and percutaneous coronary intervention and 6 is other cardiac diagnoses.
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Figure 9.15: Schoenfeld residuals versus log(time). Age 1 is under 50 years, 2 is 50-59, 3 is 60-69
and 4 is 70 years and over. Sex 2 is female and ﬁtness at baseline 1 is high, 2 is mid and 3 is low.
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